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Prostate cancer is the second most frequent cancer diagnosis in the male population 
worldwide, with 1.2 million new cases in 2018 1. Although it has a high incidence rate, 
it does not have the highest mortality rate: the overall 5-year survival rate of prostate 
cancer is 90% 2. In many cases the disease progresses very slowly; patients with prostate 
cancer might not need treatment or can benefit from a watchful waiting policy. In the 
subgroup of patients with metastases, the 5-year survival rate, however, is significantly 
lower: 50% 2. This indicates the need to characterize and stage the disease accurately, 
as this is paramount for determining a treatment strategy: underestimating the extent 
or aggressiveness of prostate cancer will lead to treatment delay, whereas the opposite 
will result in overtreatment, both which reduce patients’ quality of life and incur high 
costs on the healthcare system. Moreover, there is a trend to perform active-surveillance 
in patients with low-aggressive prostate cancer 3,4, which requires disease monitoring, 
preferably with non-invasive tools.
Figure 1: Side view of the prostate and surrounding anatomy. The prostate is a small organ that is part 
of the male reproductive system. It is an exocrine gland, located at the base of the bladder, that produces 
and stores prostatic fluid that is used to improve the mobility and survival of spermatozoa during and 
after ejaculation 5. Source: https://www.davidlaub.com/prostate-cancer-screening-santa-barbara-urologists 
Traditionally, prostate cancer is diagnosed and characterized using a digital rectal exam 
(DRE) and a blood test for prostate-specific antigen (PSA), followed by a transrectal 
ultrasound (TRUS)-guided biopsy. Unfortunately, the DRE has a low sensitivity, the 
PSA test has a high false positive rate and TRUS-guided biopsies suffer from sampling 
errors. Moreover, these tests provide no reliable method for evaluating the relation 
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between the potential cancer lesion and surrounding tissues. These techniques lead to 
over- and underestimation of disease aggressiveness and extent and result in a suboptimal 
treatment plan. Furthermore, using these tools for active monitoring requires repeated 
use of invasive TRUS-guided biopsies.
Next to assessing the local disease, metastatic spread of the disease to other organs such 
as lymph nodes needs to be evaluated. Metastases to regional lymph nodes are a strong 
indicator for disease progression and it is crucial to assess them when determining the 
correct treatment strategy 6. In current clinical practice, regional lymph node staging in 
prostate cancer is performed using a pelvic lymph node dissection (PLND). During this 
procedure, the surgeon removes the pelvic lymph nodes after which they are evaluated 
by the pathologist. Although a PLND yields definitive results if metastatic lymph nodes 
are found, not necessarily all lymph nodes are removed. Thus, a negative PLND does not 
necessarily exclude lymph node metastases. Furthermore, a PLND is invasive with a risk 
for complications such as e.g. lymphoceles. Although the PLND also removes potential 
lymph node metastases, its actual therapeutic benefit is debatable 7. The procedure 
is performed if the risk of regional metastases, according to clinical nomograms 8, is 
greater than a certain threshold. This risk threshold is often chosen rather defensively, 
in the order of 5%. Many patients therefore undergo a negative PLND. Given the high 
number of PLNDs performed and their questionable therapeutic effect, a non-invasive 
lymph node assessment would be preferable.
In the past two decades new methods were investigated for more accurate and non-
invasive local and regional staging of prostate cancer. One of these promising techniques 
is magnetic resonance imaging (MRI).
Local staging and characterization using MRI
MRI can obtain anatomical as well as functional and vascular information of the 
prostate non-invasively and is clinically performed using 1.5 or 3 Tesla MRI systems. 
To assess the local prostate, a multi-parametric MRI protocol, including anatomical 
T2-weighted (T2W) imaging, diffusion weighted imaging (DWI) and dynamic contrast 
enhanced (DCE) imaging is used 9. The risk of the presence of significant prostate 
cancer is evaluated using a standardized reporting system (PI-RADS v2 10). MRI is 
nowadays frequently used for prostate cancer detection, for example in persisting 
suspicion for prostate cancer after negative TRUS-guided biopsies, or to detect the 
presence of prostate cancer prior to performing a TRUS-guided or MR-targeted biopsy 




Figure 2: Multiparametric MRI of the prostate showing the T2-weighted imaging (a), apparent diffusion 
coefficient (ADC) map (b) and dynamic contrast enhanced imaging ktrans-map (c). On the T2 weighted 
image, the prostate is indicated with a white line and the border of the cancer lesion is indicated with 
a red line. The lesion (left of the red border) shows a lower signal intensity than the healthy part of the 
prostate. On the ADC map the prostate cancer lesion is hypo-intense (red arrow), due to reduced mobility 
of water. Dynamic contrast enhanced imaging of the cancer lesion shows increased tumor vascularization, 
as is indicated by the red color on the DCE ktrans-map.
Several studies have shown how MRI can predict or monitor its aggressiveness, i.e. 
discriminate between low-grade (Grade Group < 2) and higher-grade (Grade Group ≥ 
2) prostate cancer 12-14. Next to T2W, DWI and DCE imaging, many of these studies 
used proton MR spectroscopic imaging (1H-MRSI) in their MR protocols. 1H-MRSI 
probes the relative concentrations of several small molecules that are involved in tissue 
metabolism, also called metabolites. It has been shown that metabolite ratios such as 
total choline (tCho) over creatine (Cre) + spermine (Spm) or Cho over citrate (Cit) are 
also able to predict prostate cancer aggressiveness 13,15. 1H-MRSI may be of particular 
value in the transition zone of the prostate, where cancer lesions are often difficult to 
assess 13. 1H-MRSI has unfortunately several limitations that limit its use in the clinic: 
it is for example constrained by the signal to noise ratio (SNR) and hampered by a long 
acquisition times, particularly at high spatial resolutions. To ensure clinically acceptable 
measurement times, spatial resolution is often limited, which results in large voxel sizes 
and partial volume effects. Even then, spectroscopic imaging of the prostate easily takes 
5 - 10 minutes.
A potential advancement to improve MRSI of the prostate, would be to reduce its 
inflexible and long acquisition times by implementing a more efficient sampling scheme. 
Additionally, it would be valuable to explore 1H-MRSI at a higher magnetic field strength 
by using a 7 Tesla (7T) MRI scanner. This can offer a substantial increase in SNR that 
can be used to enhance spatial and spectral resolution. Moreover, conventional MR 
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imaging can also benefit from the SNR increase at 7T, as it can be used to increase spatial 
resolution and thus potentially improve tumor delineation, localization and detection. 
7 Tesla can also be used to explore new biomarkers using e.g. phosphorus MR 
spectroscopic imaging (31P-MRSI). Work by Lagemaat et al. shows anecdotal evidence 
of elevated levels of glycerophosphocholine (GPC) and glycerophosphoethanolamine 
(GPE) in aggressive cancer lesions 16. These metabolites might be potential biomarkers 
for prostate cancer aggressiveness. Moreover, as GPC and GPE are involved in the 
phospholipid metabolism, measuring their MR signals in vivo might improve our 
understanding of tumor biology. Ultimately, it would be interesting to investigate the 
relation between 31P- and 1H-MRSI metabolite signals and functional MRI parameters 
in one comprehensive prostate MR examination.
Before any of these technical improvements can be implemented, dedicated coil setups, 
MR sequences and protocols need to be developed and tested. 
Regional staging of prostate cancer
Next to imaging the local prostate, MRI is used to evaluate the presence of regional lymph 
node metastases. Regional lymph node metastases can be detected on conventional T1-
weighted MRI scans of the pelvis 17, particularly in advanced stages of the disease when 
metastases are large. However, when the disease is in an earlier stage and lymph node 
metastases are still small, the sensitivity of these methods is significantly lower. If nodal 
size and shape are used as the measure for malignancy, only round lymph nodes larger 
than 8 mm or oval lymph nodes larger than 10 mm are considered to be malignant. 
Smaller lymph node metastases are therefore missed, resulting in low sensitivity 17,18. 
The sensitivity for detecting small lymph node metastases can be improved with the 
use of an ultrasmall superparamagnetic iron oxide (USPIO) contrast agent 17,19,20. In 
short, intravenously administered USPIOs accumulate in healthy lymph nodes, strongly 
attenuating the MR signal in T2
*-weighted imaging. Metastases often show little or no 
uptake of USPIO and remain high in signal intensity, which yields additional functional 
information that can be used to discriminate healthy and malignant lymph nodes.
USPIO-enhanced MRI has shown a sensitivity of 82% and specificity of 93% for 
detecting lymph node metastases on a per-patient base in a large clinical study 17. 




dissection: when no or many lymph node metastases are found on USPIO-enhanced 
MRI, a pelvic lymph node dissection might be unnecessary. 
Despite being able to detect lymph node metastases smaller than 8 mm, studies have 
shown that the sensitivity of USPIO-enhanced MRI for lymph nodes < 5 mm is only 
42% 18. Many lymph node metastases are, however, smaller than this 18, thus they have 
a high probability of being be missed. Improving the spatial resolution of USPIO-
enhanced MRI, for example with 7 Tesla MRI, might enable visualization of very 
small lymph node metastases (< 5 mm). MRI at 7T of a large body part like the pelvis 
unfortunately poses particular technical challenges at this field strength. One of the 
most pressing issues at 7T is the inhomogeneity of RF excitation fields, which causes 
signal voids that are detrimental to clinical imaging.
Figure 3: MRI of a coronal view of the pelvis with conventional MRI (a) and USPIO-enhanced MRI (b). 
The lymph node annotated with a white arrow has a short axis of approximately 6 mm. On the USPIO-
enhanced MRI this lymph node is hyperintense and therefore shows no USPIO uptake, making it very 
suspicious for a lymph node metastasis.
AIM AND OUTLINE OF THIS THESIS
The technical advances that are discussed in the previous sections could improve the value 
of MRI in characterizing and staging prostate cancer. These techniques, however, need to 
be developed and tested in an experimental setting, before they can be applied in clinical 
studies. The aim of this thesis is to develop and evaluate the feasibility of novel MRI 
techniques with a potential for improving local and nodal staging and characterization 
of prostate cancer. In the first part of this thesis, the feasibility of novel techniques to 
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improve characterization and staging of local prostate cancer are examined. The second 
part focuses on technical MR advances with respect to regional lymph node staging. 
In chapter 2, the theory of the MRI techniques this thesis focusses on, is explained. 
These are: spectroscopic imaging, 7 Tesla MRI and USPIO-enhanced MRI. But first 
some basics items of magnetic resonance imaging will be introduced.
Local staging and characterization of prostate cancer
As explained in the introduction, 1H spectroscopy has shown to be of value in assessing 
prostate cancer, but is hampered by long acquisition times. In chapter 3 we use a spiral 
acquisition scheme to reduce the scanning time of 1H spectroscopic imaging while 
increasing its spatial resolution. This may enable the detection of smaller cancer lesions, 
while potentially performing spectroscopic imaging of the complete prostate within 
clinically acceptable measurement times.
Chapter 4 introduces a multi-parametric prostate MR protocol for 7 Tesla and evaluates 
its advantages and technical challenges in a small patient study. The measurement setup 
in this study uses an external body array for 1H transmit and an endorectal radiofrequency 
coil to enhance the 1H receive sensitivity locally in the prostate. Using this setup, a multi-
parametric MR protocol including T2W imaging, DWI and 
1H-MRSI is performed.
The transition to 7 Tesla MRI also provides opportunities with respect to 31P 
spectroscopy of the prostate. In chapter 5 a combined 1H and 31P endorectal coil is 
presented in combination with an external body array for 1H transmit, which allows the 
acquisition of multi-parametric and metabolic imaging of the prostate at 7 Tesla within 
one measurement session.
Regional staging of prostate cancer
Using 7 Tesla potentially allows detection and assessment with greater detail of small 
(< 5 mm) lymph nodes. To perform pelvic imaging at 7T several challenges need to be 
overcome, such as the inhomogeneous excitation fields. In chapter 6 we deal with these 
challenges by using the TIAMO (time interleaved acquisition of modes) technique and 
evaluate the method in several volunteers. 
Due to the iron-sensitive gradient echo sequence that is used, the method lends itself 




patients with rectal and prostate cancer to demonstrate the technical feasibility of 
USPIO-enhanced imaging at 7 Tesla.
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The theory within this introduction is mostly based on the literature by de Graaf and 
Haacke 1,2. Magnetic resonance imaging (MRI) makes use of the physical phenomenon 
called Nuclear Magnetic Resonance (NMR). This phenomenon arises due to the fact 
that an atomic nucleus with a net quantum mechanical spin will exhibit a motion called 
precession when exposed to an external magnetic field. This precession occurs due to the 
torque exerted by the external magnetic field on the magnetic moment (μ) of a particle 
with net quantum mechanical spin. The frequency ω, also called Larmor frequency, at 
which this precession occurs is: 
ω = –γB0
where γ is the gyromagnetic ratio of the specific nucleus and B0 is the external magnetic 
field strength. 
Not all nuclei have a net quantum mechanical spin and can exhibit magnetic resonance, 
but the naturally abundant 1H isotope of hydrogen is one of the nuclei that does. This 
enables us to use this technique for imaging biological systems, such as the human body. 
Classically, the individual magnetic moments in an ensemble of nuclei are randomly 
oriented in space when there is no external magnetic field. When a magnetic field B0 is 
present, these magnetic moments will have a tendency to align with the magnetic field, 
resulting in a net magnetization parallel to the magnetic field (Figure 1). 
Figure 1: Classical physics depiction of nuclear spin (a). The nucleus is depicted as a round charge that 
rotates around its axis, representing its spin and magnetic moment (μ). When exposed to the magnetic field 
(B0), a torque is exerted due to which the magnetic moment will start precessing around the magnetic field 
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axis with the Larmor frequency ω. (b) depicts the tendency of magnetic moments to align with the external 
magnetic field, resulting in a net magnetization vector (large grey arrow). Reprinted from 3 with permission 
from John Wiley and Sons.




with ћ the Planck constant, kb the Boltzmann constant and T the temperature. This 
magnetization builds up parallel to the magnetic field and is called longitudinal 
magnetization. For 1H at room temperature and 3 Tesla, only one in 100,000 particles 
effectively contributes to the signal. In an in vivo situation, the only experimental 
parameter that we can control to increase the equilibrium magnetization is the static 
magnetic field strength B0.
Figure 2: The longitudinal magnetization cannot be measured as it has no net rotating component. By 
using an RF pulse the magnetization M0 can be flipped 90°, into the transverse plane where it will rotate 
due to being perpendicular to the main magnetic field
According to basic electromagnetic theory, rotating magnets induce a current in an 
electric conductor. However, because the precession of the collection of hydrogen nuclei 
is incoherent, they do not produce an electromagnetic signal in an equilibrium state. 
To be able to measure the signal, a radiofrequency (RF) pulse is applied with an RF 




in net magnetization that is perpendicular to the main magnetic field (Figure 2). The 
magnetic field of the RF pulse is also called the B1 field. Immediately after the RF pulse, 
the magnetization is oriented in the transverse plane and precesses around the main 
magnetic field axis. Because the net magnetization is now rotating it induces a current 
in an RF coil, such that the macroscopic nuclear magnetization that is produced by the 
main magnetic field can be measured. 
MAGNETIC RESONANCE IMAGING
T1 and T2 relaxation
When performing an NMR experiment there are two important time constants. The 
first is the T1 relaxation time. If a sample has no longitudinal magnetization and is 
suddenly exposed to a magnetic field B0, the longitudinal magnetization Mz will 
increase exponentially over time t with a time factor T1 until it reaches the equilibrium 
magnetization M0:
Mz (t) = M0 �1- e      �
This T1 is strongly dependent on several factors, such as the magnetic field strength and 
physical and chemical characteristics. At 3 Tesla, the protons in prostate tissue have a T1 
of approximately 1.6 s, whereas the T1 of protons in subcutaneous fat tissue is around 
0.4 s 4,5. 
The other important time constant is the T2 relaxation time. After an excitation pulse, the 
magnetization precesses in the transverse plane. Due to physical interactions this transverse 
magnetization M� will decrease exponentially over time with a time constant T2:
M�(t) = M�,0e 
where M�,0 is the transverse magnetization immediately after the RF pulse. This T2 
relaxation is irreversible. Next to this irreversible decay of magnetization in the transverse 
plane, there is also reversible decay that is caused by magnetic field inhomogeneities. 
















T₂'  is the relaxation rate due to magnetic field inhomogeneities. In practical 
MRI situations, the T2
’ is much shorter than the T2, such that the magnetic field 
inhomogeneities dominate the T2
* time. 
T2
’ relaxation is called reversible because the phase effects of magnetic field inhomogeneities 
can be reversed using an RF refocusing pulse. This RF pulse is used to effectuate a spin echo. In 
general, spin echo sequences are used to generate T2-weighted images. T2
*-weighted images 
are often generated with gradient-echo sequences, which are explained in the next section. 
T1, T2 and T2
* relaxation are the main mechanisms to generate contrast in an MRI 
image.
K-space
An MR image depicts the distribution of magnetization over space. To form such an 
image, MR signals are measured with an RF coil and are then allocated within space. To 
do this, the gradient coils within the MRI scanner are used. These magnets can be used 
to produce magnetic fields that vary linearly with location. In the presence of gradient 
pulses, magnetization will precess at a location dependent frequency:
ω (x, t) = –γ(B0 + G (t) � x )
where G(t) is the magnetic field gradient introduced by the gradient coils and x is 
the location. For simplicity, only the 1D case will be described in this section. For a 
magnetization distribution M0(x), the following NMR signal s(t) will be produced at 
location x:
i∫0
t ω(x,t' )dt' –iγ (B0 t+x � ∫0
t G(t' )dt's (x,t) ∝ M0(x)e = M0(x)e
By looking at the frequency difference with respect to ω0 = –γB0  this can be simplified 
to:





This is just the signal from location x, but we receive the accumulated signal from every 
location x. After substituting 
k = G(t' )dt'γ2π �₀
t
the total signal can be written as:
s (k) ∝    M0(x)e          dx� –2πikx 
This corresponds to the Fourier transform of M0(x) with respect to k. The image M0(x) 
can therefore be reconstructed by taking the inverse Fourier transform of the measured 
signal s(k) . The abstract space used to represent the measured signal s(k) is also called 
k-space. 
Measurements are taken as discrete samples in k-space and therefore need to satisfy 
the Nyquist theorem, which puts the following requirement on the k-space sampling 
density: ∆k = 1FOV . FOV is the field of view that can be imaged without suffering from 
aliasing. For an MRI image resolution of Nx x Nγ pixels, also Nx x Nγ  measurements 




. K-space is 




2 × FOVm�                   '                   �
for every spatial dimension m. 
Spiral k-space trajectory
The path through k-space along which the points are sampled is called the k-space 
trajectory and it has a major influence on measurement time. The equation that defines 
k depicted above shows that k can be varied by either varying the gradient strength or by 
varying the time during which a gradient is turned on. One of the most commonly used 
k-space trajectories is a line by line trajectory, which is explained in Figure 3. The total 
measurement time in the case of a line-by-line acquisition is Ny × Nz × TR, where Ny is 
the number of phase encoding steps in the y-direction, Nz is the number of partitions in 
the z-direction (in the case of 3D imaging) and TR is the repetition time. 
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The data in k-space can be filled with many different techniques and each of them 
has certain advantages and disadvantages. One of these techniques is a spiral k-space 
trajectory, with which a 2D plane in k-space can be sampled per repetition time instead 
of only a single line, by varying the x- and y-gradients in a predetermined way during 
acquisition (Figure 4). Spiral trajectories therefore are time efficient sampling schemes.
To avoid aliasing, spiral trajectories also need to satisfy the Nyquist criterion. The 
distance between adjacent spiral windings should therefore be smaller than or equal to:
∆k = 1
FOV
And to obtain a spatial resolution of FOV
N




By sampling the third spatial dimension with phase encoding, a 3D volume can be 
imaged. The total measurement time is then Ni × Nz × TR, where Ni is the number 
of interleaved spirals that are needed to fill k-space. Ni is generally much smaller than 
the number of phase encoding steps, which therefore results in a substantially lower 
measurement time than with a line-by-line trajectory.
The data acquired with a spiral sampling scheme is inherently oversampled in center and 
is sampled on a spiral coordinate system. To reconstruct the spiral sampled data into an 
image, the data is first compensated for inhomogeneous sampling density and gridded 
onto Cartesian coordinates. Afterwards, a regular inverse Fourier transform can be used 




Figure 3: K-space can be filled by using a line-by-line acquisition (A). A schematic MR-sequence to perform 
such an acquisition is shown in (D). First a slice selective excitation is performed to select the slice of 
interest. Then a gradient pulse over two axes brings the magnetization to the beginning of the k-space line 
(red). In the x-direction this gradient is the same for every acquisition and is called the dephasing gradient. 
The gradient pulses in the y-direction vary between repetitions to start at a different line in k-space. This 
technique is called phase encoding. For example, the first line in k-space is acquired after travelling to the 
top-left corner of k-space (with the red gradients) by turning on the gradient in the x-direction (green). 
During this gradient, which is also called the readout gradient, the signal is measured to fill k-space. Halfway 
during this gradient pulse, at the echo time (TE), the dephasing caused by the first gradient is exactly 
reversed. During this reversal, the signal rises again, which is why it is called a gradient echo. The second line 
in k-space is acquired after a new excitation pulse by performing the same sequence with a slightly weaker 
phase encode gradient in the y-direction (blue) and the same readout gradient (orange). The paths traversed 
in k-space by the gradients are depicted with similarly colored arrows in (A). (B) shows k-space of an actual 
MR-image. The actual image is obtained by performing an inverse Fourier transform of this data (C). For 
simplicity, the spoilers were left out of the sequence diagram.
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Figure 4: The spiral trajectory to sample a 2D plane in k-space is depicted (A). This spiral trajectory starts 
at the center and traverses inside-out. The k-space trajectory in this figure represents a trajectory with a 
constant distance between the windings. A schematic sequence with a spiral readout is depicted in (B). After 
the slice selective excitation pulse, the readout is started and the x- and y-gradients are modulated such that 
k-space is traversed in a spiral trajectory in an inside-out direction. This way, a complete 2D plane can be 
covered in one repetition.
Magnetic Resonance Imaging of the prostate
MRI of the prostate is normally performed with a multi-parametric MRI protocol, 
including the following three main sequences 6:
1.  T2-weighted imaging (T2W) features high resolution and soft tissue contrast which 
enables accurate assessment of prostate anatomy. The contrast is generated using 
a turbo spin echo (TSE) sequence, which bases its contrast on the use of multiple 
spin echoes. Prostate cancer lesions often show hypointense signal on T2W 
sequences.
2.  Diffusion weighted imaging visualizes the apparent diffusion of water molecules. A 
spin-echo echo planar imaging (EPI) sequence is sensitized for random molecular 
motion by applying a pair of strong gradient pulses before and after the refocusing 
pulse. With an EPI readout k-space is sampled line after line, but covering a 
complete 2D plane of k-space within one shot. Prostate cancer lesions generally 
have a high cell density that limits water motion. Diffusion in cancer tissue is 
therefore restricted in comparison with healthy tissue. The restrictions in water 
mobility within the labeling time between the two pulsed field gradients in MRI 
imaging is expressed using the apparent diffusion coefficient (ADC), which is 




3.  Dynamic contrast enhanced imaging uses an intravenous gadolinium-based contrast 
agent to study tissue vascularization, perfusion and capillary permeability. This is 
achieved by analyzing the signal of a series of contrast enhanced images at different 
points in time after the contrast administration. Prostate tumors usually show early 
signal enhancement and relatively fast signal wash-out after peak enhancement on 
a T1-weighted sequence in comparison with healthy tissue.
MAGNETIC RESONANCE SPECTROSCOPY
Next to imaging, an MRI machine can perform spectroscopy and also spectroscopic 
imaging. The frequency at which a nucleus precesses is proportional to the magnetic field 
strength by its specific gyromagnetic ratio. The magnetic field that a nucleus actually 
experiences is not exactly the same as the external field that is applied. When exposed 
to a magnetic field, the electrons in an atom or molecule shield the nuclei from the 
magnetic field. This shielding effect results in a small change of the precession frequency, 
which is called the chemical shift σ and is expressed in parts per million (ppm):
ω = –γ (1– σ) B0
Although this chemical shift is small, it is quite specific to the chemical compound. The 
chemical shift is defined with respect to a reference compound. For example, in in vivo 
1H spectroscopy water is assigned a chemical shift of 4.7 ppm, while lipids resonate 
at different frequencies, with the main peak resonating at 1.2 ppm. By measuring the 
intensity of the MR signal at different frequencies, a spectrum is formed, which can be 
used to determine the presence or relative concentration of different molecules. 
MR spectroscopy is often performed on 1H. Many small molecules involved in tissue 
metabolism, called metabolites, contain hydrogen atoms and can be detected using 
1H spectroscopy. Many metabolites are difficult to detect because they have a signal 
overlapping with that of water or lipids, which are several orders of magnitude higher 
in signal intensity. To solve this, various methods can be applied to suppress unwanted 
signals and select the signals of interest. One of these is water-suppression, where the 
water signal is saturated before performing the measurements. Another technique is 
volume selective excitation, in which three orthogonal slabs selectively excite and refocus 
the so-called volume of interest (VOI), producing an echo only from this volume. 
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The most common example of this is PRESS (Point REsolved SpectroScopy) volume 
excitation (Figure 6). 
Prostate spectroscopy
1H spectroscopy of the prostate (Figure 5) generally focuses on the detection of the 
metabolites citrate, choline, spermine and creatine:
• Citrate is an intermediate in the Krebs cycle, is accumulated in the luminal space of 
the prostate and is a major component of the ejaculatory fluid. Its role is not entirely 
understood, but it is believed to improve the motility of sperm cells. 
• The choline peak in 1H spectroscopy consists of several signal peaks of choline- 
containing compounds as explained in the section about 31P spectroscopy. Choline 
plays an important role in cell membrane synthesis and degradation. In malignant 
processes the membrane turnover is believed to be increased, which is reflected by 
elevated choline levels in cancer tissue. 
• Polyamines, of which 50 - 95% is spermine, are secreted by specialized ductal cells 
in the prostate 7 and play an important role in cell proliferation and differentiation 8. 
• Creatine and phosphocreatine play an important role in the energy metabolism 
of tissue, as phosphocreatine can act as a buffer to maintain constant ATP levels 
through the creatine-kinase reaction 9.
Figure 5: Example spectrum of the prostate (a) with the peaks corresponding to citrate (Cit @ 2.6 ppm), 
choline (Cho @ 3.2 ppm) and creatine and spermine (Cre+Spm @ 3.0 ppm). The spectroscopic imaging 
matrix of a PRESS sequence is depicted in (b), where we indicated the field of view (FOV) (yellow box 
with green lines indicating the voxels), VOI and saturation slabs (Sat). Saturation slabs are slabs in which 
the magnetization is saturated just before the excitation pulse. This way, the protons within these slabs will 




Figure 6: PRESS sequence diagram (a) showing one slice selective excitation pulse to select a slice in the 
x-direction and two slice-selective refocusing pulses to select slices in the y- and z-directions. The echo 
occurs TE/2 – τ after the last refocusing pulse. Spoiler gradients are not depicted. b) depicts the three 
orthogonal slabs selected by the excitation pulse and the two refocusing pulses.
To acquire 1H spectroscopy of the prostate, the PRESS sequence volume selection is 
often combined with water suppression, outer volume suppression and spectrally 
selective Mescher-Garwood (MEGA) pulses 10 to suppress water and lipid signals and 
to select only the metabolites of interest. There are several alternatives/modifications to 
PRESS volume selection. Two of these are used in this thesis: the semi-LASER sequence 




One of the issues with PRESS volume selection is its reliance on conventional refocusing 
RF pulses, which have a relatively low RF pulse bandwidth. This leads to large chemical 
shift displacement errors in the volume selection, which originate from the frequency 
differences between metabolites. These conventional RF pulses can be replaced by adiabatic 
RF pulses, which feature a substantially higher pulse bandwidth. Moreover, these pulses are 
less sensitive to B1 variations. The main disadvantage of these pulses is their high level of RF 
power deposition, which may lead to issues with specific absorption rate (SAR) safety levels. 
Because RF pulses heat tissue, this is one of the main safety concerns when performing an 
MRI scan. Furthermore, adiabatic pulses introduce a frequency offset dependent phase that 
can only be inverted by applying the same pulse twice. Every conventional refocusing pulse 
in the PRESS sequence therefore needs to be replaced by two adiabatic refocusing pulses 
(Figure 8). The SAR issues can be reduced substantially by using gradient modulation during 
the RF pulse to reduce the peak RF power, which is for example achieved by implementing 
gradient offset independent adiabaticity (GOIA) pulses 13.
Spectral spatial refocusing pulses
The conventional RF pulses in the PRESS technique select a volume in space and 
additional pulses (e.g. MEGA pulses) are applied to suppress unwanted spectral signals. 
Spectral-spatial pulses combine both these aspects by selecting a volume in space while 
simultaneously selecting a spectral region of interest (Figure 7). By reducing the number 
and the power of the RF pulses, the RF power deposition can be reduced considerably, 
which is of particular importance at higher field strengths.
Figure 7: Spectral-spatial refocusing pulses are selective in the spatial as well as the spectral domain. For 
prostate spectroscopy they can be tuned such that the metabolites of interest are selected in the spectral 
domain (A) and the volume of interest is selected in the spatial domain simultaneously (B). Lipids are 
therefore suppressed spectrally, but also spatially by selecting only prostate tissue. Reprinted from 12 with 





Spectroscopic data can be localized in space by using sampling techniques similar to 
those used in MR imaging. Conventionally, this is done by phase encoding in all spatial 
directions while sampling the spectral dimension during readout. This results in a total 
measurement time of Nx × Ny × Nz × TR. For Nx' Ny' Nz = 16 and TR = 1 s, the total 
measurement time would be > 1 hour. Several methods have been developed to decrease 
the acquisition time of MR spectroscopic imaging (MRSI); one of these is spiral 
MRSI. Instead of only sampling the spectral dimension during readout, spiral MRSI 
simultaneously samples the spectral dimension and two of the spatial dimensions. The 
third direction is sampled by applying phase encoding. The measurement time then 
becomes Ni × Nz × TR,  with Ni the number of spiral interleaves. This substantially 
reduces measurement time. See also Figure 8.
Figure 8: Schematic overview of a semi-LASER sequence with spiral readout. The excitation pulse is a 
conventional 90° RF pulse for slice selection in the z-direction. The selection in the x- and y-direction is 
performed with adiabatic refocusing pulses. Every adiabatic pulse is applied twice and is combined with 
modulating gradients (GOIA pulses) to reduce SAR. At the echo time (TE) the readout starts with a 
spiral MRSI acquisition. To sample the spatial dimension, the gradients are modulated to traverse a spiral 
trajectory during readout. The same spiral trajectory is then repeated every time period ∆Ts to sample the 
spectral dimension as well. The spectral bandwidth achieved with this method is 1/ ∆Ts. The z-direction is 
sampled by performing phase encoding. Spoiler gradients are not depicted and the temporal axis is not to 
scale (RF pulses can take 4 or 5 ms, whereas ∆Ts are approximately 1 ms).
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Figure 9: Photo of an endorectal RF coil used for prostate MRI and spectroscopy. The balloon, containing 
an RF coil is inserted into the rectum of a patient in close proximity to the prostate. By inflating the balloon 
using a fluid (air would introduce susceptibility artifacts), the balloon is stabilized within the rectum. 
31P spectroscopy
Next to 1H, there are other nuclei that feature an NMR signal that can be measured 
in vivo. One of these is the natural abundant isotope of phosphorus, 31P. With a 
gyromagnetic ratio of 17.2 MHz/T, the magnetic moment of this nucleus precesses 
at a frequency of 120 MHz at 7T, which is similar to the frequency of 1H at 3T. The 
lower gyromagnetic ratio, in combination with the low number of phosphorus atoms 
in metabolites, make 31P MRSI SNR limited. 31P spectroscopy of the prostate within 
acceptable acquisition times is therefore only viable at higher field strengths and when 
using an endorectal coil (Figure 9). Metabolites of interest in the 31P spectrum are 
glycerophosphocholine (GPC), glycerophosphoethanolamine (GPE), phosphocholine 
(PC) and phosphoethanolamine (PE). Together with free choline, these metabolites play 
an important role in the cell membrane phospholipid metabolism. GPE, GPC, PE and 
PC are also present in the in vivo 1H spectrum, but all resonate at a similar frequency, 
such that they are part of the total choline peak and cannot be separated. 31P and 1H 
spectra therefore yield overlapping but also complementary information. An example 




Figure 10: 31P spectrum of a patient with prostate cancer, showing the spectral peaks of PE, PC, GPE and 
GPC. In addition, the peaks of inorganic phosphate (Pi), phosphocreatine (PCr) and one of the ATP peaks 
(γATP) are shown.
7 TESLA MRI
Magnetic resonance imaging at 7 Tesla
7 Tesla MRI machines are currently the commercially available clinical MRI scanners 
with the strongest main magnetic field. The main reason for increasing the magnetic 
field strength is the gain the intrinsic SNR, which is mainly used to perform imaging 
at a higher spatial resolution. Unfortunately, the higher magnetic field comes at a price. 
At 7T the Larmor frequency is 300 MHz, which introduces one pressing issue, as at 
this frequency the RF wavelength in tissue is only approximately 11 cm. This is smaller 
than anatomical structures in the human body, particularly in the abdomen, resulting 
in standing waves and interference effects of RF pulses that are transmitted into the 
body. RF pulses will therefore produce unpredictable and spatially dependent B1 fields, 
resulting in signal voids in the MRI images (Figure 11). These voids significantly impede 
the use of 7T for clinical purposes, and they need to be mitigated.  
The methods for correcting these signals voids that are used in this thesis are local B1 
shimming and time interleaved acquisition of modes (TIAMO) technique.
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Figure 11: 7 Tesla imaging of the prostate (marked with a white circle) when not correcting for B1 field 
inhomogeneities. White arrows indicate areas with clear signal voids. This is also the case for a small part 
of the prostate (white arrow marked by *): No signal is obtained from this part of the prostate, masking a 
possible cancer lesion.
Local B1 shimming
If the imaging volume is small, it often suffices to get a homogeneous B1 field locally. This 
can be achieved by using a multi-channel RF coil setup in which the individual coil channels 
have separate amplifiers and phase and amplitude modulation. By tuning the phase and 
amplitude settings of these individual coil channels, also called B1 shimming, the RF field 
can be optimized to obtain a locally homogeneous RF field, as shown in Figure 12.
Figure 12: An example measurement setup for prostate MRI at 7T: the 8 channel RF coil array is positioned 
around the patient. A transversal flip angle map is shown on which the prostate is annotated. The flip angle 
distribution over the body is very inhomogeneous with multiple areas of high and low flip angles. By tuning 
the phase and amplitude setting of the individual coil channels, the flip angle map can be optimized to get 





If a large volume needs to imaged, local B1 shimming often does not suffice. In this 
case TIAMO can be used, in which the same image is acquired with two different, but 
complementary, shim settings. The locations that show destructive interference in shim 
setting 1, show constructive interference in shim setting 2 and the other way around 
(Figure 13). The extra acquisition time to acquire every image twice, can be partially 
compensated by accelerating the acquisition using GRAPPA 14,15. 
Figure 13: In TIAMO, two images are acquired with two different shim settings, Shim 1 (a) and Shim 2 
(b). Both shims use different phase settings of the individual transmit coils (indicated by blocks) and show 
different signal intensities. Dark blue colors indicate low signal intensity, whereas yellow/red indicates high 
signal intensity. Shim 1 and shim 2 produce complementary images, which can be seen in the area marked 
with a white arrow. In shim 1 this area shows high signal intensity (green/yellow) and in shim 2 this area is 
low in signal intensity (dark blue). The area marked with a black arrow shows the opposite signal relation. 
In the combined image this signal (c) is averaged and shows up as a homogenous signal distribution at the 
center. The chosen phases are in this case the circularly polarized + (CP+) and the CP2+ phase settings.
Ultrasmall superparamagnetic iron oxide (USPIO) contrast agent
In this thesis ultrasmall superparamagnetic iron oxide (USPIO) particles are used to 
detect lymph node metastases 16. Their working mechanism is explained in Figure 14. 
USPIOs are superparamagnetic and therefore distort the magnetic field and cause a 
strong T2
*-effect. This effect can be exploited by using T2
*-weighted sequences, such as 
a gradient echo sequence, to detect the presence of USPIO particles. As healthy lymph 
node tissue takes up USPIOs, lymph nodes should show clear signal decay on a T2
*-
weighted sequence. Lymph node metastases, which do not take up USPIO contrast, 
should show little signal decay and can therefore be distinguished from normal lymph 
nodes. Figure 14E and F show an example of a lymph node with a metastasis.
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Figure 14: USPIO particles are injected intravenously, after which they slowly extravasate into interstitial 
space. Here they are taken up by macrophages (A). The macrophages transport these particles into lymph 
node tissue (B), but only into healthy lymph node tissue (C, D). An example image of a lymph node is 
shown before (E) and after (F) administration of an USPIO contrast agent. The bottom part of lymph node 
shows clear signal decay which indicates healthy lymph node tissue. The upper part (arrows), however, 
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Cartesian k-space sampling in 3D MRSI of the prostate limits the selection of voxel 
size and acquisition time. Therefore, large prostates are often scanned at reduced spatial 
resolutions to stay within clinically acceptable measurement times. Here we present 
a semi-localized adiabatic selective refocusing (sLASER) sequence with gradient-
modulated offset-independent adiabatic (GOIA) refocusing pulses and spiral k-space 
acquisition (GOIA-sLASER-Spiral) for fast prostate MRSI with enhanced resolution 
and extended matrix sizes.
Methods 
MR was performed at 3T with an endorectal receive coil. GOIA-sLASER-Spiral at TE = 
90 ms was compared to a PRESS with weighted, elliptical phase encoding at TE = 145 
ms using simulations and measurements of phantoms and patients (n = 9).
Results
GOIA-sLASER-Spiral acquisition allows prostate MR spectra to be obtained in ~5 min 
with a quality comparable to those acquired with a common Cartesian PRESS protocol 
in ~9 min, or at an enhanced spatial resolution showing more precise tissue allocation 
of metabolites. Extended FOVs and matrix sizes for large prostates are possible without 
compromising spatial resolution or measurement time. 
Conclusion
The flexibility of spiral sampling enables prostate MRSI with a wide range of resolutions 
and FOVs without undesirable increases in acquisition times as in Cartesian encoding. 
This approach is suitable for routine clinical exams of prostate metabolites.




Proton Magnetic Resonance Spectroscopic Imaging (MRSI) has diagnostic value in 
the detection of cancer in the prostate (PCa) and in determining its aggressiveness by 
assessing ratios of choline (Cho), polyamine (PA), creatine (Cr) and citrate (Cit) signals 
1–3. However, its routine clinical use is still hampered by some technical challenges, 
such as reliable elimination of spectral contamination with lipid signals arising from 
periprostatic fat tissue.   
Recently, we demonstrated that volume selection of the prostate by a semi Localized 
Adiabatic SElective Refocusing (sLASER) sequence with low-power gradient-
modulated offset-independent adiabatic (GOIA) refocusing pulses reduces lipid signal 
contamination compared to localization by conventional refocusing pulses in a standard 
point-resolved spectroscopy sequence (PRESS), mainly due to less chemical shift 
displacement error (CSDE) (4). Because of a shorter sLASER echo time (TE), resulting 
in an optimal absorptive spectral shape of the strongly coupled Cit spins and less T2 
relaxation, the signal-to-noise ratio (SNR) of Cit and Cho increased 4, 5. It has become 
common in MRSI to employ weighted elliptical phase encoding (PE) to avoid long 
acquisition times. Subsequent k-space apodization with a Hamming filter, matching 
the acquisition weights, optimizes the SNR and reduces side lobes of the point spread 
function (PSF), which reduces lipid signal artifacts 6, 7, but comes at the cost of less spatial 
resolution. Although this enables prostates of most sizes to be measured in about 10 min 
at nominal resolutions below 1 cc 1, 6, the measurements may become unacceptably long 
if matrix sizes need to be extended to cover larger prostates.  
MRSI can be performed more efficiently by sampling the spatial and spectral dimension 
simultaneously, e.g. by traversing k-space in several short spiral trajectories within one 
read-out period 8, 9. Spiral sampling can be useful to accelerate MRSI if the resonances 
of interest have sufficient SNR, or alternatively to acquire MRSI with larger matrix sizes 
covering a large field of view (FOV) without a time penalty. Spiral sampling is more 
flexible than classical Cartesian PE in matching FOV, matrix size and acquisition time. 
Accelerated k-space sampling is only useful if sufficient SNR is available. The SNR can 
be enhanced by the use of an endorectal receive coil (ERC), which has a high sensitivity 
because it is positioned close to the prostate. However, this reduces the maximum 
allowed radiofrequency (RF) power deposition compared with a setup with external 
array coils only, to account for potential residual coupling between the body transmit 
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coil and the ERC. To avoid long acquisition times due to this additional RF power 
limitation, the use of low power demanding RF pulses is desirable.
The aim of this study was to design and test an sLASER sequence with GOIA refocusing 
pulses (GOIA-sLASER) and spiral acquisition with an ERC for fast prostate MRSI at 
high resolution or extended matrix sizes. This sequence was compared to the commonly 
employed point-resolved spectroscopy sequence (PRESS) with weighted elliptical PE 
using simulations, phantom studies and measurements of patients with prostate cancer.
METHODS 
Measurements were performed on a 3T MR system (MAGNETOM Trio, Siemens 
Healthcare, Erlangen, Germany) with a body coil for transmission and an endorectal 
coil (ERC, Hologic Inc., Bedford, MA, USA) for signal reception. For the phantom 
measurements the standard body and spine array receive coil configuration was used.  
MR pulse sequences
A product PRESS sequence with MAO refocusing pulses and weighted elliptical k-space 
acquisition 6 and a non-product sLASER sequence with low power adiabatic GOIA-
Wurst(16,4) refocusing pulses 4, 10 and spiral k-space acquisition 8 were used. In both 
sequences the volume of interest (VOI) selected by the excitation and two refocusing 
RF pulses covered the dimensions of the prostate or phantom. The interpulse timing was 
optimized for an absorptive shape of the central lines of Cit at an intermediate echo time 
for residual lipid signal attenuation by T2 decay. This resulted in TE= 145 ms for the 
PRESS 11 and TE= 90 ms for the GOIA-sLASER sequence. Unwanted magnetization 
from RF pulses was spoiled by crusher gradients around the refocusing pulses and water 
and lipid signals were attenuated by two dual-frequency selective Mescher-Garwood 
(MEGA) pulses 12, 13. Additionally, up to 7 outer volume suppression (OVS) slices were 
added to further suppress periprostatic lipid signals. The spiral acquisition featured 
constant-density spiral trajectories with Nt time interleaves and Ns spiral interleaves, to 
sample the spectral and two spatial dimensions, respectively. The third spatial dimension 
was sampled using conventional PE, with Nz steps. The total measurement time then 
equaled Nt × Ns × Nz × TR, with TR being the repetition time. Trajectory settings were 
chosen to minimize the total measurement time and maximize SNR within slew rate 
and gradient constraints. Further details are given below.  
1H GOIA-SLASER-SPIRAL MRSI OF THE PROSTATE
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Simulations and phantom studies
The resolution of the k-space trajectories was evaluated by simulating the PSF, k-space 
sampling density and k-space sampling volume for the spiral trajectory, elliptical PE and 
elliptical PE with additional 3D Hamming k-space filter.
For the simulations of the elliptical PE we determined the PSF response of a k-space 
with evenly spaced sampling points Δk within a ellipse with respective axes  
� ― 
Nx,y,z –1
2  Δk,+ 
Nx,y,z –1
2  Δk �  for odd matrix sizes and 
� ― 
Nx,y,z –2
2  Δk,+ 
Nx,y,z –2
2  Δk � for even matrix sizes. For the spiral measurements 
the PSF was calculated from the simulated density compensated spiral trajectories. The 
applied spherical Hamming filter H(k)
⟶
was defined as:  
               |k⃗| < f                   1
H(k)
⟶





                |k⃗| > kmax                0.08
Where f is the parameter that determines the fraction of the k-space radius that is 
filtered 14. All simulations were performed with MATLAB 2013a (The Mathworks 
Inc, Natick, MA, USA) and included: FOV of 80 × 80 × 60 mm3, matrix size of 16 
× 16 × 12 and nominal voxel size of 5 × 5 × 5 mm3. The real voxel size was calculated 
by determining the volume within the Full Width at Half Maximum (FWHM) of the 
PSF.
For the experimental determination of the localization performance of the two k-space 
trajectories we used a plexi-glass cylinder (13 cm diameter and 18 cm length) filled 
with N-acetylaspartate (NAA) and a cube (20 × 20 × 20 mm3) filled with creatine (Cr) 
placed inside the cylinder. Cartesian and spiral k-space schemes were applied with a 
FOV of 160 × 160 × 160 mm3, a matrix size of 8 × 8 × 8, corresponding to a nominal 




The institutional ethics committee waived the need for informed consent. MRSI with 
both sequences was performed on 9 patients, as part of a clinical MRI protocol for PCa 
staging with an ERC. If not contraindicated, they received a dose of butylscopolamine 
and glucagon to decrease peristaltic motion.
The GOIA-sLASER MRSI with spiral acquisition was performed at two different spatial 
resolutions. The first acquisition was acquired with a FOV of 80 × 80 × 60 mm3, a 
matrix size of 16 × 16 × 12, 6 spiral interleaves and 2 temporal interleaves (nominal 
voxel size 5 × 5 × 5 mm3). The second acquisition was acquired with a FOV of 160 × 160 
× 84 mm3, a matrix size of 23 × 23 × 12, 5 spiral interleaves and 2 temporal interleaves 
(nominal voxel size 7 × 7 × 7 mm3). The TR was 1000 ms, which in one case had to 
be increased to 1100 ms due to specific absorption rate (SAR) limitations. With two 
averages this results in an acquisition time of 4:52 min or 4:04 min for the smaller and 
larger matrix size respectively.  
The PRESS sequence was also performed with two nominal voxel sizes. A voxel size of 
5 × 5 × 5 mm3 was obtained with a FOV of 70 × 60 × 60 mm3 and a matrix size of 14 
× 12 × 12 and a voxel size of 6 × 6 × 6 mm3 was obtained with a FOV of 84 × 60 × 
72 mm3 and a matrix size of 14 × 10 × 12. k-space sampling was done with weighted 
elliptical PE averaging. The TR was 750 ms and the number of weighted averages was 2 
for the larger and 3 for the smaller matrix, resulting in measurement times of 8:44 min 
and 8:19 min respectively. 
k-space filtering is applied to reduce PSF side lobes, resulting in an increased voxel size. 
Noise variance is lowest and consequently SNR efficiency is best, the more the windowing 
function is matched to the k-space sampling density 7, 15. Since the k-space sampling 
densities of the two k-space acquisition schemes differ, we applied different Hamming 
filters in order to optimally filter each acquisition. For the PRESS weighted elliptical k-space 
sampling a 100% Hamming filter was used. The spiral k-space data was filtered using a 
50% Hamming filter, which fits its k-space density better than the 100% Hamming filter.
MRSI spectra were analyzed using custom made LCModel basis sets for GOIA-sLASER 
and PRESS 16. Since acquisition parameters, like voxel size, matrix size and TE, were 
different between the sequences, a fair SNR comparison was not possible. To evaluate 
spectral quality we analyzed the outcome of the LCModel fits and calculated the 
percentage of voxels in which Cit, Cho, Cr and spermine (Spm) were fitted with a 
Cramér-Rao Lower Bound (CRLB) below 20%.





Simulations were performed to investigate the effect of the sampled k-space volume 
(Fig. 1a) on the PSF for spiral k-space encoding and for elliptical PE (Fig. 1b). Because 
of the smaller k-space volume sampled by the elliptical PE, the central lobe of its PSF is 
wider leading to a larger real voxel volume compared to spiral encoding with full PE in 
the z-direction (Fig. 1c). 
Figure 1: Simulations and phantom measurements of the elliptical PE and spiral k-space sampling: 
(a) k-space volumes sampled by the spiral trajectory (blue mesh) or weighted PE (red solid ellipsoid). 
(b) 1D PSFs of spiral k-space sampling with and without 50% Hamming filter (blue dashed and solid 
line, respectively) and elliptical PE with and without 100% Hamming filter (red dashed and solid line, 
respectively). The PSFs are normalized to their maximum values. (c) Isosurfaces of 3D PSF at FWHM of 
the spiral k-space sampling with 50% Hamming filter (blue solid ellipsoid) and elliptical PE with 100% 
Hamming filter (red mesh). All simulations were performed with a FOV of 80 × 80 × 60 mm3 and a 
matrix size of 16 × 16 × 12, resulting in a nominal voxel size of 5 × 5 × 5 mm3. (d-f) 3D MRSI phantom 
measurements to evaluate the localization performance of weighted elliptical PE and spiral encoding. The 
inner compartment of the phantom contains Cr and the outer compartment is filled with NAA. The FOV 
(160 × 160 × 160 mm3) and the matrix size (8 × 8 × 8) have been chosen that way that the resulting nominal 
voxel size (20 × 20 × 20 mm3) was as large as the Cr containing cube. Cr-maps of 100% Hamming filtered 
weighted elliptical PE (d) and 50% Hamming filtered spiral sampling (e) are shown (signals are normalized 
to their maximum intensity). In (f) the Cr signal profile for both acquisitions along the central white line 
are displayed (signal intensities are not normalized).
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The use of a 100% Hamming filter, matching the weighted elliptical PE, suppresses lipid 
signal contamination arising from the PSF side lobes 7. This causes additional widening 
of the central lobe and, therefore, a larger real voxel volume (see Fig 1b and 1c). For spiral 
k-space sampling a 50% Hamming filter was used, which results in decreased side lobes and 
widening of the central lobe of the PSF as well. Overall spiral k-space sampling with 50% 
Hamming filtering provides a higher spatial resolution, due to a narrower PSF main lobe.
Phantom measurements
Experimental verification of the localization performance of the different k-space sampling 
and filtering techniques was done with a two-compartment phantom with Cr only present 
in the inner 20 × 20 × 20 mm3 compartment (Fig. 1d-f). With the MRSI voxel size and grid 
position chosen to exactly match the compartment, no Cr signal should be observed outside 
the compartment if voxel localization were perfect. Spiral sampling in combination with 
50% Hamming filter showed less signal intensity outside the Cr containing compartment 
than the measurement acquired with elliptical PE and 100% Hamming filter (compare Fig. 
1d and 1e), which agrees with its smaller real voxel size (Table 1). Due to the narrower 
FWHM of its PSF, the spiral k-space sampling has a smaller real voxel size and therefore a 
higher spatial resolution. Hence, also the Cr signal profile of the spiral sampling is narrower 
(Fig. 1f). The slight shift to one direction might be a reconstruction inaccuracy.
Table 1: Real voxel sizes of elliptical phase encoding and spiral k-space sampling with and without Hamming 
filtering. The voxel volumes were calculated by determining the volume within the FWHM of the PSF.
Nominal voxel size Hamming filter FWHM volume
Weighted elliptical phase 
encoding
5 × 5 × 5 mm3 = 0.125 cm3
No 0.45 cm3
100% 0.60 cm3




5 × 5 × 5 mm3 = 0.125 cm3
No 0.17 cm3
50% 0.34 cm3
7 × 7 × 7 mm3 = 0.343 cm3
No 0.45 cm3
50% 0.90 cm3
As a consequence of the smaller real voxel sizes (Table 1) and shorter measurement times, the 
SNR of the GOIA-sLASER-Spiral measurements was about 20% lower than with the PRESS 
sequence. For both measurements the SNR drops towards the ventral parts of the prostate 
due to the receive profile of the ERC, but is still high enough to separate the metabolites in 
most cases. For large prostates, however, SNR in the ventral part may be insufficient with the 
current voxel sizes and number of averages of the GOIA-sLASER-Spiral acquisition.




MRSI with the GOIA-sLASER sequence with spiral acquisition (TE = 90 ms, 50% 
Hamming) and with the clinically applied PRESS sequence with weighted elliptical PE 
(TE = 145 ms, 100% Hamming) was performed successfully on all 9 patients. 3D MRSI 
spectra with relevant metabolic information of the complete prostate were obtained in 
about 9 min with PRESS and PE readout (Fig. 2a, b, c). Metabolite data of the whole 
prostate of similar quality were acquired by the GOIA-sLASER sequence with spiral 
readout (Fig. 2d,e, f ), even with a smaller real voxel size and acquisition below 5 min. 
The spectral shapes differ between both methods because of the different RF pulses and 
timings, but all spectra show a comparable separation of Cit, Cho, Spm and Cr (Fig. 2b, 
c, e, f ). The MR spectra were fitted with sequence specific LCModel basis sets (red lines). 
Figure 2: Spectral maps of in vivo prostate MRSI measurements of patient 6, obtained with (a) the PRESS 
sequence with weighted elliptical PE (TE = 145 ms, 100% Hamming filtered, real voxel size = 1.12 cm3) 
and with (d) the GOIA-sLASER sequence with spiral k-space sampling (TE = 90 ms, 50% Hamming 
filtered, real voxel size = 0.90 cm3). Spectra close (b, e) and distant (c, f) to the ERC are zoomed in on a 
range from 2.4 ppm to 3.4 ppm. The red lines show the sequence specific LCModel fits. The matrices are 
interpolated to 16 × 16, the real voxel sizes are illustrated by the circles. The VOI, indicated by the white 
box, is positioned around the prostate. OVS bands (hatched bands) are placed adjacent to the prostate.
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Table 2: Fraction of the number of voxels in which the LCModel fit of the metabolites Cit and Cho had 
a Cramér-Rao Lower Bound (CRLB) below 20%. For these calculations the central three slices of the 
patients’ prostates were used, excluding their most ventral rows because of lipid contamination in the 
PRESS measurements and interference with the OVS bands. 
patient nominal voxel size 
(mm3) 









2 5 × 5 × 5 0.62 8:44 0.99 0.47
3 6 × 6 × 6 1.12 8:19 1.00 0.37
4 6 × 6 × 6 1.12 8:19 1.00 0.32
5 6 × 6 × 6 1.12 8:50 1.00 0.33
6 6 × 6 × 6 1.12 8:19 0.99 0.33
7 6 × 6 × 6 1.12 8:19 0.96 0.13
8 6 × 6 × 6 1.12 8:19 0.47 0.74













2 5 × 5 × 5 0.33 4:52 0.97 0.33
3 5 × 5 × 5 0.33 4:52 0.84 0.24
4 5 × 5 × 5 0.33 4:52 0.92 0.22
5 5 × 5 × 5 0.33 4:52 0.94 0.13
6 7 × 7 × 7 0.90 4:04 0.92 0.74
7 7 × 7 × 7 0.90 4:04 0.94 0.63
8 7 × 7 × 7 0.90 4:31 0.78 0.64







The number of voxels for which Cit and Cho signals were fitted reliably (CRLB< 20%) in 
the central slices of the patients’ prostates was comparable for both sequences (Table 2). The 
average percentages of voxels with a CRLB < 20% for the GOIA-sLASER-Spiral and the 
PRESS-PE protocol were 91% and 93% for Cit and 38% and 35% for Cho, respectively. 
In one patient (# 8) the detection rate of Cit was only 47% in the PRESS measurement, 
while reaching 78% in the GOIA-sLASER-Spiral measurement. We observed spurious 
lipid signals overlapping the Cit resonance in spectra of a number of voxels using PRESS 
acquisition, mostly at the edges of the prostate, impeding reliable fitting of the Cit signal. In 
contrast, using GOIA-sLASER, lipid contamination was considerably reduced, resulting 
in a higher fraction of voxels with a reliably fitted Cit signal. 
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For the major metabolite signals the higher SNR provided by GOIA-sLASER at TE=90 
ms compared to PRESS at TE = 145 ms can be exploited in spiral acquisition to use 
higher matrix dimensions for smaller voxels or for a larger FOV at the same voxel size 
at a shorter measurement time.  The smaller real voxel size of the spiral acquisition also 
reduces partial volume effects. This is illustrated in Figure 3, in which spectra of the same 
prostate (patient 2) obtained at a nominal voxel size of 5 x 5 x 5 mm3 by PRESS with 
weighted elliptical PE and by GOIA-sLASER with spiral readout are compared. MR 
spectra from the seminal vesicle area show a distinct local higher choline methyl signal 
and a lower citrate signal with spiral GOIA-sLASER, whereas this is less obvious in 
the PRESS measurement, because of larger real voxel sizes and resulting partial volume 
effects. High choline and low citrate levels are expected in the seminal vesicle area, as 
secretions produced in the seminal vesicles contain mainly fructose and phosphocholine 
17, 18, but no citrate. Citrate is produced in the epithelial cells of the prostate itself.
Figure 3: Comparison of the spatial resolutions achieved with the GOIA-sLASER-Spiral sequence and the 
PRESS sequence. Coronal T2 weighted anatomical image of the prostate of patient 2 (b) and superimposed 
metabolite maps of Cho, acquired with PRESS (c) and GOIA-sLASER-Spiral (d). Regions of interest of 
3×3 voxels were drawn close to the seminal vesicles and the ejaculatory ducts, where increased Cho and 
decreased Cit signals are expected. The corresponding spectra for the PRESS (a) and the GOIA-sLASER-
Spiral acquisition (e) are zoomed in on a scale between 2.4 ppm and 3.4 ppm and scaled according to the 
highest Cit signal within the ROI. The GOIA-sLASER-Spiral acquisition shows a strongly improved signal 
localization and reduced leakage to neighboring voxels compared to PRESS (d, e), due to its smaller real 




With this work we demonstrate the feasibility of combining a GOIA-sLASER sequence 4 
with spiral k-space acquisition 8, 9, 19 in MRSI of the prostate to overcome the inflexibility 
of conventional Cartesian phase encoding. In particular we show that this combination 
allows MRSI at enhanced resolution and that FOV and matrix dimensions can be 
adjusted to fit any prostate without penalties in spatial resolution or acquisition time. 
A LASER sequence with GOIA pulses and spiral acquisition has been successfully 
applied to MRSI of the brain 20. For MRSI of the prostate with an ERC, semi-LASER 
acquisition is suited better, since it requires less RF power, and thus allows for shorter 
repetition times than a full LASER acquisition would require. Previously, we showed 
that the GOIA-sLASER sequence with TE ≈ 90 ms has several advantages compared 
to standard PRESS with TE = 145 ms, such as reduced dispersive components in the 
citrate peak, better VOI selection and a decreased CSDE of the GOIA-Wurst(16,4) 
refocusing pulses which reduces lipid contamination, facilitating more artifact-free 
spectra. Moreover, with this relatively short TE the SNR for metabolite signals increases, 
in particular for Cit, which together with a favorable J-modulation results in a 2.6 
times higher SNR as compared to PRESS at TE = 145 ms. The Cho signal intensity 
is enhanced by a factor of 1.3 4. Furthermore, as GOIA refocusing pulses need less RF 
power than conventional adiabatic pulses 10, it is possible to use an ERC for higher signal 
sensitivity while remaining within the SAR limits, adapted for ERC usage, at acceptable 
TRs. The increased SNR provided by these features can be exploited to increase spatial 
resolution within the same acquisition time or to retain similar resolution but shorten 
acquisition times. This is only possible by using efficient k-space encoding like with 
spiral trajectories. In this study we combined GOIA-sLASER with spiral acquisition 
for 3D MRSI to obtain MR spectra of real voxel sizes of 0.3 – 0.9 cm3 in measurement 
times just below 5 min instead of the common 9 min with PRESS and real voxel sizes of 
0.6 – 1.1 cm3.  Shorter acquisition times are clinically more attractive and there is also 
less chance of interference with unpredicted (peristaltic) motion and thus less chance of 
spoiling spectral quality. 
The more advantageous k-space sampling of the spiral acquisition results in smaller 
real voxel sizes than for elliptical PE, which reduces partial volume effects, as clearly 
illustrated by the better metabolic characterization of the seminal vesicle area. However, 
for large prostates the SNR of the anterior part can be critical, due to the sensitivity 
profile of the ERC and therefore more averages may be required than used in the present 
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GOIA-sLASER exams. It is possible to further improve SNR by using variable-density 
spirals in combination with a suitable k-space filter, as the match between the sampling 
density of the constant-density spirals and the 50% Hamming filter is not optimal. By 
using variable-density spirals 21 being proportional to their filter function the PSF side 
lobes and therefore signal leakage from neighboring voxels can be minimized without 
increasing the noise variance 7, 15. Furthermore, additional oversampling near the k-space 
center would be beneficial for the SNR. By the use of weighted PE and a matching 
k-space filter in the z-direction, acquisition time and SNR can be further optimized, 
slightly compromising voxel size.
A fair SNR comparison between GOIA-sLASER with spiral and PRESS with weighted 
elliptical PE acquisition is difficult due to differences such as their PSFs and therefore 
real voxel sizes. That is why we compared spectral quality instead, as detection and 
discrimination of metabolites is most important for MRSI. The average percentages of 
voxels with a CRLB < 20% for the GOIA-sLASER-Spiral and the PRESS-PE protocol 
were around 90% for Cit and around 35% for Cho. The high detection rate of Cit in 
both protocols is due to high Cit concentrations in healthy prostate tissue. The lower 
percentages for acceptable Cho fits reflect the lower SNR and overlap with spermine of 
this signal in many voxels. Longer repetition and acquisition times would be necessary to 
reach an SNR for comparable fitting of the Cho signal. However, in the characterization 
of tumor tissue, for which the Cho signal is increased, the low signal in healthy prostate 
spectra is not so much a concern.  The spectra of voxels covering the seminal vesicles, 
showing increased choline, are a good example of what what can be expect if cancer is 
present. These increased Cho signal levels are fitted very well. 
The improved lipid suppression, flat baseline, better intrinsic SNR and good signal 
separation provided by the GOIA-sLASER protocol more than compensates for the 
SNR loss due to the faster k-space sampling scheme and therefore facilitates spectral 
quality comparable to a PRESS protocol using elliptical PE and longer acquisition times 
at larger real voxel sizes.
For post processing of spiral acquisition, the sampled k-space points have to be rearranged 
to a Cartesian grid, which is a potential source of small inaccuracies. This might be a 
reason for the slight shift of the Cr signal profile in Figure 1f. This shift is however small 
compared to the dimensions of the voxel, and is not of great concern for prostate tissue 
characterization.
One drawback of spiral sampling is the need for rewinding the spiral trajectory from its 
k-space endpoint to the center. During this period no signal is recorded causing a loss in 
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SNR (~ 12%). This can be overcome by using out- and in- rewinding spirals 22, which 
however reduces the spectral bandwidth due to the increased duration of the spirals. 
CONCLUSION
A GOIA-sLASER sequence with spiral k-space acquisition is a robust and flexible 
method to obtain 3D MRSI of the prostate at a wide range of spatial and time resolutions 
and FOVs including those needed for large prostates, without undesirable increases in 
acquisition times due to the matrix extensions required in standard phase encoding. This 
MRSI approach will facilitate more routine acquisition of metabolic information of the 
prostate for clinical purposes. 
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To evaluate the technical feasibility of prostate multiparametric magnetic resonance 
imaging (mpMRI) at a magnetic field strength of 7 Tesla.
Materials and Methods
In this prospective institutional review board-approved study, fourteen patients with 
biopsy-proven prostate cancer (mean age 65.2 years; median PSA 6.2 ng/mL), all 
providing signed informed consent, underwent 7T mpMRI with an external 8-channel 
body-array transmit coil and an endorectal receive coil between September 2013 and 
October 2014. Image and spectral quality of high-resolution T2-weighted (T2W) 
imaging (0.3 × 0.3 × 2 mm3), diffusion weighted imaging (DWI, 1.4 × 1.4 × 2 mm3 
or 1.75 × 1.75 × 2 mm3) and 1H-MR spectroscopic imaging (MRSI, real voxel size 0.6 
mm3 in 7:16 min) were rated on a 5–point scale by two radiologists and a spectroscopist.
Results
Prostate mpMRI including at least two out of three MR techniques was obtained at 7T 
in 13 patients in 65 ± 12 minutes. Overall T2W and DWI image quality at 7T was scored 
as fair (38% and 17% respectively) to good or very good (55% and 83% respectively). 
The main artifacts for T2W imaging were motion and areas of low SNR, the latter 
possibly caused by radiofrequency field inhomogeneities. For DWI the primary artifact 
was ghosting of the rectal wall in the readout direction. MRSI quality was rated fair or 
good in 56% of the acquisitions, and was mainly limited by lipid contamination. 
Conclusions
Multiparametric MRI of the prostate at 7T is feasible at unprecedented spatial 
resolutions for T2W-imaging and DWI and within clinically acceptable acquisition 
times for high resolution MRSI, using the combination of an external 8-channel body-
array transmit coil and an endorectal receive coil. The higher spatial resolutions can yield 
improved delineation of prostate anatomy, but the robustness of the techniques needs to 
be improved before clinical adoption of 7T mpMRI.  




Multiparametric magnetic resonance imaging (mpMRI) is effective for the detection, 
localization and local staging of prostate cancer, in guiding biopsies in men with 
previous negative findings, and in directing localized treatments 1, 2. Prostate mpMRI 
protocols should consist of high-resolution T2-weighted (T2W) MR imaging and the 
functional MR techniques diffusion-weighted imaging (DWI) and dynamic contrast-
enhanced (DCE) MRI. Standardization of the interpretation of mpMRI examinations 
for disease detection is described in the latest Prostate Imaging Reporting and Data 
System (PIRADS 2) 3. Difficulties remain in distinguishing prostatitis from tumor in the 
peripheral zone 4, and in identifying tumors in the transition and central zones 5, 6, for 
which MR morphology and texture characteristics are important 7, 8. To estimate disease 
aggressiveness, a more quantitative interpretation of the above-mentioned functional 
techniques of mpMRI, but also of proton (1H) MR spectroscopic imaging (MRSI) can 
be of help 9, 10. 
Texture characteristics on T2W-imaging as well as tumour characterization with functional 
imaging could potentially benefit from an increased spatial resolution or higher signal-
to-noise ratio (SNR) provided by an ultra-high field strength of 7T. However, strong 
radiofrequency (RF) B1-field inhomogeneities, high specific absorption rates (SAR) and 
large susceptibility effects present challenges for prostate mpMRI at 7T. Shaping the 
RF fields in the prostate with multiple transmit channels can overcome these issues 11. 
The combination of an external 8-channel transmit array coil with an endorectal receive 
coil increases local sensitivity and allows for reduced fields of view, enabling higher 
resolution prostate images 12. This coil combination also creates opportunities for DWI 
and fast 1H MRSI. Therefore, the aim of this study was to evaluate whether a split RF 
transmit and receive setup enables performing mpMRI including T2W-imaging, DWI 
and 1H MRSI routinely and safely at 7T in patients with prostate cancer, to evaluate its 




This prospective study was approved by the institutional review board of the University 
of Duisburg-Essen and all patients provided signed informed consent. 
Study participants
Fourteen patients with biopsy-proven prostate cancer (mean age: 65.2 years, range: 51-
71 years; median PSA level: 6.2 ng/mL, range: 1.0-11.6 ng/mL; median Gleason score: 
6, range: 6-7) who had undergone a clinical 3T endorectal prostate mpMRI staging 
exam were recruited between September 2013 and October 2014. Inclusion criteria 
were a good tolerance of the 3T endorectal exam and willingness to participate in a 
separate, off-site (1.5 hours-drive one-way) MR examination at 7T. Exclusion criteria 
were general contraindications to MRI, 7T-specific contraindications (presence of any 
metallic implants) and contraindications to endorectal coil insertion. 
Scanner and patient setup
Measurements were performed with a combination of a receive-only endorectal coil 
and an 8-channel body array transmit coil on a 7T whole-body research MR system 
(MAGNETOM 7T, Siemens Healthcare, Erlangen, Germany). The gradient coil of the 
MR system was replaced after the first two subjects were scanned. The new gradient coil 
had better linearity, but lower maximum gradient amplitudes and slew rates. Patient 
preparation, SAR-monitoring, magnetic field B0 shimming, RF B1-shimming and flip 
angle calibration were performed as described previously 13, 14. 
Multiparametric MR imaging
The full mpMRI protocol included triplanar T2W turbo spin-echo imaging, DWI and 
3D MRSI. In all sequences, the external array coil was used for signal transmission and 
the endorectal coil for signal reception. The number of slices was adjusted to cover the 
full prostate (12-25 slices). 
DWI was performed using a 5-shot readout segmented echo-planar imaging sequence 15, 
with b-values of 0, 100, 400 and 800 s/mm2 in a monopolar diffusion encoding scheme. 
Sequence parameters are listed in Table 1. Apparent diffusion coefficient (ADC) maps 
and b1400 images were calculated with the scanner software, using a mono-exponential 
decay model including all b-values. 
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Metabolite levels within the prostate were measured using a dedicated 7T MRSI 
pulse sequence using spectral-spatial refocusing pulses for volume selection.16 The 
spectroscopic k-space was filled elliptically using 3D phase-encoding (default Spectral-
Spatial: SP2 MRSI), and/or using fast angular and temporal interleaved spirals which 
simultaneously encoded the spectroscopic frequency dimension and two spatial 
dimensions by constant density gradient waveforms 17, 18 (fast Spectral-Spatial-Spiral: 
SP3 MRSI). The third spatial dimension in case of spiral sampling was obtained with a 
phase-encoding gradient. Varying settings for the volume of interest (VOI), field of view 
(FOV), and matrix size were used (Supplemental Table 1) for optimization purposes and 
because of differences in prostate size. MRSI and DWI were performed with the same 
angulation as transversal T2W-MRI. 
Table 1: Parameters of T2W-MRI and DWI sequences at 7T
T2W-MRI DWI
TR (msec) 2500-5100a 3300e or 4200f
TE (msec) 80-85b 49e or 68f
Flip angles (°) 90/150-160c 90/180
FOV (mm) 96 × 96 130 × 130e or 154 × 154f
Resolution (mm) 0.3 × 0.3 1.4 × 1.4e or 1.75 × 1.75f
Slice thickness (mm) 2.0 2.0
Slice gap (mm) 0.4 0.4
No. of slices 10-25d 10-20
Imaging time (min:sec) 1:28-2:59 3:08-4:22
a  TR and total imaging time depended on number of slices. b TE depended on gradient system, 
optimized in 13. 
c Refocusing flip angle adjusted to 150° after first two patients. d Mean number of slices in patients 
transversal: 21, sagittal: 16, coronal: 15. 
e  Subjects 1 and 2, strong gradient system. f Remaining subjects, standard gradient system. 
Image analysis 
The T2W images, diffusion weighted images and ADC maps of the patients were 
evaluated by two radiologists (JJF and SFJ, 13 and 3 years of experience in prostate MRI 
respectively), blinded to patients’ clinical data, except for the fact that they had biopsy-
proven prostate cancer. The following characteristics of the transversal T2W images were 
rated on a 5-point scale (‘very good’, ‘good’, ‘fair’, ‘poor’ or ‘very poor’): visualization 
of the peripheral zone, transition zone, seminal vesicles, urethra, and benign prostatic 
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hyperplasia (BPH), delineation of dominant prostate cancer lesion and delineation of 
the prostatic capsule. Overall image quality of the T2W images was rated per available 
image orientation (transversal, sagittal and coronal). The following characteristics of 
DWI were scored on the same 5-point scale: SNR per b-value image (qualitative), overall 
image quality of the ADC maps, and visibility of BPH and of prostate cancer lesions if 
applicable. The presence of artifacts in T2W images and DWI were rated on a 4-point 
scale (‘absent’, ‘mild’, ‘moderate’, ‘severe’) or as ‘present but not affecting the prostate’. 
Predefined artifacts (Supplemental Table 2) and single examples of 7T-specific artifacts 
(Supplemental Fig. 1) were used to instruct the radiologists before their reading. The 
radiologists were asked to report other artifacts as well on the above-mentioned scale. 
The line signal void artifact near the endorectal coil was rated as ‘absent’ or ‘present’. 
The scores of the two radiologists were averaged. In cases where their individual scores 
differed by more than 1 point, an additional consensus reading by the same radiologists 
was performed. 
Spectra were evaluated by a spectroscopist (MWL) for the separation of signals of 
citrate, choline, spermine, and creatine, the shape of the citrate signal and the presence 
or absence of water and lipid signals. Overall spectral quality was judged on the 5-point 
scale introduced above. If both SP2 and fast SP3 MRSI were acquired in one subject, 
the results were compared using the criteria stated above, and on their SNR. 
The results of the different aspects of the 7T quality analysis were quantified using the 
median and interquartile range descriptive statistics. 
RESULTS
Ten out of 14 subjects underwent mpMRI protocols including T2W, DWI as well as 
MRSI. In three patients only two out of three MR techniques were performed (Fig. 1), 
twice because of MR system failure and once because of insufficient B0 shimming. One 
patient aborted the exam before any relevant images could be recorded because of severe 
back pain (see patient flow diagram, Fig. 1). All exams were performed within a local 
10-g average SAR limit of 15 W/kg averaged over 6 minutes, and the average total scan 
duration including calibration steps was 65 ± 12 min. Radiologists’ consensus read was 
necessary in 11% (55/494) of the questions. Examples of mpMRI examinations at 7T 
of different patients are presented in figures 2, 3, 4 and supplemental figure 2.
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Figure 1: Flow chart of the various mpMRI protocols performed. T2W: T2-weighted MR imaging, DWI: 
diffusion-weighted MR imaging, MRSI: MR spectroscopic imaging, TRA: transversal, SAG: sagittal, COR: 
coronal, SP2 MRSI: spectral-spatial MRSI, SP3 MRSI: spectral-spatial-spiral MRSI. 
T2-weighted imaging
High resolution anatomical imaging was performed in three orthogonal directions in 
6/10 patients. Overall image quality was scored as fair (average score of two radiologists: 
2.5 - 3), good (3.5 - 4) and very good (4.5 - 5) in 38% (11/29), 48% (14/29) and 7% 
(2/29) of the image series, respectively, with transversal images (Fig. 2A, 3A & 4B) 
yielding the highest average score, followed by coronal and sagittal images (Table 2). 
The visibility of most anatomical structures was judged fair to good. The depiction of 
the transition zone, the urethra, BPH nodules and delineation of suspected prostate 
cancer lesions yielded the best scores (3.75 - 4; good), while the neurovascular bundle 
scored worst (2.25; poor). The most pronounced artifacts in T2-weighted imaging were 
motion (Fig. 3B, C &. 4E) and areas with low SNR (Supplemental Fig. 1A), affecting 
76% (22/29) and 52% (15/29) of the image series, respectively (average artifact score ≥ 
1.5). The low SNR artifact was mostly observed in the right anterior prostate base and/
or apex. Focal signal void and coil flare artifacts were either absent or mild. 
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Figure 2: MRI with an endorectal receive coil at 7T of the prostate of a 62-year old patient with prostate 
cancer (prostate-specific antigen level 6.0 ng/mL, Gleason score 3+3). A: Five transversal T2-weighted 
turbo-spin echo images from a series of 23 slices from apex to seminal vesicles, resolution 0.3 × 0.3 × 2.0 
mm3. B: Transversal ADC maps at corresponding locations (5 images from 23 slices), resolution 1.75 × 
1.75 × 2.0 mm3. 
Diffusion weighted imaging
Native and calculated diffusion weighted images and ADC maps generally were of good 
quality (Fig. 2B, 3E-G & 4C, D, F, G). Geometric distortion of the prostate with respect 
to T2-weighted imaging was very small (Fig. 2). The overall image quality of DWI was 
scored as fair, good or very good in 17% (2/12), 75% (9/12) and 17% (2/12) of cases 
(Table 2). The visibility of anatomical structures (including PCa, Fig 3F, G & 4F, G) in 
the ADC maps was scored as good. Some artifacts were observed in DWI: ghosting of 
the rectal wall in the readout direction (scores mild to moderate, Supplemental Fig. 1B, 
C), low SNR in the anterior part of large prostates and in the same areas as reported for 
the T2W images, and geometric deviations between native b-value images in the phase-
encoding direction. This last effect resulted in less well-defined prostate edges in the 
ADC maps (Supplemental Fig. 1G), but was rated mild by the radiologists. 







Figure 3: Prostate mpMRI at 7T of a 65-year old patient with prostate cancer (PSA 11.6 ng/mL, Gleason score 
3+3). A: Transversal, B: Coronal and C: Sagittal T2-weighted images. Coronal and sagittal images were both 
affected by motion artifacts (coronal: mild-moderate, sagittal: severe). D: Transversal T2-weighted turbo-spin 
echo image with overlay of MR spectra recorded with spectral-spatial MRSI (SP2). The spectra of two outlined 
voxels are shown in detail (right, Cit: citrate; lip: lipids; Spm: spermine.). An area of low signal intensity is 
visible in the right peripheral zone and was marked by the radiologists as a significant prostate cancer lesion. 
A spectrum in the lesion (red circle) shows relatively low citrate levels with respect to spermine. Choline could 
not be resolved from the large spermine peak. E-G: DWI at the same level as A. E: Diffusion weighted image 
with b = 0 s/mm2. F: Calculated diffusion weighted image with b = 1400 s/mm2. G: Apparent diffusion 
coefficient map showing the lesion as a focus of restricted diffusion. 
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1H MR spectroscopic imaging
Good quality spectra were obtained from large parts of the prostate, with little water and 
lipid contamination (Fig. 3D, Fig. 4A). The spectra typically showed a citrate doublet 
and a large polyamine signal; choline and creatine could be distinguished from the 
broad polyamine peak in only a few spectra.  
The overall quality of the MRSI data however varied between subjects, with 4/8 and 5/8 
datasets rated fair or better for SP2 and SP3, respectively (Table 2). The main reason 
for degraded quality was lipid contamination in the spectral region between 2.6 - 2.3 
ppm, precluding detection of citrate (Fig 3A). In addition, only limited signal was left 
in spectra more distant from the endorectal coil, especially in the smaller voxels in case 
of SP3. In the four patients were both SP2 and SP3 MRSI were acquired, the spectral 
quality of the two types of MRSI was similar, apart from resolution related differences in 
SNR. Spectral shapes were not affected by using the spiral readout in SP3.
Possible cancer-related changes were observed in two patients, one showing decreased 
citrate levels with respect to the total spermine+choline peak (Fig. 3D), and the other 
showing increased choline levels in the tumor compared with adjacent prostate tissue 
(Fig. 4A).







Figure 4: Multi-parametric MRI at 7T of a 71-year old patient with prostate cancer (PSA 5.6 ng/mL). 
A: Overlay of MR spectra (SP2 MRSI) onto a coronal T2-weighted image. In the right peripheral zone 
in the apex a cancer lesion is visible (confirmed with MR guided needle biopsy, Gleason score 3+3). The 
spectrum in the lesion (red circle) showed elevated choline and low spermine and citrate levels compared 
to a spectrum in normal appearing peripheral zone tissue (green). The citrate signal in the lesion suffers 
from some additional lipid contamination, elevating the right half (at 2.55 ppm) of the citrate multiplet 
(Cho: choline; Spm: spermine; Cit: citrate.). B and E: axial T2-weighted, C and F: calculated b1400 DWI, 


































































































































































































































































































































































































































































































































































































































































































































































This pilot study demonstrates the feasibility of prostate mpMRI at 7T in a small cohort 
of patients with prostate cancer. The exams were performed safely on an investigational 
MR system, with unprecedentedly high spatial resolutions in T2W-MRI and DWI, and 
MRSI acquisitions allowing increased flexibility in terms of resolution and measurement 
times. Although good data quality was attained at 7T by combining an external array 
coil for transmit with an endorectal receive coil to receive the MR signal, this was not 
achieved consistently. The artifacts identified in this study can serve to guide further 
technical improvements, before larger clinical studies at 7T are initiated.
T2W-MRI of the prostate at 7T has been demonstrated previously 
11–14, 19, showing 
satisfactory to good image quality ratings in patients scanned with an external array coil 14. 
In this work, using an endorectal receive coil, we not only reached unprecedented spatial 
resolution in T2W MRI of the in vivo prostate, but also combined this with functional 
imaging techniques in an mpMRI examination at 7T. Apart from possible benefits of 
imaging at a higher spatial resolution, MRI at 7T can enable the investigation of other 
prostate cancer biomarkers with e.g. 31P-MRSI 20 which is very challenging to perform 
at lower magnetic fields. 
The radiological assessment of overall T2W image quality and visibility of anatomical 
structures and prostate cancer lesions indicated that sufficient quality for diagnostic 
purposes can be achieved at 7T at ultra-high resolution. However, a number of T2W images 
series had issues with areas of low SNR and motion related artifacts, which were observed 
in approximately 50% of the images. Areas of low SNR may result from an asymmetrical 
receive (B1
-) field of the endorectal coil and/or an inhomogeneous RF transmit (B1
+) field 
resulting in varying flip angles throughout the prostate. Different endorectal coil designs 
may be considered to improve the asymmetry in the B1
- field 21. Better control of the B1
+ 
field, e.g. by using more transmit channels or a larger 3D volume selection using a parallel 
transmit approach, may further mitigate the local SNR dropout. Motion artifacts are not 
7T specific, but can offset gains in spatial resolution. The relatively long total duration of 
our examinations might have outlasted the effect of antiperistaltic agents injected before 
magnet entry. Automation of the calibration procedures at 7T will shorten the total 
acquisition time and thereby possibly decrease motion artifacts in later scans. Whether 
improved structure delineation using higher resolution T2W-MRI can improve prostate 
cancer detection in challenging cases (e.g. transition zone cancer) should be investigated in 
a future study using histopathology as reference standard.
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Diffusion weighted imaging of the prostate at 7T is particularly challenging because of 
strong susceptibility effects and correspondingly short T2
* relaxation times. Our initial 
results show that DWI of the prostate at 7T is possible even without parallel imaging, 
with only minor geometric distortion and generally sufficient SNR up to b = 800 s/
mm2. Anatomical structures were visible on the ADC maps. The radiological rating 
of the 7T DWI was good, although many 7T DWI image series were affected by a 
ghosting artifact in readout direction, suggesting a relation with the readout-segmented 
acquisition. The few cases before the infrastructural change of the gradient coil, which 
were acquired with a shorter TE, did not show this artifact. Shortening the TE of 
the DWI sequence by using parallel imaging with a multi-element endorectal coil or 
stronger magnetic field gradients may therefore improve DWI quality.
The SP2 localization technique for 3D MRSI of the prostate at 7T has recently been 
introduced 16. The spectral-spatial RF pulses used in this method theoretically obviate 
the need for additional water and lipid suppression pulses and dramatically change the 
spectral appearance of spermine signals. The technique however requires a homogeneous 
B0 field throughout the full VOI to effectively eliminate lipid signals, without affecting 
the citrate resonances. The lipid contamination which was observed in several patients 
indicates that this condition was not met systematically. More careful selection of the 
B0 shimming volume and/or the use of additional lipid suppression strategies (e.g. outer 
volume suppression slabs) need to be explored to remedy this problem. Whether the 
elevated spermine signals are useful as a biomarker needs further studies in larger patient 
cohorts. 
The use of SP3 MRSI is recommended for future MRSI studies, because a spiral readout 
offers more flexibility in terms of the combinations of FOV, resolution and acquisition 
times than conventionally encoded MRSI and therefore offers more opportunities 
to take advantage of the increased SNR at 7T. Several spiral readout protocols were 
tested to find an optimum tradeoff between resolution, acquisition time and SNR. The 
combination in protocol B (FOV 120 × 120 mm in plane, real voxel size 0.6 cc) was 
judged best for prostate MRSI at 7T. At this resolution, which is slightly above the 
tumor size usually considered clinically significant (0.5 cc), the spiral readout reduced 
the acquisition time down to 7 minutes, comparable to the acquisition times of other 
functional techniques. 
This study had a number of limitations. DCE-MRI was not included, although it is 
part of clinical prostate mpMRI protocols. DCE-MRI is not SNR limited at 3T, and 
was therefore expected to benefit less from an increased field strength than the other 
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techniques 22. Automation of calibration parameters and shimming is still lacking on 
investigational 7T MR systems, which causes longer examination time and system 
instabilities. This is expected to improve with new generation 7T systems. Our patient 
cohort was small and had little variation in prostate cancer Gleason scores, but was large 
enough to illustrate the opportunities and difficulties of mpMRI of the prostate at 7T.
In summary, this report demonstrates initial results of mpMRI of the prostate at 7T in 
a small cohort of patients. Although our results are encouraging in terms of technical 
advancements, this study also revealed particular challenges in robustness. We suggested 
directions for further improvements necessary for mpMRI of the prostate to consistently 
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Supplemental Table 2: Image artifacts identified in the 7T prostate images and their possible causes
Image Type of artifact (Possible) cause 7T specific?
T2W Image blurring and ghosts of rectal 
wall and/or bladder in phase-encoding 
direction
Motion No
T2W Focal signal void or alternating bright 
and dark bands from a focal spot close 
to endorectal coil
Air bubble in balloon of 
endorectal coil† or residual current 
in endorectal coil during transmita 
No  
T2W Areas with low SNR in prostate asymmetry in B1




T2W Coil flare, i.e. extremely bright signal 
close to the endorectal coil which drops 
off rapidly further away from the coil
Sensitivity profile endorectal coil No
T2W Line signal void through seminal vesicles Endorectal coil flux pattern
b No
DWI N/2 ghosts in phase-encoding direction Eddy currents, susceptibility 
differences, motion
No
DWI Ghosting in readout direction Motion, failure of 2D navigator Yes
DWI Geometric deviations of the prostate 
between b-values
Eddy currents, motion No
 a  A small voltage may be induced in the (detuned) endorectal coil by the external B1
+ field, and the 
impedance of the coil circuit may not have been sufficiently high to block current flow in the coil. The 
residual current may locally increase flip angles. 
b  Single-loop surface coils produce signal voids in regions in which the flux pattern only has a component 
in the z-direction 1.
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Supplemental Figure 1: Typical artifacts in T2W and DWI of the prostate at 7T in three patients. A: Area 
with low SNR (dotted oval) in coronal T2W turbo-spin echo image. B,C: Ghosting in readout direction in 
transversal DWI (B: b = 0 s/mm2, C: ADC map). D: Signal void close to the endorectal coil wire (asterisk) 
in transversal T2W turbo-spin echo image. E-G: Geometric displacement in transversal DWI; the slice level 
corresponds to the T2W reference image in D. E: b = 0 s/mm
2, F: 800 s/mm2, G: ADC map. Window width 
and level were adjusted for each image individually. The blue crosses indicate the same geometric location in 
images D through G. A deviation of 3 mm is observed between the b = 0 s/mm2 and b = 800 s/mm2 image, 
resulting in a bright and a dark band lateral to the prostate in the ADC map. 
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Supplemental figure 2: Multi-parametric MRI of the prostate of a 76-year old man with a Gleason 3+4 
tumor in the left dorsolateral peripheral zone of the apex. The tumor lesion is visible on all three orientations 
of the T2W images (white arrow in A to C), and although the ADC map of the prostate shows some 
geometric distortion, the lesion is visible as an area of more restricted diffusion (low ADC) at the white 
arrow (D). Higher ADC values coincide with hyperintense areas on the transversal T2W image. E and G are 
zoomed regions of the spectral map in F of the same axial slice, indicated by the colored boxes (E: normal-
appearing tissue, G: tumor lesion). In F large lipid signals anterior and lateral posterior of the prostate are 
visible, concealing citrate or distorting the citrate shape in the neighboring prostate spectra, such as in the 
bottom spectra in E. All prostate spectra show high spermine signals, and only in a few spectra in normal-
appearing tissue choline could be separately observed. In tumor tissue (G) choline signals were present and 
higher than spermine signals. Cit: citrate; Cho: choline; lip: lipids; Spm: spermine. 
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A multitransmit external body array combined 
with a 1H and 31P endorectal coil to enable 
a multiparametric and multimetabolic MRI 
examination of the prostate at 7T
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In vivo 1H and 31P magnetic resonance spectroscopic imaging (MRSI) provide 
complementary information on the biology of prostate cancer. In this work we 
demonstrate the feasibility of performing multi-parametric imaging (mpMRI) and 1H and 
31P spectroscopic imaging of the prostate using a 31P and 1H endorectal radiofrequency coil 
(ERC) in combination with a multi-transmit body array at 7 Tesla (T). 
Methods
An ERC with a 31P transceiver loop coil and 1H receive (Rx) asymmetric microstrip 
(31P/1H ERC) was designed, constructed and tested in combination with an external 
8-channel transceiver body array coil (8CH). Electromagnetic field simulations and 
measurements and in vivo temperature measurements of the ERC were performed for 
safety validation. In addition, the SNR benefit of the 1H microstrip with respect to 
the 8CH was evaluated. Finally, the feasibility of the setup was tested in one volunteer 
and 3 patients with prostate cancer by performing T2-weighted and diffusion-weighted 
imaging in combination with 1H and 31P spectroscopic imaging.
Results
Electromagnetic field simulations of the 31P loop coil showed no differences in the E- and 
B-fields of the 31P/1H ERC compared with a previously safety validated ERC without 
1H microstrip. The hotspot of the specific absorption rate (SAR) at the feed point of the 
31P/1H ERC loop coil was 9.42 W/kg when transmitting on 31P at 1 W. Additional in 
vivo measurements showed a maximum temperature increase at the SAR hotspot of 0.7 
°C over 6 minutes on 31P at 1.9 W transmit (Tx) power, indicating safe maximum power 
levels. When transmitting with the external 1H body array at 40 W for 2:30 minutes, 
the temperature increase around the ERC was less than 0.3 °C. Up to 3.5 cm into the 
prostate the 1H microstrip of the ERC provided higher SNR than the 8CH. The total 
coil combination allowed acquisition of an mpMRI protocol and the assessment of 31P 
and 1H metabolites of the prostate in all test subjects.
Conclusion
We developed a setup with a 31P transceiver and 1H Rx endorectal coil in combination 
with an 8-channel transceiver external body array coil and demonstrated its safety 
and feasibility for obtaining multi-parametric imaging and 1H and 31P MRSI at 7T in 
patients with prostate cancer within one MR examination. 





Proton magnetic resonance spectroscopic imaging (MRSI) is used to study the in vivo 
metabolic profile of the prostate by detecting and localizing the levels of citrate, choline, 
creatine and polyamines 1-4. An increase in the ratio of choline over citrate, which is partly 
attributed to increased levels of choline, has been described as a valuable biomarker to 
discriminate prostate cancer from healthy prostate tissue 5. It indicates prostate cancer 
specific changes in the phospholipid metabolism which plays an important role in cell 
membrane generation and degradation 5-8. This phospholipid metabolism can be studied 
in more detail when using 31P-MRSI to assess the levels of the phosphomonoesters (PMEs): 
phosphocholine (PC) and phosphoethanolamine (PE), and the phosphodiesters (PDEs): 
glycerophosphocholine (GPC) and glycerophosphoethanolamine (GPE) 9-11. Parts of the 
PME and PDE signals, together with resonances of free choline, free ethanolamine, taurine 
and myo-inositol, comprise the total choline (tCho) peak at 3.2 ppm in 1H spectroscopy 
11. Since 31P and 1H spectroscopy of the prostate provide complementary information 
on tumor biology, it would be of high interest to obtain both within one measurement 
session. Ideally, this would even be combined with T2-weighted (T2W) and diffusion 
weighted imaging (DWI) of the prostate, as these are paramount in accurate localization 
and characterization of potential prostate cancer lesions.
The combination of 1H and 31P spectroscopy and 1H imaging requires a radiofrequency 
(RF) coil setup with transmit (Tx) and receive (Rx) capabilities on both nuclei 12, 
preferably one in which no coils need to be exchanged during the examination. 
Because of the lower intrinsic magnetic resonance (MR) sensitivity of 31P compared to 
1H and the low concentration of 31P metabolites in the human body, 31P spectroscopy 
of the prostate is challenging. 31P MRSI should preferably be performed at 7 Tesla with 
an endorectal radiofrequency coil (ERC) to optimize signal-to-noise (SNR) and to 
increase spectral resolution. However, for T2W imaging and DWI of the prostate at 7T, 
only using an endorectal coil is inadequate. Transmitting radiofrequency pulses with a 
small local surface coil results in substantial transition bands in T2W and DWI images 
due to its severely inhomogeneous transmit profile 12,13. This can be solved by using 
a multichannel external body array in combination with B1
+ shimming to provide a 
homogeneous transmit field 13,14. Since an endorectal coil is needed for 31P, this ERC can 
also be equipped with 1H receive capabilities to enhance 1H imaging and spectroscopy 
of the prostate, increasing SNR for 1H spectroscopy and spatial resolution for T2W 
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imaging and DWI. Moreover, the 1H transmit capabilities of the external body array 
allow the use of the nuclear Overhauser effect for an extra increase in 31P SNR 15.
Therefore, we introduce and evaluate a coil setup with a 31P Tx/Rx – 1H Rx ERC in combination 
with an 8-channel external multi-transmit 1H array to enable multi-parametric imaging and 
1H and 31P spectroscopic imaging of the prostate at 7T. We perform electromagnetic field 
simulations, phantom measurements and in vivo temperature measurements to validate 
the safety of the setup. In addition, we evaluate its SNR performance and demonstrate the 
feasibility of the complete setup in 3 patients and a volunteer. 
METHODS
Subjects
One healthy volunteer (age 40 years, weight 83 kg) and three patients (age: 60, 63 
and 67 years, weight: 97, 83 and 88 kg) with histopathologically proven prostate 
cancer were measured using the setup described below. An intramuscular injection of 
butylscopolamine bromide (Buscopan, Boehringer-Ingelheim, Ingelheim, Germany) 
was used to suppress peristalsis. For all volunteer and patient measurements, informed 
consent was signed and the study was approved by the institutional review board.
Hardware
All MR measurements were performed on a 7-Tesla whole-body MRI system 
(MAGNETOM, Siemens Healthcare, Erlangen, Germany). Specific absorption rate 
(SAR) monitoring of the 1H and 31P measurements was performed with a custom 
build SAR supervision system, which measured the time-averaged input power over 10 
seconds and over 6 minutes. This input power was not to exceed the safety levels based 
on local SAR restrictions, otherwise the safety system would stop the measurement.
Combined 31P Tx/Rx and 1H Rx endorectal coil ( 31P/ 1H ERC) - The mechanical housing 
and conductors of a 3T endorectal 1H receive (Rx) coil (MEDRAD, Pittsburgh, PA) were 
disassembled and equipped with a 1H receive element and a 31P transceiver loop coil. The 
1H Rx element was placed directly on the plastic rod 16 and consisted of an asymmetric 
microstrip of length 53 mm, with a distance of 4 mm between the conducting line and 
the ground plane (Figure 1a). By rotating the conducting line with respect to the axis of 
the plastic rod, the B1
- profile was oriented in the same direction as the receive profile of 
the 31P loop coil. The coil was tuned and matched to 297.2 MHz and a series PIN diode 
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was used for detuning the microstrip during transmit with the external 1H coil. The loop 
coil was tuned and matched to 50Ω at 120.3 MHz for 31P at 7T and was mounted on 
top of the inner balloon (Figure 1) 10. In every patient measurement, after the final coil 
placement, the tuning and matching was checked using a network analyzer, as it slightly 
depends on the inflation of the inner balloon. The inner balloon was inflated using inert 
perfluoro-polyether liquid (Fomblin, Solvay Solexis, Bollate, Italy). To eliminate any 
common modes a 1H cable trap was placed directly at the cable exit of the plastic rod. 
Finally, a balun was added to the 1H Rx element at the final part of the 1H cabling in 
the plastic rod (Figure 2). The 31P transceiver loop was connected via a coaxial cable to 
a Tx/Rx switch with integrated small-band low-noise preamplifier (Ar2 Communication 
Products, Burlington US). The received signals from the 1H microstrip were routed 
through a separate coaxial cable to its own interface with integrated 1H preamplifier (Ar2 
Communication Products, Burlington US).  These electronics were used to interface the 
elements in the ERC to the MR system.  
Figure 1: 3D drawings of the endorectal coil without any balloon (a), with the inner balloon (b) and with 
the inner and outer balloon present (c). The 31P Tx/Rx loop is positioned between the balloons while the 1H 
Rx elements is attached to the rod inside the inner balloon. The corresponding photos of the actual coil are 
depicted in d, e and f. A schematic cross section of the asymmetric 1H microstrip (g) shows its orientation 
and geometry. The copper colored parts indicate the conducting line and ground plane.
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Figure 2: Schematic of the electrical circuit of the 31P/1H combined endorectal coil. Orange/brown colored 
parts indicate the copper used for the actual 1H and 31P coils. 
1H external array coil - The 1H external multi-transmit RF body coil consisted of two 
arrays containing four microstrip elements with meanders 10,17,18. The arrays were put 
ventrally and dorsally of the body. The coil channels were powered by eight 1kW 
amplifiers (LPPA 13080W, Dressler, Germany) and were connected using a separate Tx/
Rx switch. The cable length between elements and switch box was adjusted to achieve 
preamplifier decoupling during reception. 
In vivo 1H performance of  31P/ 1H endorectal coil – To evaluate the in vivo performance of 
the asymmetric microstrip 1H receive element, we performed in vivo SNR measurements 
within the prostate to compare the SNR of the ERC with the SNR of the 8-channel 
external body array (8CH). Gradient echo (GRE) imaging in transversal and sagittal 
orientation (TR = 25 ms, TE = 4.1 ms, field of view (FOV) = 261 × 380 mm2, matrix 
= 176 × 256, 3 slices, 1 average, bandwidth 241 Hz/pixel) of the healthy volunteer 
was performed with the ERC in situ, using the external body array for transmit and 
either only the 8-channel external body array or only the ERC for receive. In the 8CH 
measurements the images of the individual coil channels were added using the sum of 
squares method, after normalizing the individual images to their noise level which was 
determined within a region of interest (ROI) of air. For both measurements exactly the 
same measurement parameters were used. The SNR in pixel (x,y) of the ERC (SNRx,y,ERC) 
and 8CH (SNRx,y,8CH) measurements was determined by:






Here, σERC(8CH) is an estimate for the noise within the prostate. A region of air was used 
for this estimation to reduce the influence of physiological noise and variation. σERC(8CH)
was determined by correcting the standard deviation within the air ROI for the Rayleigh 
distribution in single channel ERC imaging and non-central chi distribution in sum-of-
squares multi-channel 8CH imaging 19,20.
The ROI placement for noise calculation was the same for both measurements. The 





The SNR ratio image was filtered by convoluting the image with a 3 x 3 voxel wide block 
function.
Safety testing of the 31P/1H endorectal coil
Before performing any patient measurements, the setup was thoroughly validated for 
safety. The SAR safety levels of the setup were in part based on the simulations and 
measurements of a previously validated design by Kobus et al. 10. They determined the 
safety levels of a 31P-only ERC in combination with the same external body array as 
used in this study. Here we added a 1H Rx-only microstrip to their 31P ERC design, 
which could influence the 31P loop coil performance. Because of the close proximity of 
the ERC to tissue, this could introduce safety concerns with respect to the maximum 
allowed 31P transmit power. To demonstrate the safety of the 31P/1H ERC, we performed 
electromagnetic field simulations of an experimental 31P/1H ERC design which we 
compared with a design similar to that of Kobus et al. 10. In addition, we performed 
electromagnetic field measurements of this experimental 31P/1H ERC to validate the 
simulation results. The safety characteristics of the 31P/1H ERC were further investigated 
by performing SAR simulations in a more realistic prostate model and by performing in 
vivo temperature measurements.
Additional phantom measurements using a network analyzer to assess coupling between 
the ERC and the external coil array are presented in the Supplemental material (S.1).
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Electromagnetic field simulations and phantom measurements - To promote reproducibility, 
the actual 31P loop coil was replaced by a stiff PCB plate with the same dimensions, in 
both simulations and measurements (Figure 3). The electromagnetic fields of 31P/1H 
ERC were analyzed by performing Finite Integration Technique (FIT) simulations (CST 
Studio Suite 2011, Darmstadt, Germany) at 120.3 MHz of a 3D model (Autodesk 
Inventor, San Rafael, USA) of the 31P/1H endorectal coil and a similar ERC without the 
1H channel (31P-only ERC) resembling the design by Kobus et al. 10. In the simulations 
of the 3D models of the coils, the coils were surrounded by a phantom fluid with a 
relative permittivity of ϵr  = 79 and a conductivity of σ = 0.47 S/m at a frequency of 
120.3 MHz. Additional measurements were performed of the 31P/1H ERC using a setup 
with field probes (Schmid & Partner Engineering AG (SPEAG), Zürich, Switzerland, 
probes H3DV7 & ES3DV2) to collect E- and B-field measurements in the sagittal plane 
in a phantom filled with liquid (ϵr =79, σ = 0.49 S/m, measured with an Agilent 85070E 
dielectric probe kit at 120 MHz). To stay within the calibration range of the probes, two 
different power settings were used: 0.01 W for the B-field and 0.05 W for the E-field 
measurements. The measurements were performed at 120 MHz in a 2D plane using a 
sampling density of one sample per 5 × 5 mm2 area. A sagittal plane of 150 × 30 mm2 
was sampled in the midline of the coil, 10 – 40 mm above the conductors. 
SAR simulations - Electromagnetic field simulations (FIT) of the 31P loop coil at 120.3 
MHz in a more realistic prostate model were performed to determine the SAR levels at 
1 W transmit power. The 31P/1H ERC was compared to the 31P-only ERC in a model 
incorporating the different surrounding tissues (Figure 4). Both were simulated with the 
actual 31P loop coil model (Figure 1). The permittivity and electric conductivity values 
were obtained from literature 21.
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Figure 3: Electromagnetic field simulations of the 31P loop coil in transmit mode of the 31 P-only (E-field: 
a, B-field: e) and the 31P/1H (E-field: b, B-field: f) ERC. The corresponding experimental measurements 
of the 31P/1H ERC (E-field: c, B-field: g) are shown as well. An overview image (d) and a picture of the 
modified PCB coil (h) show the measurement setup and the sagittal plane (blue plane) that was used to 
perform the measurements. The 3D model used for the simulations is shown in (i). X indicates the distance 
from the conductors in mm. Both the simulations and measurements were performed within the same 
plane. The feed of the coil was positioned at the bottom of the E- and B-field maps, and the top of the coil 
was positioned at the top of the maps. For the actual measurements the transparent box (d) containing the 
coil was filled with tissue simulating fluid and the loop was covered with a balloon.
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In vivo temperature measurements - In vivo temperature measurements were performed 
with the complete setup: the 31P/1H ERC in combination with the external 1H body array. 
Three thermocouples were attached to the ERC at different locations (Figure 5). One 
temperature sensor was placed at the feed point of the coil, the location of the hotspot 
in previous SAR simulation by Kobus et al. 10, and the other two sensors were attached 
to the cable to ensure no safety compromising common modes were present. The 
thermocouple at the feeding point was attached to the outer side of the external balloon 
and a thin condom was used to cover the ERC and thermocouples. The insulating 
effect of this thin latex layer was expected to be of minimal influence and was therefore 
neglected. Two different safety tests were performed. The ERC was applied as usual and 
for the first test a time-averaged input power of 1.9 W 10 was used for a duration of 6 
minutes on the 31P channel. For the second test the external 1H body array was used 
with a power of 40 W for 2:30 minutes to test for any coupling between the body array 
and the ERC.
Figure 4: SAR simulations of the 31P transceiver loop coil in transmit-mode of the 31P-only ERC (a) and 
the 31P/1H ERC (b). The ERC model with the actual 31P loop coil (Figure 1) was used for the simulations. 
The simulations were performed with a model (c) to get a realistic simulation environment (prostate: ϵr = 
72.8, σ = 0.923 S/m, ρ = 1045 kg/m3; bladder: ϵr = 22, σ = 0.297 S/m, ρ = 1035 kg/m
3; lipids: ϵr = 12.4, σ 
= 0.0694 S/m, ρ = 911 kg/m3; rectum: ϵr = 64, σ = 0.717 S/m, ρ = 1045 kg/m
3, muscle: ϵr = 64, σ = 0.717 
S/m, ρ = 1090 kg/m3).




Figure 5: In vivo transversal (a) and sagittal (b) image of the prostate of a volunteer, illustrating the standard 
endorectal coil position during prostate MR examinations. The position of the temperature sensors that 
were placed during the in vivo temperature measurements are depicted on the sagittal image (b). The 
temperature during the 31P (at 1.9 W, left graph) and 1H (at 40 W, right graph) transmit period is depicted 
for sensor 1,2 and 3 (c). The dashed lines indicate the period in which power was transmitted (6 min for 
31P and 2.5 min for 1H).
Patient measurements
To demonstrate the feasibility of the complete setup, all patient measurements were 
performed with the external body array coil for 1H transmit only and the 31P/1H ERC 
for 1H receive and 31P transmit and receive (see Supplemental Figure S-2 for a schematic 
overview of the in vivo setup). After a localizer and B0 shimming, B1
+ shimming was 
performed by using the B1TIAMO technique 22 to acquire absolute B1
+ maps and by 
maximizing the phase coherence of the individual coil channels in a ROI within the 
prostate. 1H T2-weighted imaging and diffusion-weighted imaging were then performed 
with an in-plane spatial resolution of respectively 0.43 × 0.43 mm2 and 1.75 × 1.75 
mm2. 
Proton MRSI was performed using a PRESS-like sequence with RF refocusing pulses 
that are both spectrally and spatially selective, such that the signal of a VOI is received 
only from the spectral region of interest (2.3 - 3.3 ppm) 23. 31P MRSI was performed 
using a 3D phase-encoded pulse-acquire sequence with a non-selective BIR-4 excitation 
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The nuclear Overhauser effect was used with continuous low-power irradiation of the 
water resonance to enhance 31P SNR 15. 31P MRSI data was fitted using Metabolite 
Report (Siemens Healthineers Erlangen, Germany). PE, PC, GPE and GPC were 
modeled as a triplet of 3 Gaussian peaks with a separation equal to the J-coupling 
(6 - 7.1 Hz) and amplitudes in a 1:2:1 ratio. The PCr lineshape, which was fitted with 
a single Gaussian shape, was used as a constraint to the linewidth for all signals 9. The 
spectra shown in this work were corrected for constant and linear phase, an exponential 
time filter (40 ms for 31P and 150 ms for 1H) was applied and the spectra were zero-filled 
to 2048 points. In the 31P spectra the PCr signal was referenced to 0.0 ppm and in the 
1H spectra water was referenced to 4.7 ppm. 
RESULTS 
The 31P/1H ERC was constructed according to the circuit and model specifications (Figure 
1, Figure 2) and all validations and in vivo experiments were performed successfully. 
Simulations of the B1
- profile of the 1H microstrip were performed and are shown in the 
Supplemental Figure S-1.
Safety
The electromagnetic field simulations to test the safety when transmitting at 31P showed 
no differences between the 31P-only ERC by Kobus et al. and the 31P/1H ERC proposed 
in this work (Figure 3). The hotspot with respect to the electric field in both the 31P-only 
and the 31P/1H ERC was identified at the same location at the feed point of the coil. 
Both the E- and B-field simulations corresponded well with the actual measurements of 
the 31P/1H ERC, yielding similar E- and B-field peak locations and intensities. The SAR 
simulations in the prostate tissue model also showed no substantial differences between 
the two coils. Maximum SAR10g values of 9.48 W/kg for the 
31P-only ERC and 9.42 W/
kg for the 31P-1H ERC were found at the feed point of the coil when transmitting with 
the 31P loop coil at 1 W (Figure 4).
When transmitting on 31P at 1.9 W power, the in vivo temperature measurements showed 
a maximum temperature increase of approximately 0.7 °C over 6 min at the feed point of 
the coil, converging to a plateau in the second half of the 6-minute period. The maximum 
temperature increase measured at the sensors located on the cable was less than 0.5 
°C. When transmitting with the external 1H body array at 40 W for 2:30 minutes, the 
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temperature increase was less than 0.3 °C in any of the temperature sensors, indicating that 
there is no significant coupling between the external array and the ERC (Figure 5). 
There was no evidence for significant coupling between the 1H ERC channel, the 31P ERC 
channel and the external body array in the phantom measurements with the network 
analyzer. There was also no influence when manipulating the cables (Supplemental 
material S.1 and Supplemental Table S-1).
Volunteer and patient measurements
Using the external body array for 1H transmit resulted in a homogeneous flip angle 
distribution over an ROI in the prostate of the volunteer of 78.5 ± 3.9 ° (Supplemental 
Figure S-2). In combination with the high local sensitivity of the ERC’s 1H Rx channel 
this allowed high resolution T2W and DW imaging without artefacts (Figure 7, 
Supplemental Figure S-3). The ERC’s 1H asymmetric microstrip showed improved SNR 
in the prostate of the healthy volunteer when compared with the external array, up to 
3.5 cm anterior to the ERC at the center of the microstrip and 3 cm when 20 mm 
superior or inferior to the center of the microstrip (Figure 6d and f ). In the midline 
through the ERC, 1 cm into the prostate, the SNR (mean ± standard error of the mean) 
over the center ten voxels was 316 ± 7 for the ERC microstrip and 59 ± 0.6 for the 8CH 
array. Due to the asymmetric microstrip design, the receive profile is symmetric with 
respect to and oriented towards the prostate (Figure 6c, Supplemental Figure S-1). 30 
mm anterior to the ERC, the ERC had a higher SNR than the 8CH within a range of ≥ 
30 mm in the left-right direction (Figure 6c and e).
>>
Figure 6: GRE imaging of the prostate of a healthy volunteer in transversal (a) and sagittal (b) orientation using 
the 8-channel external body array (8CH). The red circles indicate the outline of the prostate and the black 
circle indicates the outline of the seminal vesicles. The dashed lines indicate the location of the transversal and 
sagittal slice with respect to each other (a,b), the white box indicates the position of the respective colormap 
image (c,d) and the red box indicates the ROI in air that was used to estimate the noise. A map of the ratio of 
the SNR (SNRERC/SNR8CH) obtained with only the ERC’s 
1H asymmetric microstrip and only the 8CH array 
was determined and overlaid on the GRE transversal (c) and sagittal (d) imaging. The cross section of the SNR 
ratio was obtained at three different locations in the left right direction on the transversal imaging at 10, 20 
and 30 mm anterior to the endorectal coil (e). The cross section of the SNR ratio was also determined at three 
different location on the sagittal images, through the center of the ERC and 20 mm superior and inferior to 
center of the ERC (f). The natural logarithm of the SNR ratio (ln(SNRERC/SNR8CH) ) was plotted with respect 
to the location. The first pixel anterior to the ERC with actual signal was taken as x = 0 for the sagittal cross 
section and the center of the prostate was used as x = 0 in the transversal cross section. The absolute SNR of 
the ERC and the 8CH are also shown for the cross section at 10 mm anterior to the ERC on the transversal 
image (g) and for the central cross section on the sagittal image (h). 





Figure 7: T2W imaging, DWI ADC maps, 
31P MRSI spectral maps (31P) and 1H MRSI spectral maps (1H) 
of three different regions of a healthy volunteer (40 years, 83 kg): the apex, mid-prostate and the seminal 
vesicles (SV). The spectral maps of 31P MRSI were taken of the spectral region 4.6 – 8.3 ppm, showing the 
PE signal (left peak) and PC signal (right peak). In some spectra the inorganic phosphate (Pi) signal is also 
visible on the right of the spectrum. The 1H spectra are shown of the spectral region 2.3-3.6 ppm, showing 
mainly spermine (left side of the spectrum) and citrate (right side of the spectrum). 31P MRSI measurement 
set a) was used. To provide a more detailed view, four of these spectra are shown separately (Spectra), two 
for 31P (green and red) and two for 1H (yellow and blue). The location of these spectra is indicated with 
colored boxes on the spectral maps.
We were able to detect prostate cancer lesions in the three patients with the imaging 
sequences, such that voxels with 1H and 31P spectra could be localized within these 
lesions. Prostate cancer lesions were verified by MR-guided biopsy (1 patient), MR-
TRUS guided biopsy (1 patient) or TRUS biopsy and 3T clinical MRI results (1 patient). 
The ERC’s sensitivity profile was wide enough to perform T2W and DW imaging of the 
seminal vesicles, apex of the prostate and anterior regions of the prostate (Figure 7), even 
in a relatively large prostate (Supplemental Figure S-3). Due to the overlap between the 
31P and 1H sensitivity profiles ,31P spectroscopy of those regions can be obtained as well 
with sufficient SNR to measure PE and PC in a healthy volunteer or patient (Figure 7, 
Figure 8).  The 1H spectral map shows adequate SNR for citrate and spermine from apex 
to base in the prostate. The line widths achieved after B0 shimming within a VOI around 
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the prostate ranged from 30 – 60 Hz. Close to the ERC and in the seminal vesicles the 
spectral map shows wider peaks because those areas are generally harder to B0 shim 
properly. This was less noticeable in the 31P spectra due to the larger ppm difference of 
the 31P signals. For both 31P and 1H spectroscopy the signal drops anteriorly in prostate. 
31P spectroscopic imaging was obtained successfully in the volunteer and in all patients. 
PE, PC, PCr and γ- and αNTP were detectable in spectra that were located within 
the prostate. Similar to previous results 9 the PDEs were occasionally within detectable 
ranges, and if so, they were well separable (Figure 8). 1H spectroscopy showed well 
distinguishable tCho and Spm signals and also showed Cit which occasionally suffered 
from lipid contamination. High spermine signals were present in 1H spectra (Figure 8, 
Supplemental Figure S-3).
In one of the patients with a high-grade Gleason 4+4 prostate cancer lesion the GPC, 
GPE and PC levels were clearly identifiable and elevated in the spectra located within 
the cancer lesion, whereas these signals were almost absent in contralateral healthy 
prostate tissue (Figure 8). PCr, which is mostly present in muscle tissue, could serve as 
an indicator for the 31P coil sensitivity profile due to its assumed symmetric distribution 
over the prostate and nearby smooth muscles. As PCr was highest on the healthy side 
of the prostate, the GPE, GPC and PC elevations in the lesion were not caused by any 
asymmetry in the coil profile, but were due to real locally increased metabolite levels. 
The increase in 31P metabolites in tumor tissue corresponded with an elevated 1H tCho 
peak, which was absent on the contralateral side of the prostate. Other patients did 
not show detectable GPC or GPE within the cancer lesion (Supplemental Figure S-4). 
Please refer to the supplemental material (S.4) for additional patient measurements.
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Figure 8: GPC+GPE, PC+PE and PCr metabolite maps of a patient with metastatic Gleason 4+4 prostate 
cancer (67 years old, 88 kg, MR-TRUS guided biopsy) (a,b and c) overlaid over a T2-weighted image. The 
corresponding ADC map (d) is also shown, indicating a large prostate cancer lesion on the right side of the 
prostate. 1H (e,f)  and 31P (g,h) spectra are shown of the cancer lesion (red circle) as well as a location within 
healthy tissue (blue circle). 31P MRSI measurement set a) was used.




31P spectroscopic imaging of the prostate is only possible with an ERC at an ultra-
high field strength. When adding a 1H receive channel to the ERC and combining 
it with an external body array coil for 1H transmit, 31P spectroscopic imaging can be 
performed within the same MR examination as high-resolution prostate imaging and 
1H spectroscopic imaging.
Safety
To validate the safety of our setup, we used the results of previous work by Kobus et al. 
10 with a 31P Tx/Rx ERC combined with an external body coil. Their work showed no 
substantial coupling between the ERC and the external body array. Furthermore, when 
transmitting at 31P with a power of 1.9 W their simulations stayed within the SAR10g 
limit of the first level operation mode in the hotspot at the feed of the coil. 
In our proposed 31P Tx/Rx – 1H Rx endorectal coil we added a 1H receive microstrip 
to the 31P Tx/Rx ERC by Kobus et al. 10. This addition may pose safety concerns for 
the 31P transmit safety levels. We performed electromagnetic field and SAR simulations 
of both the 31P-only ERC by Kobus et al. and our proposed design with an additional 
1H microstrip and found no influence of the 1H microstrip on the simulation results 
or local hotspot locations. We also validated these results with experimental phantom 
measurements. These results indicate that we can use the SAR safety levels of Kobus et 
al. 10 for our design and that our design stays within the local SAR10g limit of first level 
operation mode when transmitting at 1.9 W on 31P. Moreover, new in vivo temperature 
measurements of the proposed 31P/1H ERC also showed a temperature increase less than 
1 °C in the local hotspot when transmitting at this power level, again indicating safe 
power levels.
In vivo measurements
Kobus et al. 10 and Lagemaat et al. 9 used a measurement setup with an external body 
array in combination with a 31P-only ERC, which allowed them to obtain imaging and 
31P spectroscopy. No 1H spectroscopic imaging was performed, as this is challenging 
without a local receive coil due to SNR restrictions. In this work we equipped the ERC 
with a 1H Rx element to substantially increase local receive sensitivity. Not only did 
this facilitate the acquisition of 1H MRSI, it also enabled high resolution T2W imaging 
and DWI with a zoomed field-of-view of the prostate. The imaging resolution was 
substantially higher than the reported spatial resolution of 0.75 × 0.75 × 3 mm3 in 
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earlier work at 7T without an ERC 24 and similar to the resolution of 0.4 × 0.4 × 3 
mm3 in earlier work at 3T with a dedicated 1H ERC 25. This resolution is possible due 
to the SNR increase that the ERC 1H microstrip offered in the prostate. Up to 3.5 
cm anterior to the ERC, the ERC has a higher SNR than the 8-channel external body 
array, which is comparable to previously published work on 1H imaging at 7T 26. When 
combined with the external body array for receive, the ERC would provide additional 
performance up to about 5 cm in the prostate (when taking the -0.5 logarithmic SNR 
ratio criterium for added benefit in Figure 6). The SNR measurements were performed 
in one healthy volunteer of average body composition and we corrected for differences 
in noise distribution between the reconstruction algorithms used, to perform a fair 
comparison. The SNR gain of the ERC with respect to a multi-channel array surely 
also depends upon the exact body composition: in larger body circumferences the 
elements of the external coil array are further away from the prostate, decreasing their 
SNR within the prostate, increasing the relative SNR contribution from the ERC over 
a larger area. The opposite holds for smaller body compositions. The overlap in the 
31P and 1H sensitivity profile of the ERC allowed combining 1H with 31P MRSI in the 
same patient, enabling us to correlate tCho signals to individual phosphorus containing 
choline signals. Because of the SNR constraints of spectroscopy, the ERC might not 
be optimal for assessing the anterior regions of (very) large prostates, as the sensitivity 
profile of an ERC drops significantly at large distances. 
Because of the increased SNR due to the use of 7T MRI in combination with the 
nuclear Overhauser effect, 31P spectroscopic imaging was obtained with high quality 
spectra in all patients, using a spectroscopic imaging method to accurately localize 
signals. Although the true voxel size was 4.9 or 9.1 cc, it allows voxel localization with 
respect to the T2W and DWI images within or covering suspicious lesions, instead of 
relying on coil profile-based localization with an unlocalized pulse sequence. Using a 
31P/1H ERC without external multi-transmit array coil also enables the acquisition of 
31P and 1H MRSI. However, one would need to revert to the use of many adiabatic RF 
refocusing pulses and T2-weighted MRI and DWI becomes particularly problematic 
with the use of only a small endorectal coil 12.
1H MRSI was also obtained with a high SNR and with well distinguishable tCho and 
Spm signals, but it suffered from lipid contamination in some cases. This is most likely 
caused by B0 inhomogeneities, the small chemical shift separation between the citrate and 
lipid signals and the spectral selectivity of the spectral-spatial pulses of the 1H spectroscopy 
sequence. 1H MRSI was performed with a corrected voxel size of 1.4 cc, enabling voxel 
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localization within or covering lesions. The spectral spatial refocusing pulses selectively 
inverted the 3.1 ppm resonance of Spm, refocusing its J-coupling at the echo time 23, 
resulting in high spermine signals that might yield additional biological information 1,27.
In the seminal vesicles an increased PC/PE ratio and a high tCho signal with an almost 
absent Spm peak were found (Supplemental Figure S-3). In one particular case (Figure 
8) with an aggressive Gleason 4+4 prostate cancer with bone metastases, increased 
levels of total choline were observed in the cancer lesion. The elevated tCho correlated 
with increases in GPE, GPC and PC levels and suggests an increased degradation of 
membrane phospholipids 7. 
Although there is a correlation between 31P and 1H choline signals, it appears as though 
the increase in 31P metabolites cannot completely account for the large difference in 
tCho levels observed between cancer and normal tissue. This indicates that also other 
overlapping signals, such as free choline, change significantly, but drawing conclusions 
about specific free choline levels may be difficult using the current setup. Due to the 
ERC profile, absolute quantification of the metabolites is difficult and necessitates the 
use of metabolite ratios or coil profile corrections to draw more quantitative conclusions. 
For 31P spectroscopy, relevant ratios would be PDE/PME, PC/PE or PE/(PDE+PME) 
9. For 1H spectroscopy tCho/Spm could be used, as tCho tends to be elevated in cancer 
lesions, whereas spermine tends to decrease in cancer tissue 27.
CONCLUSION
Using a 31P Tx/Rx 1H Rx endorectal coil in combination with an external multi-
transmit 1H body array enables high resolution multi-parametric MR imaging and 1H 
and 31P spectroscopy of the prostate at 7T. The setup does not pose any safety issues and 
provides superior 1H SNR locally in the prostate in comparison with a 1H external body 
array alone. The clinical data shown in this study is anecdotal but it illustrates how the 
proposed setup would be particularly suitable to combine anatomical and functional 
with metabolic imaging in prostate cancer. 
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S.1 31P Tx/Rx -1H Rx endorectal coil and 8-channel 1H array coil coupling 
To evaluate whether there was any coupling between the endorectal coil and the external 
body array, we determined the respective scattering parameters (S-parameters). We 
determined the S11 of the external body array for each channel with and without the 
31P/1H endorectal coil. In addition, the S21 was determined between the external body 
array and the 31P and the detuned 1H receive element of the 31P/1H endorectal coil. For 
these measurements the external body array was positioned around a body phantom 
(oval shaped; 28 × 19.5 cm and height 70 cm) filled a fluid (ϵr  = 43 and a conductivity 
of σ = 0.72 S/m at a frequency of 297 MHz). When the endorectal coil was included 
in the measurements it was placed in the center of the body phantom. All open coil 
connections were terminated with 50 Ω.
The S21 coupling coefficient between the external body array channels and the endorectal 
coil was < -53 dB for the 31P element and < -67 dB for the detuned 1H element. No 
substantial influence of the endorectal coil was found on the reflection coefficients S11 
of the external body array. There was also no influence when manipulating the cables. 
(Supplemental Table S-1). 
Supplemental Table S-1: Coupling between 31P/1H endorectal coil and external 1H body array in dB. S11 of 
1H external body array was determined with and without endorectal coil placed in the center of the setup. The 
S21 was determined between the external body array and the 
31P or 1H channel of the 31P/1H endorectal coil.
External coil channel S12
 31P  endo S12 
1H endo S11 with endo S11 without endo
1 -60 -80 -22 -22
2 -60 -70 -23 -23
3 -53 -67 -31 -36
4 -55 -70 -20 -20
5 -64 -80 -9 -9
6 -59 -70 -18 -18
7 -60 -70 -17 -17
8 -60 -80 -10 -10
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S.2 Simulations of the 1H receive asymmetric microstrip
To assess the performance of the asymmetric microstrip 1H receive element of the 
31P/1H endorectal coil, Finite Integration Technique (FIT) simulations (CST Studio 
Suite 2011, Darmstadt, Germany) of a 3D model (Autodesk Inventor, San Rafael, USA) 
of the endorectal coil at 297.2 MHz were performed. To ascertain that our practical 
approach to this coil design did not influence SNR performance when compared to 
a conventional loop design, these simulations were also performed using the model 
of the 31P/1H endorectal coil in which the microstrip was replaced by a loop coil of 
equal length and width (Supplemental Figure S-1). This would be an alternative design 
compact enough to also be installed on top of the plastic rod. This loop coil was not 
located exactly on top of the rod, but rotated 35° to optimize the orientation of the B1
- 
profile. The simulated 1H receive profile of the asymmetric coil was validated in phantom 
measurements (cylinder of diameter 85 mm) with fluid of the same permittivity and 
conductivity as in the simulations (ϵr  = 43 and a conductivity of σ = 0.72 S/m at a 
frequency of 297 MHz). Both coils were tuned and matched to 1H using fixed capacitors. 
MR-measurements were performed on a 7 Tesla animal MR system (Clinscan, Bruker 
Biospin, Ettlingen Germany). A rodent body volume coil was used for transmit and the 
asymmetric microstrip coil was used to receive the MR signal generated with a gradient 
echo (GRE) sequence. Simulations of the 31P loop coil were performed as well.
B1
- simulations of the asymmetric 1H microstrip showed a similar profile as a loop 
coil with similar dimensions. The position and rotation of the coil within the balloon, 
combined with the sensitivity profile, provided a symmetric coil profile and optimized 
SNR profile with respect to the prostate (Supplemental Figure S-1). Furthermore, the 
31P B1
- profile simulations show good overlap with the B1
- profile of the 1H microstrip. 
There is a minor mismatch at the top of the coil, where the B1
- profile of the 1H 
microstrip reaches beyond the sensitivity profile of the 31P loop coil. The 31P loop coil 
also maintains a higher sensitivity at the bottom of the ERC. As with any endorectal 
coil, for patients with very large prostates the coverage of the coil might not suffice to 
cover the complete prostate.
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Supplemental Figure S-1: B1
- simulations of the 1H Rx asymmetric microstrip (a,c,e) and a loop coil with 
similar length (b,d,f). Sagittal (e,f) as well as transversal (c,d) cross sections of the simulations are shown. 
The dashed lines in the transversal (sagittal) images indicate the cross section through which the sagittal 
(transversal) images are shown. The 1H simulations are performed with an ϵr = 43 and a conductivity of σ = 
0.72 S/m at a frequency of 297 MHz. Simulations of the B1
- profile through the same sagittal cross section 
of the 31P loop coil are shown as well (within fluid with ϵr = 79, σ = 0.49 S/m at a frequency of 120 MHz) 
(h). A transversal experimentally determined coil profile of the asymmetric microstip is shown in (g) and 
matches the location of the transversal slice in (c). The coil was oriented in the same direction as in the 
simulations.
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S.3 In vivo measurement setup and B1
+ with external body array
Supplemental Figure S-2: A schematic transversal overview of the complete in vivo measurement setup, 
including a transversal flip angle map through the abdomen (volunteer, age 40 years, weight 83 kg) when 
transmitting with the combined 8-channel coil array after B1
+ shimming. The patient is positioned on top of 
the bottom part of the 8-channel external body array. The top part of the body array is then placed on top 
of the patient. After performing the B1
+ shimming sequence, an ROI (indicated by white border) is drawn 
to indicate the location of the prostate, such that the B1
+ can be optimized for local transmit homogeneity 
within the prostate. A flip angle distribution of 78.5 ± 3.9 ° was achieved within the ROI, using a block 
pulse of 1 ms at 300V pulse voltage. The endorectal coil (ERC) is placed endorectally, close to the prostate. 
The 31P loop coil for 31P Tx and Rx and the 1H microstrip for 1H Rx are indicated.
S.4 Additonal patient examples
The seminal vesicles had a high tCho signal on 1H spectroscopy, but significantly lower 
spermine than normal prostate tissue (Supplemental Figure S-3). 31P spectroscopy within the 
vesicles showed an increased ratio of PC/PE compared to the prostate, which is also reflected 
by the metabolite map. GPC and GPE were undetectable within the seminal vesicles.
It is known that the seminal vesicles and particularly the ejaculatory ducts feature elevated 
tCho and PC levels and decreased PE signals 9. The presented case (Supplemental Figure 
S-3) confirms these results and shows an increased PC/PE ratio and a high tCho signal 
with an almost absent Spm peak. We did not detect any GPC and GPE in the seminal 
vesicles, indicating that the elevated tCho signal is in this case not related to any increases 
in GPE and GPC.
Supplemental Figure S-4 shows an additional patient example.
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Supplemental Figure S-3: Transversal T2W imaging of a patient (60 years old, 97 kg) in the seminal vesicles 
(a), the mid-prostate (b) and the apex (c) of the prostate. In addition, a coronal localizer with overlapping 
metabolite map is shown (d). The metabolite map shows the ratio of PC/PE, which was determined by 
dividing the integral of the PC peak by the integral of the PE peak. 1H (e,f) and 31P (g,h) spectra are shown 
of the locations in the correspondingly colored circles (seminal vesicles: yellow; prostate tissue: green). The 
apex T2W image shows a cancer lesion, annotated by white arrows. The localizer images were obtained with 
the body array only. 31P MRSI measurement set b) was used.
Supplemental Figure S-4: ADC map (a), T2W image (b) and 
31P MRSI spectrum (c) of a patient (63 
years, 83 kg) with prostate cancer (Gleason 3+4). The lesion identified as cancer was annotated with a blue 
circle that also indicates the location of the 31P spectrum. 31P MRSI measurement set b) was used.
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Pelvic lymph node (PLN) metastases are often smaller than 5mm and difficult to detect. 
This work presents a method to perform PLN imaging with ultra-high field MRI, using 
spectrally-selective excitation to acquire water- and lipid-selective imaging at high spatial 
resolution.
Methods
A 3D water-selective multi gradient echo (mGRE) sequence and lipid-selective GRE 
sequence were tested in six healthy volunteers on a 7T MRI system, using Time-
Interleaved-Acquisition-of-Modes (TIAMO) to improve image homogeneity. The size 
distribution of the first 10 iliac PLNs detected in each volunteer was determined, and 
the contrast-to-noise ratio (CNR) of these LNs was compared for the individual mGRE 
images, sum-of-squares echo addition and computed T2




LN imaging was acquired robustly at ultra-high field with high resolution and 
homogeneous lipid- or water-selective contrast. PLNs down to 1.5 mm short axis 
were detected with mean ± SEM short and long axes of 2.2 ± 0.1 and 3.7 ± 0.2 mm 
respectively. Computed T2
*-weighted imaging allowed flexibility in T2
*-contrast while 
featuring a CNR up to 90% of the sum-of-squares echo addition.
Conclusion
Ultra-high field MRI in combination with TIAMO and frequency-selective excitation 
enables high resolution, large field-of-view MRI of the lower abdomen and may 
ultimately be suitable for detecting small PLN metastases.




The presence of pelvic lymph node metastases is an important prognostic marker in 
gynecological, rectal and prostate cancers. In clinical situations, the detection of lymph 
node metastases is often challenging, as they are frequently smaller than 5 mm in 
size and are located deep within the body 1-3. Traditionally, the status of pelvic lymph 
nodes is assessed using surgical procedures such as pelvic lymph node dissection or 
total mesorectal excision, followed by pathologic evaluation of the harvested lymph 
nodes 4,5. These procedures are invasive and are associated with significant morbidity 6. 
Additionally, the performance of these methods depends on the surgeons’ ability to find 
and excise the right lymph nodes, which may lead to underestimation of lymph node 
involvement in patients 1. For node negative patients, this method implies an invasive 
procedure without any therapeutic benefit. Imaging modalities such as magnetic 
resonance imaging (MRI), computed tomography (CT) and ultrasonography (US) 
are non-invasive alternatives to surgery and commonly use size criteria to distinguish 
metastatic from non-metastatic lymph nodes. Size is however a poor criterion, as many 
lymph node metastases are smaller than the proposed threshold 2,3,7-9. MRI can provide 
additional information to distinguish metastatic lymph nodes from healthy ones, as it 
can assess lymph node morphology, such as heterogeneous signal intensity, irregular 
border and shape 10, or be used in conjunction with contrast agents (e.g. ultrasmall 
superparamagnetic iron oxide particles (USPIOs)). These methods enable the detection 
of lymph node metastases on other criteria than size, such that lymph node metastases 
smaller than 5 mm might become detectable if the images are acquired with high 
enough spatial resolution 1,10. Ultra-high field MRI, i.e. at 7 Tesla (T) or higher, could be 
a good candidate for providing this resolution, due to its intrinsic signal-to-noise ratio 
(SNR) gain compared to current clinical MRI systems 11. Body imaging at ultra-high 
field is however quite challenging, because its short associated RF wavelengths approach 
the dimensions of human body structures. This causes inhomogeneous B1
+ transmit 
fields, which lead to areas of signal void that impede a complete abdominal assessment. 
Several solutions, such as B1
+ shimming and parallel transmit, have been proposed to 
address these issues. These methods modulate the B1
+ field in such way that areas of 
homogeneous RF fields are obtained 12-14. However, most of these methods require 
complicated hardware and extensive calibration for every measurement, and many are 
SAR inefficient. Next to that, some of these methods can obtain high homogeneity 
locally, but need a large number of transmit channels to provide reliable homogeneity 
over a large area 15.
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One recent technical development, Time Interleaved Acquisition of Modes (TIAMO) 
16,  has opened up possibilities for routine body imaging at 7T by robustly providing 
homogeneous images over a large field of view (FOV). In this method, two images with 
two different but complementary B1
+ shimming settings are acquired in an interleaved 
fashion. These are combined into a single, homogeneous image by reconstructing them 
with the generalized autocalibrating partial parallel acquisition (GRAPPA) algorithm as 
a single acquisition obtained with twice the number of receiver channels 16,17.
Apart from obtaining homogeneous images it is important to accurately visualize the 
lymph nodes’ size and morphology as well as the relation to their surrounding tissue. 
Most lymph nodes can essentially be regarded as water containing structures located 
within lipid tissue 18. By using a pulse sequence to selectively excite water or lipids, or 
by disentangling the two from a combined acquisition (e.g. Dixon), lymph nodes can 
be visualized. With the large chemical shift dispersion between water and lipids at 7T, 
selective excitation of either of the two with short simple pulses becomes an attractive 
option. Water selective sequences could allow the detection of bright lymph nodes on 
a dark lipid background and the assessment of their relation to other water containing 
anatomical structures, while lipid selective sequences may enable the evaluation of the 
fatty hilum of the lymph nodes and the lymph nodes’ relation to the surrounding fatty 
tissue 7. 
In this study we therefore propose and evaluate a method to perform high resolution 
lymph node imaging of the lower abdomen and pelvis at 7 Tesla, using water and 
lipid selective excitation to provide multiple contrasts, and TIAMO to improve image 
homogeneity over large fields of views. 
METHODS
Subjects
Measurements of the pelvic lymph nodes were performed on 6 healthy male volunteers 
with a median age of 29 years (range 25-39 years) and weight of 80 kg (range 65-85 kg). 
Unless contraindicated, volunteers received intramuscular injections of butylscopolamine 
and glucagon just prior to the MRI exam to reduce peristaltic motion of the bowel. The 
study was approved by the local institutional review board and all subjects gave written 
informed consent prior to the MR exam.




All measurements were performed on a 7T whole body research MR system (Magnetom 
7T,  Siemens Healthcare, Erlangen, Germany) with an 8 channel 1H transceiver body-
array coil with meander-type microstrip elements 19. The body array was powered by 8 
separate 1 kW amplifiers for RF transmission, and SAR monitoring was performed with 
custom SAR monitoring hardware and software 20. TIAMO shimming was performed 
in all subjects, using a phase and amplitude RF shimming algorithm to optimize the two 
complementary B1
+ modes for root sum of squares (RSS) homogeneity 21. B1
+ shimming 
was based on a series of single-slice low flip angle Fast Low Angle Shot (FLASH) images 
of the individual coil elements with the slice positioned transversally through the pelvis. 
For comparison, one image set was obtained using a static phase-only B1
+ shimming 
approach based on an algorithm to maximize phase coherence 13.
Calibration measurements
The relationship between pulse amplitudes and the root-sum-of-squares (RSS) flip angle 
produced by the alternating B1
+ modes in TIAMO imaging is not straightforward, and 
a sufficiently accurate pulse voltage calibration method is currently lacking. Therefore, 
all 3D GRE sequences were performed using fixed pulse voltages, which were estimated 
in a separate imaging examination in a single volunteer (healthy male, height 1.78 
m, weight 80 kg).  Low resolution variants of the water- and lipid-selective sequence 
described below were used, in which the pulse voltage was varied in the range of 
60 - 100 V for the water-selective sequence and 52 - 90 V for the lipid selective sequence. 
The signal was determined by taking the average signal within regions of interest (ROI) 
drawn in muscle tissue and bladder content for the water selective measurements and 
abdominal lipid tissue for the lipid-selective sequence. The same ROIs were used across 
measurements at different pulse voltages. Based on these calibration measurements a 
pulse voltage of 60 V was used for the water-selective images and a pulse voltage of 70 V 
was used for the lipid-selective imaging in all volunteer measurements.
Imaging protocol
After a localizer and B0 and B1
+ shimming, a large FOV 3D slab-selective image set 
with a fixed pulse voltage of 230 V was acquired for an anatomical overview (FOV 
384 × 384 × 192 mm3, matrix 384 × 384 × 192, repetition time (TR) 4.1 ms, echo 
time (TE) 1.81 ms, two interleaved acquisitions for TIAMO and acquisition time 1:33 
min). Subsequently, a lipid- and water-selective sequence were performed to visualize 
the water containing lymph nodes effectively within their lipid surrounding tissue.
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Figure 1: Magnetization profile of a 970 μs block pulse centered on lipid resonance (A) and on water 
resonance (B). Water is not excited in the former case (A) and lipids are not excited in the latter case (B). 
This example is for a 10° flip angle (γB1 = 28,6 Hz).
Lipid-selective imaging was performed with a 3D GRE sequence using a 970 μs block 
pulse tailored such that the main lipid resonance (1.3 ppm) was located in the middle 
of its pass band and water was exactly at the zero crossing in the excitation profile. 
Figure 1A shows Bloch simulations of this block pulse, performed in Matlab 2015a 
(The Mathworks, Natick, MA). The images were acquired with a TE of 2.09 ms, a TR 
of 5.2 ms, bandwidth per pixel of 625 Hz and an isotropic voxel size of 0.66 × 0.66 × 
0.66 mm3 (FOV 210 × 210 × 169 mm3, matrix 320 × 320 × 256, phase oversampling 
50%) with 2 interleaved acquisitions for TIAMO and an acquisition time of 2 min and 
51 seconds. The acquisitions were GRAPPA accelerated with a factor of 2 in both phase 
encode directions.
Water-selective imaging was performed using a multi-echo 3D GRE sequence to enable 
T2
* fits of the signal. The same block pulse as in lipid-selective imaging was used, now 
tuned to the water resonance (Figure 1B). Separate images were acquired at echo times 
of 2.10, 4.19, 6.21, 8.30 and 10.32 ms with a TR of 14 ms and bandwidth per pixel of 
625 Hz, using monopolar readout gradients. Further settings were kept the same as in 
the lipid-selective imaging, resulting in an acquisition time of 8 minutes and 23 seconds. 
The FOV of the lipid- and water-selective images was placed such that it included at least 
the area from of the aortic bifurcation to the floor of the bladder in head-feet direction.
In each voxel, a monoexponential model was fitted to the signals from the 5 echoes, 
yielding estimates S0�  and S2*� of the signal magnitude at TE = 0 ms and the T2* relaxation 
rate, respectively, allowing the computation of images at arbitrary echo times. Fitting 
was performed using a weighted linear least squares (WLLS) fitting procedure with 
5 iterations implemented in Matlab 2015a, applied to the logarithm of the signal 
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magnitudes 22. This procedure was used instead of a regular Linear Least Squares (LLS) 
method to account for the signal dependent noise in the log transformed image data 22. 
Computed TE images S�TE were calculated using:
S�TE = S0� e–R2
�  ∙TE
In addition, the root-mean-square (RMS) over all echo times was calculated 23.
Image analysis
In order to estimate the minimum size of MR-visible lymph nodes, the first 10 lymph 
nodes detected near the iliac arteries and veins in each volunteer were selected using 
the water-selective computed TE image set at TE = 6.21 ms. The long and short axis 
diameters of these lymph nodes were determined on the transversal and coronal views in 
the slice through the apparent center of the corresponding lymph node.
Furthermore, to evaluate the contrast-to-noise-ratio (CNR) performance of the 
computed TE imaging, the CNR of these lymph nodes with respect to their surrounding 
tissue was determined in the acquired, computed echo time and RMS water-selective 




where SLN is the mean signal magnitude in an ROI drawn within the lymph node in such 
a way that most of the lymph node signal was included. SOLN and SDOLN are respectively 
the mean and standard deviation of the signal magnitude in an ROI drawn in the lipid 
tissue surrounding the respective lymph node. This location was chosen because noise in 
the images was not homogeneously distributed over the FOV due to the use of multiple 
receive coils, parallel imaging, and the non-linear combination of signals from multiple 
echoes. Because of the water-selective excitation the lipid tissue should not contribute 
to the signal intensity. The ROIs were drawn on the computed echo time water-selective 
images at TE = 6.21 ms in MevisLab (MeVis Medical Solutions AG, Bremen, Germany) 
by BWJP and were approved by a radiologist (ASF), and automatically transferred to all 
other images. Care was taken not to include any visible structures such as blood vessels 
in the SOLN ROIs (Figure 2). Statistical analysis of signal intensities and CNRs was 
performed using Graphpad Prism version 5 (Graphpad Software, La Jolla, CA).
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Figure 2: An example of a Lymph Node (LN) and Outside Lymph Node (OLN) ROI in an overview water-
selective image (TE = 6.21 ms, Left) and a zoomed in version of the same image (Right). The LN ROI 
was drawn within the lymph node such that most of the lymph node signal was included, while excluding 
the signal from outside the lymph node. The OLN ROI was drawn within the lipid tissue surrounding the 
lymph node, taking care to exclude lymph node or other apparent tissue signal. The OLN ROI was selected 
close to the lymph node because of the inhomogeneous distribution of noise over the image. Both ROIs 
were drawn in the slice through the apparent center of the lymph node.
RESULTS 
All measurements were completed successfully. Images of all 6 volunteers are included 
in Figures 4 to 7. The total measurement protocol including B0 and B1
+ shimming was 
performed within an average time of 35 min (range: 30 – 50 min), of which the localizer 
scans and B0 and B1
+ shimming took 18 min on average (range: 13 - 36 min). SAR 
remained < 25% of the specified limit (i.e. 10 gram average of 10 W/kg averaged over 
6 minutes) in all cases. 
A relatively constant signal intensity was observed in muscle and lipid tissue over a large 
pulse voltage range (52 - 90 V for lipid-selective imaging, 60 - 100 V for water-selective 
imaging) using the two complementary TIAMO B1
+ shim settings (Figure 3). For the 
bladder contents, the signal intensity decreased towards higher pulse voltages, indicative 
of saturation effects due to their long T1 compared to muscle or lipid tissue 25.
In the water-selective images, structures with high water content such as muscle, bladder 
and blood vessels appeared bright, whereas lipid tissue had a low signal intensity. In the 
lipid-selective images this was the other way around: lipid tissue, i.e. mesentery, had a 
high signal intensity, while water-rich structures appeared dark. The water- and lipid 
selective, and large-FOV slab-selective images all featured high image homogeneity over 
the FOV and a high spatial resolution (Figures 4-7). 
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Figure 3: Pulse calibration measurements: Average signal magnitude in three ROIs in a single volunteer 
plotted against the pulse voltage. The ROIs are located in abdominal fatty tissue for the lipid-selective 
sequence and in muscle and bladder content (urine) for the water-selective sequence.
Lymph nodes were clearly identifiable in all volunteers, and even small lymph nodes 
down to 1.5 mm were clearly distinguishable from surrounding tissue (Figure 4). The 
short axis size distribution of the 60 selected lymph nodes had a maximum at 1.5 - 2 mm 
and steeply declined below that, indicating a lower limit of about 1.5 mm for detecting 
lymph nodes using this method. This was also reflected by the CNR distribution over 
the different lymph node sizes (Table 1). For lymph nodes smaller than 1.5 mm, the 
CNR was lower than for lymph nodes with a short axis larger than 1.5 mm. This is most 
likely caused by partial volume effects in nodes of dimensions that are comparable to 
the used spatial resolution. The long axis size distribution featured a maximum at 3 mm. 
(Figure 4D). The mean±SEM (standard error of the mean) of the short and long axes of 
the detected lymph nodes were 2.2 ± 0.1 mm and 3.7 ± 0.2 mm, respectively.




CNR < 2 2 ≤ CNR < 5 5 ≤ CNR < 8 CNR ≥ 8 Mean CNR
< 1.5 0 3 2 0 4.7
≥ 1.5 and < 2.5 0 7 15 11 7.5
≥ 2.5 0 0 10 12 8.7
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Figure 4: Water- and lipid-selective images in which lymph nodes are annotated by red arrows. Several 
lymph nodes are indicated in volunteer 2 (male, age 36 years) on coronal water- and lipid-selective images 
(A). Coronal water-, transversal water- and zoomed water-selective coronal images of volunteer 5 show three 
lymph nodes of 2 - 3 mm in size within the mesorectal fatty tissue. The blue arrow indicates the lymph 
node that is shown in the transversal water-selective image (B). A zoomed-in image of a small lymph node 
of 2 mm is depicted in volunteer 4 (male, age 25 years) (C). The size distribution of the short and long axes 
of the lymph nodes used in the CNR analysis is shown in (D). To provide a better overview, the x-axis of 
the CNR analysis only shows sizes shorter than 6 mm. This included the short axis of all lymph nodes and 
the long axis of 55 of the 60 lymph nodes. The remaining long axes were 6.0, 6.5, 7.5, 8.0 and 11.0 mm.
Several artifacts were observed in the images. First, bowel motion artifacts appeared in 
the lipid- as well as the water-selective images; however, these did not influence the areas 
of interest such as the iliac veins and obturator region (Figure 5). Furthermore, signal 
dropout in the area below the femoral head occurred in some volunteers, most likely 
due to the limited size of the coil coverage (Figure 5). Finally, residual water excitation in 
the lipid-selective images resulted in a minor chemical shift readout artifact (1-2 pixels 
at 625 Hz) in some volunteers (Figure 5). This artifact was absent in the water-selective 
images.
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Figure 5: Typical water- (top) and lipid-selective (bottom) images of the pelvis at a computed echo time of 
6.21 ms in three different volunteers (6 images on the right) (all males, ages 27, 36 and 31 years respectively). 
A slab-selective image with a large FOV (384 × 384 mm2) of volunteer 2 is also shown (left). The red box 
shows the reduced FOV of the water- and lipid-selective sequences. Motion artifacts (blue arrows) as well 
as some signal dropout in the lower part of the FOV (green arrows) are observed. A slight chemical shift 
artifact can be seen in the slab-selective image (purple arrow). Because of the spectrally selective excitation 
pulse, this artifact was absent in the water-selective images and almost negligible in the lipid selective images 
(purple arrow).
Image homogeneity was degraded when using phase-only B1
+ shimming instead of 
TIAMO. Although shimmed for homogeneity over the complete FOV, the phase-only 
B1
+ shimmed images showed severe signal dropouts due to B1
+ inhomogeneities (Figure 
6B and D). The lymph node that was clearly visible in the TIAMO images (Figure 6A 
and C) was therefore missed in the phase-only B1
+ shimmed image. 
The computed echo time images showed similar contrast as the acquired water-selective 
images at the same or similar echo time, but particularly for the longer echo times, an 
increased SNR was observed (Figure 7A). This was also reflected in the quantitative 
CNR measurements, that were performed to compare the different reconstructed 
images. In the acquired images a decreasing CNR over the echo time was observed, 
whereas the computed echo time images showed an optimum CNR at an echo time 
of 6 - 7 ms. The RMS image addition featured the highest CNR. At an echo time of 
6.21 ms, the difference of the computed echo time imaging with the RMS image was 
approximately 10% (Figure 7B). The acquired echo time images were fitted well with 
the WLLS algorithm (Figure 7C). At TE = 4.19 ms the signal from lymph nodes was 
slightly lower than expected based on pure monoexponential decay, and the abdominal 
lipid tissue appeared with some signal intensity (Figure 7A, C). These effects resulted in 
a slight drop in CNR at that specific echo time (Figure 7B).  
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Figure 6: Water- (A and B) and lipid-selective (C and D) images of volunteer 5 (male, age 39 years) of a 
lymph node (red arrows) close to the left iliac vein acquired using the TIAMO method (A and C) and static 
phase-only B1
+ shimming (B and D). Due to B1
+ inhomogeneity the lymph node is not visible in the static 
phase-only B1
+ shimming approach.
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Figure 7: The computed TE water-selective images of volunteer 6 (male, age 27 years) are shown for 
different echo times (0, 2.1, 4.19, 6.21 and 10.32 ms), and are compared to the corresponding acquired 
water-selective images and the reconstructed RMS image (A). The CNR, determined by averaging the CNR 
over all lymph nodes (10 per volunteer) is depicted for the different acquired echo times, the corresponding 
computed echo times and the RMS image (B). The CNR of the RMS reconstruction in (B) is depicted as a 
constant line at mean ± SEM, to provide a reference line to compare the computed TE reconstruction with. 
The signals of all lymph nodes in all volunteers were averaged for each echo time and plotted against the 
echo time (dots) together with a WLLS fit of this signal (dashed line) (C). The blue arrows in the images of 
(A) indicate a signal increase of the abdominal lipid tissue that is only apparent in the acquired echo time 
images at echo time 4.19 ms. The green arrows denote the absence of this signal at other acquired echo times 





In this study we have shown the feasibility of high resolution 3D isotropic pelvic 
imaging over large fields of view at an ultra high magnetic field strength. The proposed 
method uses the SNR gain of ultra high field to obtain high resolution images, TIAMO 
to overcome B1
+ inhomogeneities, water- and lipid-selective excitation to provide 
different contrasts, and multi-echo GRE to allow flexibility in T2
*-weighting. Due to 
the simplicity of the water-lipid separation (a simple block pulse) and the reliability of 
TIAMO, we were able to perform this method robustly in all volunteers with a low SAR 
and a negligible chemical shift artifact.
High field MRI provided the necessary SNR to perform pelvic lymph node imaging with 
an unprecedented resolution of 0.66 × 0.66 × 0.66 mm3 within 8 and a half minutes. 
This enabled the detection of lymph nodes down to 1 mm in short axis and may allow 
in vivo assessment of intra-nodal morphology in larger lymph nodes. Although the 
TIAMO technique needs interleaved acquisitions with two different B1
+ shimming 
settings, resulting in longer acquisition times, it reliably provided the image homogeneity 
that is paramount for lymph node imaging. Conventional B1
+ shimming approaches, 
such as the static phase-only B1
+ shimming method shown, did not provide this level of 
image homogeneity and reliability. Moreover, due to the GRAPPA algorithm used for 
reconstruction, TIAMO naturally lends itself for acceleration by parallel imaging. In 
this study an acceleration factor of 2 in-plane and 2 in the 3rd direction was used. With 
the recent trend of increasing the number of receive coil elements and corresponding 
receive channels, even higher acceleration factors may be reached with low g-factor 
penalties in more advanced coil designs. 
At the moment, there is no reliable method for flip angle calibration when using TIAMO. 
We therefore relied on a fixed pulse voltage that was used in all volunteers, yielding 
satisfactory results. This can most likely be explained by the range of the T1 times of 
the tissues that are imaged and the slowly varying SNR versus flip angle relation around 
the Ernst angle in spoiled GRE sequences. Additional calibration measurements might, 
however, be beneficial when measuring subjects with strongly different physiques. The 
volunteers featured in this study were all of similar physique and are therefore expected to 
yield similar results with the same pulse voltage. Next to that, the T1 contrast generated 
by TIAMO depends on the actual flip angles generated in each individual subject 21, 
which can only be calibrated in the subject itself. So, although a fixed pulse voltage 
provided robust results in our measurements, a reliable and fast method for flip angle 
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calibration that can be used with TIAMO would further enhance the applicability of the 
method, and may allow quantitative T1-measurements.
The 3D matrices and long acquisition times used in this work increased the sensitivity 
to motion artifacts, which were indeed observed around the bowels. Nevertheless, the 
areas of interest in lymph node imaging, such as the iliac artery and vein and obturator 
area, were assessable without any significant motion artifacts. This was also the case for 
the most distal part of the mesentery, the mesorectum, which is mostly fixated to static 
anatomical structures and therefore does not suffer much from these motion artifacts. 
The FOV with the current coil setup was large enough to cover the important pelvic 
lymph node stations, including the aortic bifurcation and pre-sacral region, in one 
measurement. Depending on the type of cancer and application, the FOV might have 
to be shifted in the head-feet direction to, for example, include even the lower inguinal 
nodes, or to image para-aortic nodes in additional breath holding scans.
The computed echo time images showed a substantial increase in CNR for longer 
echo times compared to the acquired images. This is expected as computed echo time 
imaging uses the information from all the acquired images at different echo times. RMS 
reconstruction (known as Multiple Echo Recombined Gradient Echo (MERGE), Multi-
Echo Data Image Combination (MEDIC) or Merged Fast Field Echo (M-FFE)) 23, 
provided an even higher CNR than computed echo time imaging. However, the RMS 
method does not provide a pure T2
* contrast: its signal magnitude becomes increasingly 
weighted towards shorter echo times with decreasing T2
*. Computed echo time imaging 
on the other hand does feature a pure T2
* contrast, and provides flexibility because the 
echo time can be chosen and tuned after the measurement. Future patient studies are 
needed to evaluate which of these methods and which specific TE is best for detecting 
lymph node metastases.
An alternative method to obtain a high CNR would be to acquire only one echo 
time and reduce the receiver bandwidth. To provide a comparable SNR, this would 
require a bandwidth that is about a factor 5 lower, resulting in a bandwidth per pixel 
of approximately 125 Hz and total acquisition window of 8 ms. Based on Figure 7 this 
would result in a significant signal decay of more than 30% within one gradient echo 
readout, which could introduce blurring that may impede detection of the smallest LNs. 
Although the present study shows that small lymph nodes can be detected in healthy 
volunteers using the proposed method, further patient studies are needed to determine 
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its effectiveness in assessing metastatic lymph nodes, and to evaluate the additional 
clinical benefit of detecting smaller nodal metastases. One technique to detect metastases 
in small pelvic lymph nodes is the combination of our proposed method with an 
USPIO contrast agent. On T2
*-weighted water-selective images, healthy lymph nodes 
with accumulated USPIOs would appear dark, while metastatic lymph nodes would 
remain bright due to their decreased uptake of USPIOs. Due to the high resolution 
offered by ultra-high field MRI, this would allow the detection of very small lymph 
node metastases. The sensitivity to the contrast agent would be adjustable by tuning the 
echo time of computed echo time imaging to the echo time with the optimal sensitivity 
and specificity for metastatic lymph node detection. 
CONCLUSION
In summary, we have demonstrated a robust method to provide high resolution imaging 
of pelvic lymph nodes, which exploits the SNR gain and overcomes the challenges of 
large field-of-view MRI at 7T.
Acknowledgements 
Dutch Cancer Society: KUN 2014-6624




1. Fortuin AS, Deserno WM, Meijer HJ, et al. Value of PET/CT and MR lymphography in treatment 
of prostate cancer patients with lymph node metastases. Int J Radiat Oncol Biol Phys. 2012;84(3):712-
718.
2. Heesakkers RA, Jager GJ, Hovels AM, et al. Prostate cancer: detection of lymph node metastases outside 
the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology. 2009;251(2):408-
414.
3. Topor B, Acland R, Kolodko V, Galandiuk S. Mesorectal lymph nodes: their location and distribution 
within the mesorectum. Dis Colon Rectum. 2003;46(6):779-785.
4. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol. 
2009;55(6):1251-1265.
5. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic 
lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res. 2014;40(2):301-
311.
6. Musch M, Klevecka V, Roggenbuck U, Kroepfl D. Complications of pelvic lymphadenectomy 
in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006. J Urol. 
2008;179(3):923-929.
7. McMahon CJ, Rofsky NM, Pedrosa I. Lymphatic metastases from pelvic tumors: anatomic 
classification, characterization, and staging. Radiology. 2010;254(1):31-46.
8. Fortuin A, Rooij M, Zamecnik P, Haberkorn U, Barentsz J. Molecular and functional imaging for 
detection of lymph node metastases in prostate cancer. Int J Mol Sci. 2013;14(7):13842-13875.
9. Hovels AM, Heesakkers RA, Adang EM, et al. The diagnostic accuracy of CT and MRI in the staging 
of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63(4):387-
395.
10. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal 
cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 
2003;227(2):371-377.
11. Freitag MT, Breithaupt M, Berger M, et al. In vivo visualization of mesoscopic anatomy of healthy and 
pathological lymph nodes using 7T MRI: a feasibility study. J Magn Reson Imaging. 2015;41(5):1405-
1412.
12. Katscher U, Bornert P, Leussler C, van den Brink JS. Transmit SENSE. Magn Reson Med. 
2003;49(1):144-150.
13. Metzger GJ, Snyder C, Akgun C, Vaughan T, Ugurbil K, Van de Moortele PF. Local B1+ shimming 
for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase 
measurements. Magn Reson Med. 2008;59(2):396-409.
CHAPTER 6
138
14. Collins CM, Liu W, Swift BJ, Smith MB. Combination of optimized transmit arrays and some receive 
array reconstruction methods can yield homogeneous images at very high frequencies. Magn Reson 
Med. 2005;54(6):1327-1332.
15. Mao W, Smith MB, Collins CM. Exploring the limits of RF shimming for high-field MRI of the 
human head. Magn Reson Med. 2006;56(4):918-922.
16. Orzada S, Maderwald S, Poser BA, Bitz AK, Quick HH, Ladd ME. RF excitation using time interleaved 
acquisition of modes (TIAMO) to address B1 inhomogeneity in high-field MRI. Magnetic resonance in 
medicine. 2010;64(2):327-333.
17. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel 
acquisitions (GRAPPA). Magn Reson Med. 2002;47(6):1202-1210.
18. Pond CM, Mattacks CA. In vivo evidence for the involvement of the adipose tissue surrounding 
lymph nodes in immune responses. Immunol Lett. 1998;63(3):159-167.
19. Orzada S, Quick HH, Ladd ME, et al. A flexible 8-channel transmit/receive body coil for 7 T human 
imaging Paper presented at: In Proceedings of the 17th Annual Meetingof ISMRM2009; Honolulu, 
Hawaii, USA.
20. Kobus T, Bitz AK, van Uden MJ, et al. In vivo 31P MR spectroscopic imaging of the human prostate 
at 7 T: safety and feasibility. Magnetic resonance in medicine. 2012;68(6):1683-1695.
21. Orzada S, Maderwald S, Poser BA, et al. Time-interleaved acquisition of modes: an analysis of SAR 
and image contrast implications. Magn Reson Med. 2012;67(4):1033-1041.
22. Veraart J, Sijbers J, Sunaert S, Leemans A, Jeurissen B. Weighted linear least squares estimation of 
diffusion MRI parameters: strengths, limitations, and pitfalls. Neuroimage. 2013;81:335-346.
23. Martin N, Malfair D, Zhao Y, et al. Comparison of MERGE and axial T2-weighted fast spin-echo 
sequences for detection of multiple sclerosis lesions in the cervical spinal cord. AJR Am J Roentgenol. 
2012;199(1):157-162.
24. Maas MC, Futterer JJ, Scheenen TW. Quantitative evaluation of computed high B value diffusion-
weighted magnetic resonance imaging of the prostate. Invest Radiol. 2013;48(11):779-786.
25. Gold GE, Han E, Stainsby J, Wright G, Brittain J, Beaulieu C. Musculoskeletal MRI at 3.0 T: 
relaxation times and image contrast. AJR Am J Roentgenol. 2004;183(2):343-351.





USPIO-enhanced MRI of pelvic lymph nodes at 7T: 
preliminary experience
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To evaluate the technical feasibility of high resolution USPIO-enhanced magnetic 
resonance imaging of pelvic lymph nodes (LNs) at ultrahigh magnetic field strength.
Materials and methods
The ethics review board approved this study and written informed consent was obtained 
from all patients. Three patients with rectal cancer and three selected patients with 
(recurrent) prostate cancer were examined at 7T, 24 - 36 hours after intravenous 
ferumoxtran-10 administration; rectal cancer patients also received a 3T MRI. Pelvic 
LN imaging was performed using the TIAMO technique in combination with water-
selective multi-GRE imaging and lipid-selective GRE imaging with a spatial resolution 
of 0.66 × 0.66 × 0.66 mm3. T2
*-weighted images of the water-selective imaging were 
computed from the multi-GRE images at TE = 0, 8 and 14 ms and used for the 
assessment of USPIO uptake. 
Results
High-resolution 7T MR gradient-echo imaging was obtained robustly in all patients 
without suffering from RF-related signal voids. USPIO signal decay in LNs was visualized 
using computed TE imaging at TE = 8 ms and an R2
*-map derived from water-selective 
imaging. Anatomically, LNs were identified on combined reading of computed TE = 0 
ms images from water-selective scans and images from lipid-selective scans. A range of 
3 - 48 LNs without USPIO signal decay were found per patient. These LNs showed high 
signal intensity on computed TE = 8 and 14 ms imaging and low R2
* (corresponding to 
high T2
*) values on the R2
*-map.
Conclusion
USPIO-enhanced MRI of the pelvis at 7 Tesla is technically feasible and offers 
opportunities for detecting USPIO uptake in normal-sized LNs, due to its high intrinsic 
signal-to-noise ratio and spatial resolution. 




Lymph nodes often are the first organs to which cancer metastasizes. It is important 
to detect metastatic nodes at an early stage as a signal of systematic disease, such that 
adequate treatment can be provided. Prostate cancer, rectal cancer and gynecological 
cancers, the major cancers that occur within the pelvis, all metastasize primarily to pelvic 
lymph nodes 1 and their lymph node status in patients is still primarily diagnosed using 
invasive surgical techniques, such as a pelvic lymph node dissection 2. 
Given its high sensitivity (82% - 96%) and specificity (93% - 98%) 3-7, MRI in 
combination with a lymphotropic ultrasmall superparamagnetic particles of iron oxide 
(USPIO) contrast agent may be a valid non-invasive alternative for pelvic lymph node 
staging and has recently gained renewed interest 8,9. In short, intravenously administered 
USPIOs accumulate in healthy lymph nodes, strongly attenuating the MR signal in 
T2
*-weighted imaging. Suspicious lymph nodes without USPIO uptake retain their 
MR signal. Although the reported sensitivities and specificities of this technique are 
promising, they depend on study design, inclusion criteria and reader experience 5,10,11. 
Furthermore, the sensitivity decreases to 41% for lymph nodes smaller than 5 mm 4. 
These studies were performed on 1.5T MR systems in the early 2000s 4. Later work 11,12 
already showed improved image quality at 3T versus 1.5T, indicating that higher field 
strengths can improve the detection of lymph node metastases, particularly for lymph 
nodes smaller than 5 mm 13-15. Moreover, a higher spatial resolution may allow a better 
identification of lymph node resembling structures such as nerve ganglia. 
New technologies such as 7T MRI systems offer a substantial increase in intrinsic signal-
to-noise ratio (SNR) 16. Moreover, the decrease of T2
* in non-metastatic lymph nodes 
due to USPIO uptake is more pronounced at higher field strengths due to increased 
susceptibility effects 17. These effects can be used to further enhance spatial resolution 
and increase the signal difference between USPIO accumulating normal lymph nodes 
and metastatic lymph nodes retaining MR signal 18,19. 
MR imaging of the pelvis at 7T is technically challenging due to severe signal voids 
that are caused by RF transmission interferences 20. Time interleaved acquisition of 
modes (TIAMO) 21 is a method that efficiently uses two different shim settings to 
acquire two complementary images that are combined into one image with an apparent 
homogeneous RF excitation. This method has been used in combination with water- 
and lipid selective excitation to obtain high resolution 7T MR images of the pelvis in 
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healthy volunteers 19. Because imaging was performed with a low flip-angle, T2
*-sensitive 
gradient echo (GRE) sequence, this method can easily be adapted for USPIO-enhanced 
7T MR imaging without any issues with increased radiofrequency power deposition.
The aim of this paper is to demonstrate the technical feasibility of 7T high-resolution 
USPIO-enhanced MRI of pelvic lymph nodes in patients with pelvic cancers. 
METHODS
Subjects
To illustrate the technical feasibility of our method three patients with histologically 
proven prostate cancer were selected based on the presence of multiple small lymph 
nodes without USPIO uptake on their clinical 3T examination. These patients 
were asked permission to perform a 7T examination. Three additional patients with 
histologically proven rectal cancer were included before undergoing a total mesorectal 
excision and underwent 3T as well as 7T examinations (part of a larger patient trial of 
20 patients, clinical trials identifier NCT02751606). The study was approved by the 
ethics review board (CMO region Arnhem-Nijmegen and the Ethics committee of the 
Medical Faculty of the University of Duisburg-Essen) and signed informed consent was 
obtained for inclusion into the study from all patients before participation. Patients were 
excluded when contra-indications for 7T MRI (metal implants, epilepsy, abdominal 
circumference > 120cm) or USPIO contrast (any prior contrast reaction, allergy to 
dextran or ferumoxtran-10, hemochromatosis, thalassemia, sickle cell anemia) were 
present and all inclusions were performed prospectively between June 2014 and October 
2017. All patients (see Table 1 for clinical information) were scanned 24 - 36 hours 
after an intravenous infusion of USPIOs (ferumoxtran-10, which is an investigational 
product produced by Radboudumc, Nijmegen, The Netherland; from September 2015: 
SPL Medical B.V., Nijmegen, The Netherlands) 9 of 2.6 mg iron per kg of bodyweight. 
For the infusion, the USPIOs were diluted in 100 cc saline solution and administered 
over 30 minutes using a Minisart NML 0.22 µm pore size filter (Minisart NML Syringe 
Filters 16534-k; Sartorius AG, Germany). Patients were observed during and shortly 
after the 30-minute contrast administration period for adverse reactions. On the day 
of the MRI scan patients were asked whether any adverse reactions had occurred. All 
rectal cancer patients were scanned before surgical treatment. All patients received 
intramuscular smooth muscle and bowel relaxant and rectal cancer patients received a 
laxative (Table 2).















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































All 7T MRI measurements were performed on a whole-body research MR system 
(MAGNETOM 7T, Siemens Healthcare GmbH, Germany). The patients with prostate 
cancer were examined using a custom-built 8-channel transceiver (8Tx/8Rx) body-
array coil 22 and the three patients with rectal cancer were scanned using a custom-built 
combined 8-channel transmit / 32-channel receive (8Tx/32Rx) body array 23, both with 
meander-type microstrip elements 24. TIAMO shimming was performed in all subjects, 
using a phase and amplitude RF shimming algorithm to optimize two complementary 
B1
+ modes for root-sum-of-squares (RSS) homogeneity 25. For measurements with the 
8Tx/Rx coil, B1
+-shimming was based on a series of single-slice low flip angle (FA) GRE 
images of the individual coil elements with the slice positioned transversally through the 
pelvis. The 8Tx/32Rx measurements were performed using the B1TIAMO B1
+ mapping 
technique 26, which, next to relative B1
+ maps, also yielded absolute B1
+ results.
The 3T MRI scan (MAGNETOM Prisma-Fit, Siemens Healthcare GmbH, Germany) 
in patients with rectal cancer was performed with table and body phased array coils 
(Table 2).
Imaging
After a localizer, B0 and B1
+ shimming, a large field of view (FOV) 3D slab-selective 
GRE image was acquired for an anatomical overview (FOV 384 × 384 ×192 mm3, 
matrix 384 × 384 × 192, repetition time (TR) 4.1 ms, echo time (TE) 1.81 ms, RSS FA 
of 6° over 2 TRs, acquisition time 1:33 min). For water-selective imaging 5 echoes were 
acquired (referred to as ‘original images’) using a multi-gradient echo (mGRE) sequence. 
A monoexponential decay model was fitted to the signal decay across the 5 echoes for 
every pixel in these images using a Weighted Linear Least Squares (WLLS) algorithm 
19,27, yielding maps of the R2
* relaxation rate (where R2
* = 1/T2
*). The WLLS weights the 
measurement points based on their signal level to account for the non-zero mean of noise 
in magnitude images. Based on the fit results, computed echo time images (referred to as 
‘computed TE images’) were reconstructed at TEs 0, 8 and 14 ms. In addition, a lipid-
selective imaging series was performed for an additional complementary anatomical 
overview of the lower abdomen at the same spatial resolution. The FOV covered at least 
the area from the aortic bifurcation to the bottom of the urinary bladder (for prostate 




Both 3T and 7T scans were performed within the 24-36 hours timeframe after USPIO 
contrast administration, with no more than 5 hours between the start of the studies.
Image analysis
As RF transmit inhomogeneity leading to inhomogeneous FA distributions is a major 
issue in 7T body imaging, FA maps were acquired with the B1TIAMO technique to 
evaluate the individual FA distributions. We calculated the effective FA distribution 
(mean ± standard deviation (SD)) in the water- and lipid-selective imaging by 
determining the FA range within a region of interest (ROI) relevant for lymph node 
imaging.
To evaluate the T2
* signal-decay within lymph nodes, ROIs were drawn within the 
lymph nodes on the original TE = 2.1 ms images and copied to the original images at the 
other TEs. A WLLS fit of the voxel-averaged signal at different TEs within these ROIs 
was performed. To account for the Rician noise distribution of magnitude images, the 
average intensity of the noise of a nearby ROI within lipid tissue (no signal on the water-
selective images) was subtracted from each lymph node ROI signal. The uncertainty of 
the R2
* value in each node was calculated based on the fitting accuracy, and expressed as 
a standard deviation.
To provide initial descriptive findings of visible lymph nodes in the 6 patients, the 
images were evaluated by one of two radiologists (7 and 11 years of experience) to assess 
the USPIO signal decay of lymph nodes on the isotropic 3D datasets in at least two 
orientations. The lymph nodes were identified on combined reading of lipid-selective 
images and computed TE = 0 ms images of water-selective scans. Nodes were annotated 
as “without USPIO signal decay” if they retained high signal intensity on the computed 
TE = 8 ms imaging according to a “metastatic” or “possibly metastatic” pattern as 
described in Heesakkers et al. 5. The short axis of lymph nodes without USPIO signal 
decay was evaluated on the computed TE = 8 ms image by the coordinating researcher 
(B.W.J. Philips). 
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Figure 1: The TIAMO flip angle maps corresponding to the two individual B1
+ shim settings (A and B) 
and the combined root sum of squares (RSS) flip angle map (C) in patient 5 (male, 64 years old, rectal 
cancer). The white box in (C) indicates the ROI in which the flip angle distribution was evaluated. The 
two complementary shim settings produced a RSS homogenous flip angle distribution over a large FOV 
(water-selective GRE overview image example in D and E) (see also Table 2). A single axial slice (A, B, C) 
was used for B1
+ shimming (indicated by dashed line in coronal image D). The corresponding axial overview 
GRE image is depicted in (E).
RESULTS
No adverse drug reactions occurred during contrast administration and all patients 
accepted the 7T MRI scan without any complaints. We performed susceptibility-
sensitive water- and lipid-selective pelvic imaging at 7T without suffering from any 
RF related signal voids in any of the patients, using the TIAMO technique (Figure 
1). Total measurement time, including patient and RF coil positioning and calibration 
measurements, was less than one hour. Only at the superior and inferior edges of the 
large FOV images, some reduced signal was observed due to the limited size of the RF 
coil array in this dimension. Within the depicted ROI (Figure 1C) the calculated RSS 
FA over two TRs was 16.2 ± 2.8° (mean ± SD) for the water-selective imaging and 21.0 
± 3.6° for the lipid-selective imaging.
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Figure 2: Imaging at 7 Tesla of patient 1 (male, 54 years old, prostate cancer). A sagittal image is 
shown at different computed TEs (A-C), lipid selective imaging (D) and the original mGRE water-
selective imaging at TE 8.3 ms (E). In addition, a map of R2
* relaxation rates obtained from the WLLS 
fit is depicted (F). Three lymph nodes with USPIO signal decay (white circles) and one lymph node 
without USPIO signal decay (white arrow) were annotated. A sagittal overview image is also shown 
(G). The GRE signal decay of a normal LN with USPIO signal decay (annotated in images A-F with 
*) and a suspicious LN with low USPIO signal decay (annotated with #) are depicted in (H). The 
lymph node marked with (#) showed a slow signal decay with an low R2
* value of 80 ± 6 s-1, whereas 
the lymph node marked with (*) showed a fast R2
* decay with an high R2
* value of 247 ± 25 s-1. 
In addition, a lymph node is shown with homogenous high signal intensity at the computed TE = 0 ms 
image (I), that shows partial USPIO signal decay in a small region, indicated by the arrow. In this region, 
signal intensity on the TE = 8 ms image (J) is low and the R2
* values on the R2
*-map (K) are high, whereas 
the rest of the lymph node shows low USPIO signal decay indicated by high signal intensity at TE = 8 ms 
and low R2
* values.
Reading the combination of lipid series and water-selective TE = 0 ms images, lymph 
nodes with high and low USPIO signal decay could be detected. A range of 3 - 48 lymph 
nodes without USPIO signal decay were found in the 6 patients with a maximum short 
axis diameter within the range of 1.5 – 8.5 mm (Table 1). Normal lymph nodes, which 
show high USPIO uptake, appeared dark on the water-selective computed TE imaging 
at long TE due to the strong R2
* decay effectuated by the USPIOs. This resulted in high 
R2
* values on the R2
* maps. Suspicious lymph nodes, without USPIO signal decay, had 
a high signal intensity at long TE and low R2
* values, as they did not experience the 
strong R2
* effect of USPIOs. With extrapolation to TE = 0 ms, the signal intensity of 
lymph nodes with high USPIO uptake was recovered, such that computed TE imaging 
was also used for detecting normal lymph nodes (Figure 2). Computed TE images had 
a higher SNR than the original images, but similar contrast (Figure 2B and E). Lymph 
nodes that take up USPIO contrast only within a small part of the cortex could also be 
observed, as illustrated by the 4.5 mm lymph node shown in Figure 2I, J, and K, which 
shows distinct regions of high and low USPIO signal decay.
Water-selective 7T lymph node imaging was performed at a higher spatial resolution 
in a similar acquisition time compared with 3T. In the three patients with rectal cancer 
examined on 3 and 7 T, vessel and node delineation were sharper at 7T (example in 
Figure 3). The high spatial resolution at 7T enabled visualization of lymph nodes down 
to sizes of 1.5 mm short axis (Figure 4).  In the water-selective images at 3T the blood 
vessels were somewhat hyperintense due to the T1-shortening effect of  USPIO contrast 
in the blood pool.  
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Figure 3: Water- (computed TE = 8 ms) (A,C,D,E,G and H) and lipid selective imaging (B and F) at 7T 
(top) and 3T (bottom) in coronal  (A, B, E and F) and axial direction (C,D,G and H) of patient 4 (male, 
77 years old, rectal cancer). A lymph node with low USPIO signal decay and bright signal intensity is 
annotated with a white arrow, and was marked as “without USPIO signal decay”. Note particularly the 
better visibility and delineation of the pathological lymph node and other structures within the mesorectal 
area at 7T. 
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Figure 4: Coronal (A,B,C) and transversal (D) zoomed computed TE = 8 ms images at 7T of the four 
patients not depicted in Figure 2 and Figure 3. A: Patient 2 (male, 52 years old, prostate cancer). B: Patient 
3 (male, 62 years old, prostate cancer). C: Patient 5 (female, 64 years old, rectal cancer). D: Patient 6 
(female, 55 years old, rectal cancer). The images indicate a lymph node and its short-axis that was marked 
as lymph node without USPIO signal decay by a radiologist (white arrow). Note how these lymph nodes 
without USPIO signal decay, although small, are clearly visible due to bright signal and can be delineated 
well from other structures. The node identified in (D) shows signal heterogeneity, which could indicate 
partial USPIO signal decay within this node.
DISCUSSION
This work demonstrates the technical feasibility of USPIO-enhanced pelvic MRI at 
7T and shows its potential for diagnosing small lymph node metastases in patients 
with rectal cancer and prostate cancer. Our approach mitigates many of the technical 
challenges associated with 7T body imaging, enabling large FOV USPIO-enhanced 
imaging of the pelvis without any RF related signal voids.
Water-selective mGRE imaging lends itself particularly well for ultrahigh field, as it 
exploits the T2
* effect of USPIOs and can be performed at low FAs to reduce specific 
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absorption rate (SAR) issues. It can be performed reliably using the TIAMO technique 
and can already compete with our clinical protocol at 3 Tesla. It provides a higher spatial 
resolution which may allow the assessment of USPIO uptake in normal sized lymph 
nodes down to 1.5 mm in short-axis diameter or the evaluation of partial uptake within 
a lymph node. 
The B1TIAMO B1
+ mapping technique enables patient-specific flip angle calibration, 
such that a similar SNR and contrast are obtained in all patients. It shows relatively 
homogenous root-sum-of-squares FA distributions. 
A general observation of GRE imaging at 7T is the shorter overall T2
*. This is 
compensated by a shorter T2
* of lymph nodes with USPIO uptake at 7T and it may 
even lead to a contrast advantage at higher field strengths. Because this T2
* effect is field 
strength dependent, the TE should be adjusted as well to provide optimal distinction 
between normal and suspicious lymph nodes at 7 Tesla. Current literature is, however, 
inconclusive about the exact TE that should be used for optimal T2
*-weighting, reporting 
values in the range of 11 – 27 ms at 1.5T 5,28-30. Furthermore, these reported values often 
correspond to effective TEs, which are obtained by the sum of squares combination of 
several images with different TEs, resulting in ambiguous T2
* contrast. We therefore used 
computed TE imaging 19, in which a voxel-wise exponential fit is performed over the 
TEs, pooling information from all images without losing the T2
* contrast information. 
This approach allows calculation of images at arbitrary TE, so that an optimal computed 
TE for detecting lymph node metastases can be assessed retrospectively (in validation 
studies). 
As the acquisition time of the current GRE imaging protocol is about 9 minutes, bowel 
motion can cause motion artefacts despite of administration of butylscopolamine, 
rendering mesenteric lymph nodes difficult to assess. Fortunately, this did not appear 
for iliac or mesorectal lymph nodes, particularly when combined with butylscopolamine 
and bowel preparation 31. Lymph nodes in prostate and rectal cancer were therefore well 
visible.
7 Tesla MRI offers advantages in SNR and the susceptibility to USPIOs, which can 
be used to increase spatial resolution and sensitivity to USPIO-uptake compared with 
current clinical 3T MRI. Its main downside at this time is its limited availability and 
absence of a standard RF body coil configuration and standard body imaging methods. 
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This work shows preliminary observations of the use of USPIO-enhanced MRI at 7T 
in a small number of patients. Although USPIO-enhanced MRI was validated for the 
detection of pelvic lymph nodes in previous studies 5, there is not much literature on its 
validity in the small lymph nodes that are visualized with high resolution 3D MRI. The 
patients in this study, particularly those with prostate cancer, show a large number of 
small lymph nodes without USPIO signal decay. A reason for this large number of nodes 
could be our selection of prostate cancer patients with a high number of suspicious 
lymph nodes based on a clinical USPIO-enhanced MRI scan. Whether all these lymph 
nodes were indeed metastatic could not be validated in this work: no systematic follow 
up or node-to-node pathological data was available. Although lymph nodes with USPIO 
signal decay were found in all patients, we cannot be sure that our method is sensitive 
enough to visualize small quantities of USPIO uptake robustly. Moreover, as is known 
for inguinal lymph nodes 32, there could be regional differences in lymph node USPIO 
uptake. Larger patient studies with standardized radiological evaluation are therefore 
necessary to demonstrate the clinical feasibility of USPIO-enhanced MRI at 7T for 
detecting lymph node metastases, particularly in normal sized lymph nodes. To perform 
a validation on lymph nodes of this size requires a very systematic and meticulous 
correlation between imaging and pathology in a relatively large group of patients and 
is therefore not within the scope of this technical note. Another possibility would be to 
compare the results of USPIO-enhanced 7T MRI with other imaging methods such as 
PET-CT or diffusion weighted imaging (DWI). These methods, however, lose sensitivity 
for smaller lymph node metastases 33 and whole pelvis DWI at 7T is technically very 
challenging.
In conclusion, 3D large field-of-view lymph node MR imaging at 7 Tesla is technically 
feasible and permits assessing USPIO signal decay in normal sized lymph nodes 
throughout the lower abdomen in patients suffering from primary pelvic cancers. Its 
clinical effectiveness needs to be evaluated in further clinical studies. 
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In the last decade MRI has obtained a more prominent role in prostate cancer management 
and is now used in the clinic to detect significant prostate cancer. In addition to detection 
and localization, MRI is also used for staging and characterization. Although results 
reported in literature are promising, this is still performed with suboptimal techniques 
and, therefore, more advanced technologies are being investigated. Several of these, e.g. 
7 Tesla MRI, magnetic resonance spectroscopic imaging (MRSI) and USPIO-enhanced 
MRI, have shown great potential, but they have several shortcomings when applied in 
prostate cancer. For example, prostate MRSI is hampered by long acquisition times, 
31P-MRSI needs a dedicated coil setup and 7T MRI suffers from signal voids due to RF 
inhomogeneity when performing prostate or pelvic imaging. 
To deal with these shortcomings we have developed and explored the feasibility of 
several MR-hardware, MR-sequence and protocol developments in this thesis. First, we 
designed a 1H-MRSI sequence to reduce acquisition time and increase spatial resolution. 
Next, we developed the MR-hardware and scanning protocol to perform combined 
multi-parametric and metabolic imaging (1H and 31P) of the prostate at 7T. Finally, we 
developed an MR technique for pelvic imaging at 7T without signal voids to perform 
USPIO-enhanced MRI of the regional lymph nodes. In the next sections we will discuss 
the implications of this thesis, with respect to local staging and characterization of 
prostate cancer, regional staging, and 7T body imaging.
Local staging and characterization of prostate cancer
Currently, prostate MRI is often performed to prevent invasive TRUS-guided biopsies if 
no suspicious lesions are visible on the MRI-scan, and to guide these biopsies if lesions 
are present. In this setting MRI needs to be performed fast, which means that the MRI 
protocol can only contain 2 or 3 fast and reliable imaging methods. In general, diffusion 
weighted imaging (DWI), anatomical T2-weighted (T2W) imaging and dynamic 
contrast enhanced MRI (DCE) are the methods of choice. Spectroscopy and 7T MRI 
currently play no role in this particular setting.
However, MRI of the prostate is also used in other clinical contexts, such as active 
surveillance, treatment planning and follow-up. In these settings the focus of the exam 
is not on performing a fast MRI in a large population to detect potential cancer, but 
rather on a comprehensive exam, that provides as much clinically relevant information 
as possible. One of the interesting applications of MRI is its potential to discriminate 
between significant and insignificant cancer lesions 1-4. Several studies show how the 
results of multiparametric MRI correlate with the Gleason score. One of the important 
techniques that is used in these studies is 1H-MRSI, which showed to be of particular 
interest in assessing prostate cancer in the transition zone 5.
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Although spectroscopic imaging can provide additional information about tumor 
aggressiveness 6,7, it suffers from artifacts, inflexibility and long acquisition times, which 
keeps it from being incorporated into clinical MRI protocols. In chapter 3 we propose 
a semi-LASER sequence with SAR-efficient GOIA refocusing pulses combined with 
a spiral readout, to obtain robust spectroscopic imaging with improved flexibility in 
choosing imaging parameters 1,7-9. Whole-prostate 1H-MRSI with true voxel sizes in 
the order of 0.3 cc is feasible with spiral MRSI, even in large prostates. This results in a 
reduced partial volume effect, such that spectroscopic differences between healthy and 
cancerous voxels are more pronounced, particularly in smaller tumor foci. Eventually, 
this may lead to a better characterization of prostate cancer.
Spiral MRSI acquisition shows accurate localization on a clinical 3T MRI machine 
with an adequately calibrated and high performance clinical gradient system. Spiral 
trajectories can, however, suffer from spatial and temporal variations in the static 
magnetic field (B0) due to eddy currents, tissue susceptibilities, subject/physiological 
motion, and hardware instabilities. 10,11. In this work no corrections were performed for 
these issues, but several correction strategies have been proposed in literature: Bogner et 
al. 12 have for example shown how MR-navigators can be used for real-time corrections 
for motion- and scanner instability-related artifacts in spiral MRSI of the brain. 
An additional improvement in assessing prostate cancer stage and aggressiveness may be 
reached by increasing the main magnetic field strength to 7 Tesla. The increased sensitivity 
of MR at this field strength can be used to increase the spatial resolution of prostate MRI 
which may lead to improved local staging 13,14. Performing the conventional prostate 
MRI techniques on 7T is challenging due to RF field inhomogeneities. Chapter 4 shows 
how these issues can be mitigated by using a local 1H receive ERC in combination with 
an external body array, enabling a multi-parametric imaging protocol including T2W 
imaging, DWI and 1H-MRSI 14,15. 
7 Tesla MRI has also been used to explore 31P-MRSI of the prostate, showing promising 
first results. Lagemaat et al. have found that the relative levels of glycerophosphocholine 
(GPC) and glycerophosphoethanolamine (GPE) 6,16-19 increased in several patients with 
high grade prostate cancer. Although the evidence is anecdotal, these cases suggest that 
it is worth further investigating the role of 31P-MRSI in characterizing PCa. Studying 
these metabolites in vivo in patients may improve our understanding of tumor biology 
in prostate cancer, particularly the phospholipid metabolism. Moreover, the additional 
metabolic information might provide clinical biomarkers for tumor aggressiveness, 




phospholipid metabolism in response to neoadjuvant chemotherapy have been observed 
in breast cancer patients using 31P spectroscopy 20. 
In Chapter 5 we demonstrate how the work discussed in Chapter 4 can be combined 
with 31P-MRSI, by using an ERC with both a 31P transceiver loop coil and a 1H receive 
microstrip.
This enables an extensive multi-parametric (T2W and DWI) and metabolic (
1H- and 
31P-MRSI) MR protocol within one measurement session.
The protocol would be suitable to investigate the role of high spatial resolution in multi-
parametric imaging in combination with metabolic imaging. This could be studied 
in a trial including patients with high grade primary prostate cancers to investigate 
particularly the patient group in which altered GPC and GPE levels are observed and in 
which the assessment of extra-capsular extension is important. 
One limitation to the setup is that anteriorly located tumor foci may be more difficult 
to assess on 1H- and 31P-MRSI due to the drop of signal reception of the ERC in this 
region 19,21. A possible solution for 1H-MRSI could be to also use the external body array 
for signal reception 22. For 31P-MRSI no quick solution is available as both transmit and 
receive are performed with a local ERC, which both suffer from the inhomogeneous 
B1 profile. It may be necessary to develop a dual-tuned external body array to receive 
more signal from the anterior side of the prostate and to improve the homogeneity 
of the excitation profile within the prostate 23. Using an external body array for 31P 
transmission would not only deal with the inhomogeneity of the excitation profile, 
but would also obviate the need for adiabatic excitation, reducing SAR and increasing 
flexibility in choosing an optimal combination of flip angle and repetition time. 
An alternative design of the ERC is a dual-tuned loop coil as proposed by Luttje et al. 21. 
Their main reason for dual-tuning was to use the coil for transmit and receive for both 31P 
and 1H. One possible advantage of using the dual-tuned setup from Luttje et al. 21 is that it 
may provide some additional SNR in the lateral sides of the prostate. Whether it provides 
additional SNR anteriorly in the prostate requires further investigation, as the B1
- profiles 
of the loop coil and microstrip in their design do not completely overlap anteriorly 24. 
Chapter 5 also discusses how the spectral-spatial PRESS-like sequence 25 used in this 
work still occasionally suffers from substantial lipid contamination. The refocusing 
pulses in this method are both spectrally and spatially selective, but their selectivity 
profile is suboptimal. For example, the spatial profile has a rather gradual Gaussian 
shape25. Moreover, long RF pulses are needed to achieve optimal selectivity in the 
spectral domain. As an alternative, a semi-LASER approach  could be used, for example 
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by implementing SAR-efficient GOIA-WURST RF pulses for refocusing 26-28, MEGA 
pulses combined with gradient crushers for water and lipid suppression and outer 
volume saturation bands for additional lipid signal removal. This would likely require 
the use of repetition times in the order of 2-3 seconds to stay within SAR limits, which 
is still reasonable in combination with a 90° excitation pulse and it would likely result in 
more robust spectral and spatial selectivity.
Regional staging of prostate cancer
In current clinical practice, regional lymph node staging in prostate cancer is performed 
using a diagnostic pelvic lymph node dissection. Although pelvic lymph node dissections 
yield definitive results if lymph node metastases are found, they are invasive, expensive 
and can cause complications such as lymphoceles 29. Furthermore, a recent systematic 
review concluded that the therapeutic effects are not evident from literature, meaning 
they should only be performed for diagnostic purposes 30. This underlines the need for 
a non-invasive alternative for regional lymph node staging. USPIO-enhanced MRI is 
such a promising technique.
One of the prominent USPIO contrast agents, ferumoxtran-10, was withdrawn in 2009 
31 and was never approved by the FDA and EMEA due to inconclusive results in the 
pivotal trial. One large clinical study by Heesakkers et al. 32 showed, however, favorable 
results with a sensitivity in the order of 70% - 90% and specificity of 94% - 98% in 
the detection of lymph node metastases from prostate cancer 32-36. It would therefore be 
interesting to further investigate this method.
One of the limitations of previous studies was a reported loss of sensitivity with USPIO-
enhanced MRI for lymph node metastases smaller than 5 mm 34. As many lymph node 
metastases in prostate cancer are smaller than 5 mm, it is important to overcome this 
limitation 34,37-40. One of the reasons for this loss could be the lack of spatial resolution, 
either due to low in-plane resolution or due to 2D imaging with a large slice thickness. In 
this thesis we are the first to successfully present the use of 7T MRI of the whole pelvis, 
by eliminating the signal voids due to B1
+ inhomogeneity with the TIAMO technique.
We acquired images of the pelvic lymph nodes in volunteers (chapter 6) and patients 
with USPIO contrast (chapter 7) at an unprecedented spatial resolution of 0.66 × 0.66 
× 0.66 mm3. Particularly, the spatial resolution at 7T is substantially higher than the 
highest resolution of 0.85 × 0.85 × 0.85 mm3 reported for USPIO enhanced MRI at 3T 
in recent literature 31, corresponding to a reduction in voxel volume of approximately a 




Being able to assess USPIO uptake in lymph nodes this small in the entire pelvis shows 
promise to increase the sensitivity of USPIO enhanced MRI for small nodal metastases, 
while maintaining equally high specificity. This work focused mainly on feasibility and 
no pathological validation was performed to assess whether these small lymph node-
like structures without USPIO uptake in the pelvis are indeed lymph node metastases. 
USPIO-enhanced MRI has been validated histopathologically in previous research, but 
this was done over 10 years ago and did not focus on lymph nodes < 5 mm in size. Some 
anecdotal evidence is presented in this thesis suggesting these lymph nodes are indeed 
metastatic, but based on the present data we cannot draw any definitive conclusions. 
Additional histopathological validation of USPIO-enhanced-MRI at 7 Tesla needs to be 
performed in larger patient trials.
Such a trial should preferably include a meticulous and extensive node-to-node correlation 
between pathology and imaging results. Since the relevant lymph nodes are so small this 
could be challenging to perform in patients with prostate cancer, as they will be difficult 
to find and remove peri-operatively. The urologist would then need to accurately note 
where lymph nodes are removed, preferably under some form of peri-operative guidance 
41. Additionally, post-surgical MRIs should be performed to confirm or deny surgical 
removal. As an alternative, this study could be performed with a different cancer type, 
such as rectal cancer, where an en-bloc resection of the lymph node containing tissue 
is performed as primary therapy (total mesorectal excision). In this case correlation of 
imaging with ex-vivo pathology may be performed more accurately, making it more 
likely that lymph nodes found in in vivo MRI are actually removed and identified. This 
also requires a very precise approach by the pathologist, as these small lymph nodes are 
difficult to find in a large surgical specimen and thus easily overlooked.
The radiological evaluation of USPIO-enhanced MRI is generally based on assessing 
the signal intensity on a T2
*-weighted sequence. The echo time that is selected in this 
sequence plays a key role in differentiating metastatic from normal lymph nodes: a 
short echo time might underestimate USPIO uptake, whereas a long echo time might 
overestimate it. In our work we have used a multi-gradient echo sequence from which 
we estimated the R2
* and the signal intensity at TE = 0 ms. This enables the flexibility 
of calculating the images at arbitrary echo times, without having to perform additional 
measurements. Moreover, because the T2
* of USPIO based contrast agents depends on 
the main magnetic field strength 42,43, the echo time should be optimized with respect 
to field strength. The value of TE = 8 ms used in this work was based on our experience 




The algorithm used to perform the R2
* calculation in our work is an iterative procedure 
that weighs the signal points based on signal intensity. This was done to account for 
the non-zero mean of the Rician distributed noise in magnitude images, which causes 
an underestimation of the R2
* when using non-weighted estimation methods. Further 
improvements in fitting accuracy could be made by using the original complex data 
(magnitude and phase). Hernando et al. have for example used a cost function based 
method which acquired accurate T2
* fits, while also estimating the fat/water content, B0 
field map and T2
* simultaneously, based on magnitude and phase data 44.
One of the other imaging techniques for diagnosing metastases in normal-sized pelvic 
lymph nodes is 68Ga labelled PSMA PET-CT. A meta-analysis of 37 articles including 
4790 patients was performed recently by Perera et al. 45. Although the majority of the 
included articles were derived from retrospective, potentially selective single-institution 
studies, their results are promising, showing a high pooled sensitivity of 75% and 
specificity of 99% on a per-lesion analysis (not only including lesions in lymph nodes, 
but also prostate, bone and distant viscera) in advanced prostate cancer.
In PSMA PET-CT a radioactive tracer is bound to a prostate specific membrane antigen 
(PSMA) ligand. This results in a specific marker for prostate cancer, as PSMA is often 
strongly expressed on prostate cancer cells. Accumulation of this tracer in lymph nodes 
is therefore a strong indicator for the presence of a metastasis. Its main advantages are its 
high specificity 46 and its ability to detect organ or bone metastases. 
In USPIO-enhanced MRI on the other hand, the contrast is taken up by healthy lymph 
nodes, so that it can also be applied to cancers other than prostate cancer. We have also 
shown its feasibility at 7 Tesla in rectal cancer in this thesis. 
Moreover, USPIO-enhanced MRI can be performed at a greater spatial resolution. This 
thesis demonstrates the technical feasibility of assessing USPIO signal decay in lymph 
nodes down to 1 - 2 mm short axis at 7T. The actual size limit for detecting lymph node 
metastases reliably using USPIO-enhanced MRI at 7T should be further investigated 
in clinical studies, as this will likely depend on several factors, such as USPIO uptake 
differences between healthy and metastatic lymph nodes, lymph node location, motion 
artifacts and sequence parameters. Whether detecting the presence of such small lymph 
node metastases is clinically relevant is still unanswered, but their presence could 
indicate oligometastatic disease, which may need a different treatment than prostate 
cancer without or with many (large) nodal metastases 47.  
Because of recent developments in imaging methods like USPIO-enhanced MRI, and 




techniques may not remain the clinical standard for lymph node staging in prostate 
cancer for much longer. This will depend on the outcome of large clinical trials to 
investigate the clinical value of these imaging techniques in the next 5 - 10 years.
7 Tesla body MR imaging
Much of the work in this thesis was performed on an experimental 7 Tesla MRI machine. 
Clinical 7T scanners have recently become available, but thus far there are only EMA-
approved solutions for musculoskeletal and brain imaging. Many research sites have 
designed their own novel coil designs for body imaging, as vendors do not provide them 
yet. This is mostly due to the fact that body imaging technology has not fully matured 
at 7T, thus techniques to solve the RF related signal voids are still being investigated. 
In this thesis we have applied two of these methods to perform imaging of the local 
prostate and the pelvis: local B1
+ shimming and time interleaved acquisition of modes 
(TIAMO). 
Local B1
+ shimming: For the prostate, we have used a B1
+ shimming method to create 
a homogeneous excitation field locally in the prostate similar to how Metzger et al. 
performed prostate MRI at 7T by separating transmit and receive 48. This enabled T2W 
imaging, DWI and 1H-MRSI. Since the prostate is small, only a locally homogeneous 
RF field is needed, and B1
+ shimming suffices in this case. 
TIAMO: The local B1
+ shimming method is insufficient when imaging a FOV as large as 
the whole pelvis. To overcome this, we used the TIAMO method by Orzada et al. 49, which 
acquires the same image with two complementary B1
+ shimming configurations. Since 
the settings are complementary, the images add up to one homogeneous image. Although 
every image needs to be acquired twice it can be accelerated efficiently using the GRAPPA 
method and the method therefore does not necessarily increase measurement time. 
In our experience both methods perform very robustly and they allow imaging at 7T 
with image quality at least comparable to that at 3T. 
One major challenge with both these methods is that flip angle/B1
+ calibration is not 
straightforward at 7T, particularly when using variable shim settings as in TIAMO. 
Brunheim et al. have recently proposed the B1TIAMO method 50, which apart from 
the TIAMO shim settings also yields absolute B1
+ maps. The method also works in 
combination with other shim methods and it therefore provides a fast B1
+ shimming 
and flip angle calibration within one measurement. The workflow currently still 
requires transfer of data between scanner and a PC on which the shimming algorithm 
is implemented. The shimming procedure now takes about 10 minutes to perform, but 
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this could easily be reduced to within 1 minute when automated and implemented on 
the scanner.
Our results show that both local B1
+ shimming and TIAMO are robust and well suitable 
for prostate and pelvic MRI applications. Implementation of these techniques into 
commercial scanners would likely make 7T MRI applicable to a larger public. Both 
techniques could even be combined in one prostate MR examination, for example by 
performing 7T multiparametric and metabolic imaging of the prostate and USPIO-
enhanced imaging of the pelvis in one measurement session. This would enable us to 
characterize prostate cancer locally and perform regional staging within one examination. 
Another upcoming technique to solve RF related issues at 7T that may provide many 
solutions within one measurement is the Plug-and –Play MR fingerprinting (pnp-
MRF) method by Cloos et al 51. It resolves B1
+ inhomogeneities by acquiring MR 
fingerprinting 52 with different shim settings to acquire estimations of T1, T2 and B1
+. 
One interesting possibility of pnp-MRF is that it allows the estimation of several 
parameters within one acquisition. One example could be with respect to USPIO-
enhanced MRI at 7T by performing simultaneous estimation of fat/water fraction, B0-
mapping, T2
* fitting and B1
+-mapping. This would solve RF related inhomogeneities 
while also acquiring lipid/water maps and computed imaging TE imaging. As the 
method is still rather new, it currently does not provide a high spatial resolution over 
a large FOV due to the spiral k-space data acquisition, and its performance in other 
applications needs to be investigated.
To conclude, body imaging at 7 Tesla remains challenging, but its technology is evolving 
and its advantages are becoming more apparent. The work in this thesis has shown 
potential for clinical applications of 7T with respect to the local and regional staging 
and characterization of prostate cancer. Further investigating these techniques would 
be particularly interesting in patients with advanced prostate cancer where extensive 
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Prostate cancer is the second most frequent cancer diagnosis in the male population. 
Adequate management of the disease requires accurate staging and characterization 
to reduce over- and undertreatment. This thesis proposes and evaluates several novel 
magnetic resonance imaging (MRI) techniques to potentially improve staging and 
characterization of prostate cancer.
Chapter 1 and 2 introduce the current challenges in the characterization and staging of 
prostate cancer with MRI and provide a theoretical background for the MRI techniques 
used in this work. 
Chapter 3 aims to improve the spatial resolution of prostate MR spectroscopy, while 
maintaining clinically acceptable measurement times. A semi-LASER approach with 
GOIA refocusing RF pulses and spiral k-space acquisition is proposed and evaluated in 
nine patients with prostate cancer. This sequence, with a TE of 90 ms, is compared to 
a PRESS sequence, with a TE of 144 ms, using simulations and patient and phantom 
measurements. The semi-LASER sequence with spiral acquisition allowed prostate MR 
spectroscopic imaging (MRSI) within ≈ 5 min, with a quality comparable to that of the 
PRESS sequence in ≈ 9 min. This can be used to either reduce measurement time or 
enhance spatial resolution. It also allows MRSI of large prostates without a significant 
increase in measurement time.
Chapter 4 evaluates the technical feasibility of multiparametric MRI (mpMRI) of the 
prostate at a magnetic field strength of 7 Tesla. Fourteen patients with biopsy-proven 
prostate cancer underwent a 7 Tesla mpMRI with an 8-channel body-array transmit coil 
and an endorectal receive coil. The mpMRI protocol consisted of T2-weighted (T2W) 
imaging (0.3 × 0.3 × 2 mm3), diffusion weighted imaging (DWI, 1.4 × 1.4 × 2 mm3 
or 1.75 × 1.75 × 2 mm3), and 1H MRSI (real voxel size 0.6 mm3).  The overall T2W 
and DWI image quality of the mpMRI examinations was rated as fair (38% and 17% 
respectively) to good or very good (55% and 83% respectively) by two radiologists. The 
main artifacts in T2W-imaging and DWI where caused by motion and radiofrequency 
field inhomogeneities. MRSI quality was rated by a spectroscopist as fair or good in 
56% of the acquisitions, and was mainly limited by lipid contamination. These findings 
demonstrate that mpMRI of the prostate at 7T is feasible at unprecedented spatial 
resolutions for T2W-imaging and DWI and within clinically acceptable acquisition 
times for high resolution MRSI.
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In Chapter 5 a combined 31P and 1H endorectal radiofrequency coil (ERC) was developed 
and used in combination with a multi-channel transmit body array to demonstrate the 
feasibility of performing mpMRI and 1H and 31P MRSI of the prostate. Electromagnetic 
field simulations and measurements and in in vivo temperature measurements show 
the safety of the setup. Among others, a safe maximum temperature increase at the 
SAR hotspot of 0.7 °C over 6 minutes was found when transmitting on 31P at the 
proposed safety levels. In vivo measurements in one volunteer and three patients with 
biopsy proven-prostate cancer were performed to test the method’s feasibility, showing 
an increased signal to noise ratio (SNR) of the ERC when compared to the external 
body array, up to 3.5 cm in the prostate. In addition, the setup allowed acquisition of 
an mpMRI protocol including T2W-imaging, DWI and 
1H and 31P MRSI within one 
measurement session. Anecdotal findings show an increased PC/PE ratio in 31P MRSI 
in prostate cancer.
In Chapter 6 a method to perform high resolution pelvic lymph node imaging at 7 
Tesla is presented. 3D lipid selective gradient echo (GRE) imaging and water-selective 
multi-GRE imaging were performed at 7 Tesla in six healthy volunteers, using time 
interleaved acquisition of modes (TIAMO) to improve image homogeneity. The multi-
GRE images at different TEs were combined using computed T2
*-imaging derived 
from T2
*-fits. Imaging was acquired robustly at 7T with homogeneous contrast in all 
volunteers, showing lymph nodes down to a short axis size of 1.5 mm. In addition, 
computed TE imaging offered flexibility in T2
*-contrast while maintaining good SNR. 
These results indicate that pelvic lymph node imaging at 7T is feasible at high spatial 
resolution and may ultimately be suitable for detecting small lymph node metastases.
Chapter 7 focuses on demonstrating the technical feasibility of high resolution USPIO-
enhanced imaging of the pelvic lymph nodes at 7 Tesla. Three patients with rectal cancer 
and three patients with prostate cancer were examined at 7 Tesla, 24-36 hours after 
intravenous ferumoxtran-10 administration. Pelvic lymph node imaging was performed 
at a spatial resolution of 0.66 × 0.66 × 0.66 mm3 using TIAMO in combination with 
T2
*-weighted multi-GRE imaging at a computed TE of 0, 8 and 14 ms. A range of 3 - 48 
lymph nodes, down to a short axis size of 1.5 mm, without USPIO signal decay were 
found per patient. These lymph nodes showed high signal intensity on the computed 
TE = 8 ms images and low values on the R2
*-map. Due to its high SNR and spatial 




Chapter 8 discusses and explains the proposed methods and findings of this thesis with 






Prostaatkanker is de tweede meest voorkomende vorm van kanker onder mannen. 
Omdat deze aandoening meestal een traag maar soms ook een grillig ziektebeloop kent, 
is het van belang om de ziekte na diagnose goed te stadiëren en karakteriseren. In dit 
proefschrift worden nieuwe magnetic resonance imaging (MRI) technieken voorgesteld 
die de stadiëring en karakterisering van prostaatkanker in de toekomst mogelijk kunnen 
verbeteren.
Hoofdstuk 1 en 2 introduceren de huidige stand van zaken in de stadiëring en 
karakterisering van prostaatkanker en bespreken de relevante theoretische achtergrond 
van MRI.
In hoofdstuk 3 wordt een methode beschreven om, binnen klinisch acceptabele 
meettijden, het MR spectroscopie onderzoek van de prostaat te verrichten met een 
hogere spatiële resolutie. Hierbij werd de k-ruimte volgens een spiraal gevuld en werd 
er gebruik gemaakt van de semi-localized adiabatic selective refocusing (semi-LASER) 
techniek met gradient-modulated offset-independent adiabatic (GOIA) pulsen. Deze 
sequentie werd, middels simulaties en fantoommetingen, vergeleken met de point-
resolved spectroscopy (PRESS) methode. De semi-LASER sequentie met een meettijd 
van 5 minuten, had een vergelijkbare kwaliteit als de PRESS sequentie van 9 minuten. 
De methode kan daarom gebruikt worden om de meettijd van MR spectroscopische 
beeldvorming (MRSI) van de prostaat te verkorten of om de spatiële resolutie te 
verhogen. Daarnaast kan MR spectroscopie verricht worden van een prostaat met een 
groter volume, zonder de meettijd te moeten verlengen.
Hoofdstuk 4 evalueert de technische haalbaarheid van multiparametrische MRI 
(mpMRI) van de prostaat op een magnetisch veld van 7 Tesla. Het onderzoek werd 
verricht in 14 patiënten met bewezen prostaatkanker. Alle patiënten ondergingen 
een 7 Tesla mpMRI scan met een 8-kanaals body-array spoel en een endorectale 
spoel (ERC). Het mpMRI protocol bestond uit T2-gewogen beeldvorming (T2W, 
0.3 × 0.3 × 2 mm3), diffusie-gewogen beeldvorming (DWI, 1.4 × 1.4 × 2 mm3 of 
1.75 × 1.75 × 2 mm3) en proton-MRSI (ware voxel grootte 0.6 mm3).  De algemene 
kwaliteit van de T2W- en DWI-beeldvorming werd door twee radiologen beoordeeld 
als redelijk (38% en 17% respectievelijk) tot goed of zeer goed (55% en 83% 
respectievelijk). Met name beweging en inhomogeniteiten in het radiofrequente 
veld werden benoemd als aanwezige artefacten. De kwaliteit van de spectroscopische 
APPENDICES
186
beeldvorming werd door een spectroscopist beoordeeld als redelijk tot goed in 56% van 
de gevallen en werd hoofdzakelijk beperkt door storingen ten gevolge van vetsignalen. 
De resultaten tonen aan dat mpMRI van de prostaat met een hoge spatiële resolutie op 
7 Tesla mogelijk is voor T2W- en DWI-beeldvorming. Ook laat het onderzoek zien dat 
het mogelijk is om hoge resolutie MRSI te verrichten van de prostaat binnen klinisch 
acceptabele meettijden.
Hoofdstuk 5 beschrijft een methode om mpMRI en 1H en 31P MRSI van de prostaat 
te verrichten, middels een gecombineerde fosfor (31P) en proton (1H) ERC welke 
gebruikt wordt in combinatie met een multikanaals body array. Om de veiligheid 
van de opstelling aan te tonen werden simulaties, fantoom en in vivo metingen van 
het elektromagnetische veld verricht. Onder andere werd een veilige maximale 
temperatuurverhoging van 0,7 °C gevonden in de SAR hotspot na 6 minuten zenden 
op 31P met de voorgestelde veiligheidsniveaus. In vivo metingen in één vrijwilliger 
en drie patiënten met biopsie-bewezen prostaatkanker lieten een hogere signaal-
ruisverhouding (SNR) zien met de ERC dan met de externe body-array in het 
posterieure deel van de prostaat. Ook werd er in een enkele patiënt met een hooggradige 
prostaatkankerlaesie een verhoogde fosfocholine/fosfoethanolamine ratio gevonden. 
Deze methode maakt het daarom mogelijk om naast T2W- en DWI-beeldvorming, ook 
1H en 31P spectroscopie te verrichten binnen één onderzoekssessie. 
In hoofdstuk 6 wordt een methode gepresenteerd om hoge resolutie MRI-beeldvorming 
te verrichten van de pelviene lymfeklieren op 7 Tesla. 3D vet-selectieve en water-
selectieve gradiënt echo (GRE) beeldvorming werd verricht in zes vrijwilligers, waarbij 
gebruik werd gemaakt van de time interleaved acquisition of modes (TIAMO) methode 
om de beeldhomogeniteit te verbeteren. De verschillende echotijden van de multi-GRE 
water-selectieve beeldvorming werden gecombineerd om het contrast op verschillende 
echotijden te berekenen. Dit resulteerde in een robuuste methode voor homogeen 
contrast op 7 Tesla in alle vrijwilligers, waarbij lymfeklieren tot een afmeting van 1,5 
mm (korte as) zichtbaar waren. 
Hoofdstuk 7 beschrijft hoe de methode uit hoofdstuk 6 gebruikt kan worden in 
combinatie met ultrasmall superparamagnetic iron oxide (USPIO)-constrast om 
pelviene lymfekliermetastasen op te sporen. Hierbij wordt de nadruk gelegd op de 
technische haalbaarheid van de methode. Drie patiënten met een rectumcarcinoom 
en drie patiënten met een prostaatcarcinoom ondergingen in deze studie een 7 
Tesla MRI scan, 24 - 36 uur nadat een USPIO-contrastmiddel was toegediend. De 
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beeldvorming werd verricht met een spatiële resolutie van 0.66 × 0.66 × 0.66 mm3 
in combinatie met TIAMO en T2
*-gewogen GRE-beeldvorming op berekende 
TE 0, 8 en 14 ms. Per patiënt werden er 3 - 48 lymfeklieren met geen tot weinig 
USPIO-signaalverval gevonden. Deze lymfeklieren werden gekarakteriseerd door 
een hoog signaal op de berekende TE = 8ms beelden en lage waardes op de R2
*-map. 
Dit hoofdstuk laat zien dat beeldvorming van de pelviene lymfeklieren met een USPIO-
contrastmiddel op 7 Tesla haalbaar is met een hoge spatiële resolutie. De beschreven 
techniek zou in de toekomst mogelijk gebruikt kunnen worden om lymfekliermetastasen 
op te sporen.
Tot slot worden de bevindingen van dit proefschrift, met betrekking tot de stadiëring en 






1H-MRSI  proton magnetic resonance spectroscopic imaging
31P-MRSI  phosphorus magnetic resonance spectroscopic imaging
2D    2 dimensional
3D    3 dimensional
7T    7 Tesla
ADC   apparent diffusion coefficient
ATP    adenosine triphosphate
BIR    B1 insensitive pulse
B1TIAMO  B1
+
 mapping technique for TIAMO B1
+ shim calculation
BPH   benign prostate hyperplasia
Cho    choline
Cit    citrate
CNR   contrast to noise ratio
Cr    creatine
CRLB   Cramér-Rao lower bound
CT    computed tomography
DCE   dynamic contrast enhanced
DRE   digital rectal exam
DWI   diffusion weighted imaging
EPI    echo planar imaging
ERC   endorectal receive coil
FA    flip angle
FLASH   fast low angle shot
FOV   field of view
FWHM  full width at half maximum
GOIA   gradient offset independent adiabaticity
GPC   glycerophosphocholine
GPE   glycerophosphoethanolamine
GRAPPA   Generalized autocalibrating partially parallel acquisitions
GRE   gradient echo
LLS    linear least squares
LN    lymph node
MEGA   Mescher-Garwood
mGRE   multi-gradient echo
APPENDICES
190
mpMRI   multiparametric magnetic resonance imaging
MR    magnetic resonance
MRF   magnetic resonance fingerprinting
MRI   magnetic resonance imaging
MRSI   magnetic resonance spectroscopic imaging
NAA   N-acetylaspartate
NMR   nuclear magnetic resonance
NOE   nuclear Overhauser effect
NTP   nucleoside triphosphate
PA    polyamine
PCa    prostate cancer
PCB   printed circuit board
PDE   phosphodiesters
PC    phosphocholine
PCr    phosphocreatine
PE    phase encoding
PE (metabolite)  phosphoethanolamine
PET    positron emission tomography
PI-RADS  prostate imaging reporting and data system
PLN   pelvic lymph node
PLND   pelvic lymph node dissection
PME   phosphomonoesters
PRESS   point resolved spectroscopy
PSA    prostate-specific antigen
PSF    point spread function
PSMA   prostate specific membrane antigen
RF    radiofrequency
RMS   root mean square
ROI    region of interest
RSS    root sum of squares
Rx    receive
SAR    specific absorption rate
SAR10g   specific absorption rate averaged over 10g
SD    standard deviation
SEM   standard error of the mean




SNR   signal to noise ratio
Spm    spermine
T2W   T2-weighted
tCho   total choline
TE    echo time
TIAMO  time interleaved acquisition of modes
TME   total mesorectal excision
TR    repetition time
TRUS   transrectal ultrasound
TSE    turbo spin echo
Tx    transmit
US    ultrasonography
USPIO   ultrasmall superparamagnetic iron oxide
VOI    volume of interest
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